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Abstract
Toxoplasma gondii is an extremely successful parasite capable of infecting all
warm blooded animals. However, there is a wide variation between different animal
species in their vulnerability to infection, providing a fascinating opportunity for
comparative studies on the host/parasite relationship.
The main purpose of this thesis was to compare primary oral Toxoplasma
gondii infection in two animal species, sheep and cattle, which are thought to differ
in their respective vulnerability to infection. The parameters examined were the
immune responses, pathogenesis and persistence of the parasite within tissues.
The rationale behind this study was based on reports that cattle seem to be
more resistant to the outcome of Toxoplasma infection. Congenital disease is rarely
reported and cattle are thought to harbour fewer parasite tissue cysts which may not
persist for the life time of the host. Whereas in sheep, a primary infection usually
results in the host remaining chronically infected for life and may result in abortion if
primary infection occurs during pregnancy. It was hoped that these studies may
indicate the critical factors involved in controlling T. gondii infection and increase
our understanding of the events leading to persistence of the parasite within tissue
cysts in the muscles and central nervous system of infected food animals. T. gondii
tissue cysts in animal meat are an important source of infection for people, and
recrudescence of parasites within tissue cysts in the central nervous system of
immunosuppressed people, is one of the most common causes of death in AIDS
patients. Host immune responses, in particular T cells and IFNy, are known to play an
important role in determining the outcome of Toxoplasma infection. Much of the
data on host immune responses is derived from the study of laboratory mice which
are extremely vulnerable to infection. There is comparatively little data from other
animal species.
Ill
An initial experiment was conducted to determine an appropriate dose of T.
gondii oocysts which would consistently produce detectable amounts of parasite
cysts in sheep tissues. Groups of sheep were orally infected with a titrated dose of
oocysts ranging from 103 to 105 and their tissues were examined 6 weeks later at post
mortem. An infective dose of 105 sporulated oocysts gave the best result with T.
gondii parasites being detected consistently in samples of heart and brain tissues.
Two further experiments were conducted to compare T. gondii infection and host
immune response in groups of sheep and cattle which were orally infected with either
103 or 105 T. gondii oocysts. Clinical responses, humoral and cell mediated immune
responses were examined along with parasitaemia and the presence of T. gondii in
various tissues at post mortem. The most striking difference between the sheep and
the cattle was that T. gondii was more frequently and consistently detected in ovine
tissues, in particular within brain and heart tissues, whereas parasites were not
detected in the cattle samples. Although there was a marked difference in parasite
detection, negative results do not necessarily exclude the possibility of persistent
infection due to the limitations of sample size. Infection of sheep and cattle with
either a low (103) or high (105) dose of oocysts provoked no more than a mild clinical
response. The sheep developed an earlier febrile response which persisted longer than
in the cattle. T. gondii was more frequently detected in the blood of sheep and cattle
given the high dose of oocysts (105). Both, cattle and sheep, seroconverted following
oral infection with antibody titres appearing to correlate with the infective dose. The
higher the infective dose the higher the antibody titre. Specific antibody was detected
earlier in sheep given 105 oocysts compared with 104 or 103. In agreement with
previous studies on the immune response of sheep to T. gondii, an increase in the
ratio of CD8+: CD4+ T cells occurred in peripheral blood following Toxoplasma
infection. In cattle there was an early, brief increase in the percentage of CD4+ T
cells. The cytokine IFNy was more frequently detected in blood plasma samples from
cattle compared to sheep in the 3 weeks following infection with either 103 or 105
oocysts. In addition when in vivo primed peripheral blood lymphocytes were
stimulated in vitro with specific T. gondii antigen the cells from cattle showed
stronger proliferative activity which was detected more frequently compared with the
IV
sheep cells under the same conditions. There was more IFNy present in supernatants
from activated cattle cells compared to sheep cells.
It is difficult to draw any precise conclusion as to why cattle may be less
vulnerable to T. gondii infection than sheep. In general the cattle appear to be better
able to control the parasitaemia resulting in fewer T. gondii cysts being detected in
their tissues compared with sheep. Interestingly the cytokine IFNy was more
frequently detected either from plasma or activated cell supernatants in the infected
cattle compared to the sheep. This cytokine is known to play an important role in
protection against T. gondii and has been implicated as a factor involved in the
differentiation of tachyzoites to bradyzoites (tissue cyst stage). Recent data would
suggest that production of IFNy can occur via NK cells very early in infection and
that this may have a profound effect on the ability of the host to withstand infection.
Future studies should perhaps focus on local responses at the very early stages of
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Since the first description of the protozoan parasite Toxoplasma gondii by
Nicole and Manceaux in 1908, numerous studies have been carried out to better our
understanding of this parasite and its relationship with numerous intermediate hosts.
The definitive host of T. gondii is only found in members of the felidae
family, however, this coccidian has a wide range of intermediate hosts and it is
capable of infecting all warm blooded animals. The sexual stage of the life cycle only
occurs in the enteroepithelium of felids but the asexual stage (tachyzoite) is able to
infect and multiply in numerous organs within the intermediate and final host
(Frenkel, 1973).
The consequences of infection are very variable among different animal
species. The most vulnerable species include Marsupials and New World monkeys,
in which acute infection can prove fatal (Dubey et al., 1988c; Cunningham et al.,
1992). Whereas species, such as cattle, in which infection readily occurs but no
disease is provoked are comparatively more resistant (Dubey, 1986b). In species such
as humans or sheep, infection is generally unapparent in the adult host, but primary
infection during pregnancy can cause serious disease or death in the foetus (Aparicio
Garrido, 1978; Buxton, 1990). Toxoplasma infection has serious consequences in
immunocompromised individuals such as the immunologically immature foetus,
acquired immunodeficiency syndrome (AIDS) patients or people undergoing organ
transplant and are therefore in receipt of immunosuppressive drugs (Luft and
Remington, 1992).
The reasons for such a variation in species vulnerability to this protozoan
parasite are not well understood. Perhaps the more vulnerable species become
overwhelmed by the infection before the immune system is able to effectively
respond. While in species, such as sheep and humans, the parasite provokes an
effective immune response which is able to control the parasitaemia and the parasite
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differentiates into bradyzoites, which will persist in the tissues for the life time of the
host. Therefore in this case the host/parasite relationship resembles a stalemate
situation which remains for the life time of the host unless some form of
immunosuppression occurs. More resistant species such as cattle are thought to be
able to control the infection very efficiently resulting in no clinical disease in the
adult or abortion and there is controversy as to whether T. gondii persists in tissues
(Dubey, 1986b).
A review of the literature reveals the extensive work conducted in the study
of immunity to T. gondii infection largely carried out using experimentally infected
mice (reviewed by Wong and Remington, 1993 and Gazzinelli et al., 1993). While
these studies have provided comprehensive knowledge on the immune mechanisms
involved in controlling infection, one should be careful when extrapolating data
arising from studies in mice to the situation in other species due to the different
degrees of susceptibility to this parasite (Innes, 1997).
The main objective of this thesis is to compare host immune responses,
pathogenesis and the development of tissue cysts in sheep and the more resistant
species cattle following a primary oral infection with T. gondii oocysts.
It is hoped that these studies may indicate the critical factors involved in
controlling T. gondii infection and maintenance of the tissue cysts in the muscles and
central nervous system of infected animals. T. gondii tissue cysts in animal meat are
not only an important source of infection for people, but recrudescence of such tissue
cysts in the central nervous system of immunosuppressed people with Toxoplasma






2.1 Toxoplasma gondii; historical background
Toxoplasma gondii is an intestinal coccidian of felids with a world-wide
distribution, affecting most warm-blooded animals, including man. T. gondii was
first isolated in a rodent, Ctenodactylus gundi, in 1908 by Nicolle and Manceaux
(1908). Charles Nicolle from the Pasteur Institute of Tunis, explored infantile
splenomegaly already described in India as kala-azar, and the Oriental sore locally
known as Gafsa pimple. He succeeded in establishing cultures of Leishmania
parasites, and then embarked on an experimental and epidemiological study of the
disease. Suspecting that rodents played the same role in the oriental sore as dogs did
in the kala-azar, he captured rodents (gondi) in the Djerid desert. In two gondis which
died and showed splenomegaly upon post-mortem examination, Nicolle and
Manceaux (1908) observed parasites both free and within mononucleate cells.
Because of its similarity with Leishmania spp, it was known as Leishmania gondii.
However, the following year the name Toxoplasma was suggested for a new genus,
different from Leishmania as the new parasite did not have a centrosome, and from
the Piroplasma as Toxoplasma replicated in the white cells (Nicolle and Manceaux,
1909). Toxoplasma gondii was born. The name derived from the Greek toxon, bow or
arc, referring to the lunate shape of the extracellular tachyzoite.
Splendore (1908) described the parasite in a laboratory rabbit (Oryctolagus
cuniculus) in Sao Paulo in the same year, calling it Toxoplasma cuniculi (Splendore,
1909). Although Nicolle and Manceaux's and Splendore's descriptions agreed about
the kidney-shaped and asymmetric morphology of the parasite, they differed on two
points. Splendore identified schizogony or "multiple endogenous division",
considering that the parasite formed true cysts, while Nicole and Manceaux denied
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formation of a real wall and mentioned only simple artifacts resulting from the
destruction of the host cell.
2.1.1 Toxoplasmosis in humans
Darling (1908) described what could be the first case of Toxoplasma infection
in man in Panama although it was not until 1923 that the first case of toxoplasmosis
was recognised in humans when Jankii (cited by Dubey and Beattie, 1988) found the
parasite in the retina of a hydrocephalic child. In 1937, Wolf and coworkers
described congenital Toxoplasma infection in the human neonate confirming the
parasite as an important human pathogen. In the following years, Pinkerton and
Weinman (1940) described the first case of fatal toxoplasmosis in adult human
patient and Sabin defined the four characteristic symptoms of congenital
toxoplasmosis: retinochoroiditis, cerebral calcification, hydrocephalus and mental
retardation (Sabin, 1941). In the early 1950's the ocular form of toxoplasmosis in
humans was claimed to be a consequence of congenital infection (Hogan, 1951). This
was confirmed by Feldman (1952).
2.1.2 Toxoplasmosis in domestic animals
The first case of toxoplasmosis in domestic animals was reported in 1910,
when Mello described a fatal case in a 4-month-old dog. He named the parasite
described as Toxoplasma canis (Mello, 1910). However, owing to the similar
morphology of T. gondii and Neospora caninum, perhaps this was the first case of
neosporosis, which is now recognised to be a major cause of disease in puppies and
young dogs. In the 1950's T. gondii was recognised as a significant cause of abortion
in sheep by Hartley and Marshall (1957) and subsequently also in goats by Munday
and Mason (1979), and pigs by Cole and associates (cited by Dubey, 1990).
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2.1.3 Transmission and life cycle
As T. gondii was found in the blood, Chatton and Blanc (1917) suspected that
the parasite may be transmitted via an arthropod vector. This group in Tunisia, as
well as Woke and coworkers in USA, investigated transmission by arthropods,
without success (Chatton and Blanc, 1917; Woke et al., 1953). Transmission by the
ingestion of the undercooked meat was suggested by Weinman and Chandler in
1954. This hypothesis of transmission through the ingestion of infected meat was
experimentally verified in children in a tuberculosis hospital in Paris in 1965 by
Desmont and collaborators. They compared the acquisition rates of T. gondii
infection in children with tuberculosis before and after admission to the sanitarium,
they found that acquisition of T. gondii rose after adding either barely cooked or
undercooked meat to their diet. Later, Kean and collaborators (1969) described
toxoplasmosis infection in medical students at Cornell University (Ithaca, New
York), who ate undercooked hamburgers. The idea of transmission through infected
meat was supported by the studies of the resistance of tissue cysts containing T.
gondii bradyzoites to proteolytic enzymes, which would be present in the gut of the
intermediate host (Jacobs et al., 1960b). However, congenital transmission and
carnivorism did not explain the fact that T. gondii seroprevalence rates in vegetarians
were similar to those in non vegetarians (Desmonts et al., 1965).
Clearly there was another route of transmission. Hutchison, (1965) put
forward the theory that T. gondii was transmitted with the egg of the nematode
Toxocara cati. However, this theory was invalidated when Toxoplasma infectivity
was found in faeces of worm-free cats fed T. gondii (Frenkel et al., 1969; Sheffield
and Melton, 1969). Finally, the complete life cycle of T. gondii was described in
1970 following the discovery of the sexual life cycle of the parasite in the small
intestine of the cat. Several groups described this cycle around the same time and




Studies of the host-parasite relationship were first reported in 1937 when
Sabin and Olitsky demonstrated that mice and rabbits experimentally inoculated with
parasites and immune serum did not develop the infection. Since then most of the
studies on immune responses to T. gondii have taken place using murine infection
models and they have demonstrated that cell-mediated immune mechanisms are
important in protective immunity (Beaman et al., 1992; Gazzinelli et al., 1993;
Subauste and Remington, 1993). Specific antibodies to T. gondii are useful for
diagnostic purposes. This was originally demonstrated with the development of the
methylene blue "dye test" for detection of Toxoplasma specific antibodies described
by Sabin and Feldman in 1948.
2.2 Life cycle
Toxoplasma gondii is an obligate intracellular parasite included in the phylum
Apicomplexa, class Sporozoa and subclass Coccidia (Levine et al., 1980). Although
T. gondii is the only species in the genus Toxoplasma, Isospora, Eimeria, Neospora
and Sarcocystis are other cyst-forming coccidia members of the same order.
In brief, the life cycle comprises two stages; sexual cycle, (endodyogeny,
endopolygeny, schizogony and gametogony) restricted to the epithelium of the small
intestine of the cat (definitive host), and an asexual cycle (tachyzoites and
bradyzoites) occurring in the intermediate hosts exhibiting little host or cellular
specificity (Figure 2. 1).
2.2.1 Asexual cycle
Following the ingestion of contaminated food and water that contains any of
the infectious stages of T. gondii: either tissue cysts (containing bradyzoites) or
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oocysts (containing sporozoites), infection of the host occurs as a result of asexual
multiplication of the parasite. The asexual cycle takes place in virtually all warm
blooded animals including man, although there is considerable variation amongst
different host species concerning the severity and consequences of the infection
(Dubey and Beattie, 1988; Innes, 1997). Following ingestion, the outer walls of cysts
or oocysts are disrupted by enzymatic degradation and the infective phases
(bradyzoites or sporozoites) are liberated in the lumen of the intestine. They rapidly
invade and multiply within surrounding cells, where they become tachyzoites. The
parasite actively penetrates the host cells, becomes surrounded by a parasitophorus
vacuole and multiplies by a process called endodyogeny (Joiner at al., 1990).
Multiplication continues until the host cell ruptures and the organisms are released to
invade contiguous cells. Dissemination of the parasite occurs via the blood and
lymphatic vessels. T. gondii can invade virtually all cells and tissues of the body
(Krahenbuhl and Remington, 1982).
Figure 2. 1 The life cycle of the intracellular protozoan parasite T. gondii
asexual cycle sexual cycle
all warm blooded animals









The tachyzoite is the invasive rapidly dividing stage of the parasite
responsible for the acute infection. It is crescent shaped with its anterior end pointed
and its posterior end rounded and is approximately 7x3|lm in size (Figure 2. 2).
Although they are eukaryotic cells and contain Golgi apparatus, ribosomes and
mitochondria, T. gondii require an intracellular habitat for survival and
multiplication. They can infect phagocytic and non-phagocytic, nucleated and non
nucleated cells (Werk, 1985).
Figure 2. 2 Crescent-shaped T. gondii tachyzoites in a cell free suspension
Photograph courtesy of Dr. D. Buxton
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Tachyzoites are coated with three unit membranes forming the pellicle. The
outer membrane is continuous, while the inner two membranes are closely opposed,
discontinuous and end at the anterior and posterior ends in structures known as polar
rings (Sheffield and Melton, 1968). The subpellicular cytoskeleton is composed of 22
microtubules that stretch from the anterior polar ring, running almost the length of
the entire cell (Sheffield and Melton, 1968). The conoid, situated within the anterior
end of the parasite, is composed of a truncated cone of spiral wound fibers. This
structure is projected outwards during the parasite entry into host cells (Aikawa et al.,
1977). The four to eight rhoptries are club-shaped organelles that terminate in the
conoid and have a secretory function (Schwartzman, 1986). The micronemes are
tubular structures situated close to the rhoptries and are thought to have a secretory
function. Current evidence would suggest that the conoid and rhoptries are involved
in cell penetration (Chiappino et al., 1984). Dense granules are organelles distributed
throughout the cytoplasm and their contents are released into the protein-rich,
reticulate network in the parasitophorous vacuole. Proteins from the dense granules
are also released into the external environment defined as excretory/secretory
antigens (Leriche and Dubremetz, 1990).
The parasite at this stage is contained inside the parasitophorous vacuole
within the host cell and in this way is able to survive the normal hostile environment
of the cell. This is because the parasitophorous vacuole neither fuses with lysosomes
of the host nor does it become acidic (Joiner and Dubremetz, 1993).
2.2.1.2 Bradyzoites within the tissue cyst
Rapid multiplication of the parasite as tachyzoites continues until the host
develops immunity to the parasite or in some cases the host dies. Thereafter a
persistent infection is established, extracellular parasites are eliminated, intracellular
multiplication slows down and the parasite accumulates in tissue cysts as bradyzoites.
Bradyzoites are the slow multiplying forms of T. gondii, similar in size and shape to
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the tachyzoites, and constitute the persistent stage of the parasite characteristic of the
chronic (latent) infection (Figure 2. 3).
Figure 2. 3 Brain of a mouse showing bradyzoites within the tissue cysts. Parasites are labelled using an
indirect immunofluorescence stain ( = 50pm)
Photograph courtesy of Dr. D. Buxton
T. gondii parasites differentiate from the tachyzoite stage to the bradyzoite
stage within the compartment created by the parasitophorous vacuole, which converts
itself into a cyst. The bradyzoite is the stage that can initiate the sexual cycle in the
gut of the cat (Dubey and Frenkel, 1976; Wong and Remington, 1993). Bradyzoites
express stage-specific antigens which will allow discrimination between bradyzoites
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and tachyzoites which are morphologically very similar (Kasper, 1989; Tomavo et
al., 1991). In the early stages of differentiation from tachyzoites to bradyzoites T.
gondii parasites express both tachyzoite and bradyzoite specific antigens, indicating
that this process does not occur simultaneously within a tachyzoite population (Soete
et al., 1993). Unlike tachyzoites, bradyzoites have a higher content of micronemes
and amylopectin granules (Ferguson and Hutchison, 1987) and are relatively more
resistant to pepsin and trypsin than tachyzoites, making them able to resist the
digestive processes upon ingestion, despite the immediate disruption of the cyst by
the enzymes (Jacobs and Melton, 1957; Jacobs et al., 1960b).
The mechanisms involved in the transformation of the actively dividing
tachyzoite to the slowly dividing stage, bradyzoite, are unknown. Using stage-
specific monoclonal antibodies, the kinetics of conversion into bradyzoites has been
analysed in vitro by several research groups (Jones et al., 1986; Lindsay et al., 1991;
McHugh et al., 1994). Spontaneous transformation from tachyzoites to bradyzoites
has been observed in cell cultures, leading to the formation of tissue cysts. The
conversion has been described as a gradual process, with a sequential expression of
stage-specific molecules and gradual morphological conversion (Gross et al., 1996).
However, experiments conducted on differentiation in vitro have also shown that
conversion from tachyzoite to bradyzoite stage can be induced by several immune
factors (interferon gamma (IFNy), nitric oxide) and metabolic, chemical or physical
stress factors (alkaline pH, sodium arsenite, heat shock). In all of these studies it is
important to note that T. gondii parasite stages are defined by the expression of stage
specific antigens (Bohne et al., 1993; Soete et al., 1994).
2.2.1.3 Tissue cysts
Generally control of T. gondii within infected hosts is associated with
cessation of tachyzoite replication and invasion, and then the formation of
bradyzoites contained within the tissue cysts. Cysts, containing anything from a few
tens to thousands of bradyzoites are 10 to 100 pm in size and are found most
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frequently in brain, heart and skeletal muscle and in most cases persist for the life
time of the host (Jacobs et al., 1960a; Remington and Cavanaugh, 1965; Conley and
Jenkins, 1981; Dubey and Thulliez, 1993). The outer membrane of the cyst is derived
from components of both host cell and parasite. The intact tissue cyst does not evoke
an inflammatory response. Immature tissue cysts may be detected as early as 1 to 2
weeks after challenge in experimental infections (Remington and Cavanaugh, 1965;
Dubey and Frenkel, 1976; Conley and Jenkins, 1981; Dubey et al., 1996).
The mechanisms involved in T. gondii stage differentiation and persistence of
bradyzoites within tissue cysts are the subject of much research interest and are at
present not well understood. Interestingly there have been reports in the literature that
some species, such as cattle are able to eliminate or markedly reduce the numbers of
parasite cysts in their tissues (Beverley et al., 1977; Costa et al., 1977; Fayer and
Frenkel, 1979; Stalheim et al., 1980b). Genetic investigations in mice have revealed
that genes at the H-2L locus (class I genes) appear to regulate the number of cysts in
the brains of mice orally infected with tissue cysts of T. gondii (Brown and McLeod,
1990).
Wong and Remington, (1993) reported evidence supporting the hypothesis
that individual bradyzoites may escape from cysts without complete cyst wall
disruption, proceeding to invade contiguous cells and thereby resulting in what is
called a daughter cyst often seen in chronically infected mice. It is of major
importance in understanding the host-parasite relationship to know whether tissue
cysts are solely intracellular or can persist extracellularly (Wong and Remington,
1993) as well as why some species are able to reduce or even eliminate the number of
tissue cyst from their tissues.
Because Toxoplasma encephalitis in AIDS patients is almost always the result
of reactivation of a previous infection (Navia et al., 1986; Luft and Remington,
1992), it was suggested that intermittent cyst rupture or leakage of parasite out of the
cysts occurs most frequently in the central nervous system (CNS) and that the
defective immune response results in uncontrolled proliferation and progressive
encephalitis (Frenkel and Escajadillo, 1987). Development of TE in mice appears to
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be controlled by a gene(s) located in the H-2D region, one of the class I genes of the
major histocompatibility complex (MHC) (Suzuki et al., 1991; Blackwell et al.,
1993).
The mechanisms that promote tachyzoite to bradyzoite interconversion in
T. gondii are very complex and as yet poorly understood. However, new technologies
and strategies will facilitate a better understanding of this important event in the
pathogenesis of toxoplasmosis.
2.2.2 Sexual phase: enteroepithelial cycle
Initiation of the sexual cycle occurs mainly when nonimmune members of the
Felidae family (domestic or wild) ingest tissues contaminated with the cyst form
containing bradyzoites (Frenkel et al., 1970; Dubey and Frenkel, 1972). Following
ingestion, the outer walls of cysts are disrupted by enzymatic degradation and the
infective phase (bradyzoites) are liberated into the intestinal lumen. The free
bradyzoites enter the enteroepithelial cells and begin the differentiation into male and
female gametes in the feline enterocyte. The female gamete (macrogamont) is
subspherical and contains a single nucleus with several organelles. Mature male
gamont (microgamont) is ovoid to ellipsoidal in shape. Microgametes are biflagellate
organisms which consist mainly of nuclear material and contain a large
mitochondrium. Male gametes are few and constitute 2 to 4 % of the mature gamont
population. After the penetration of the macrogamont by the male gamete, a
protective oocyst wall is formed around the zygote (termed oocysts).
2.2.2.1 Oocysts
When the oocysts are mature, they are shed into the intestinal lumen by the
rupture of the intestinal epithelium. Unsporulated subspherical oocysts (10xl2|im),
contain the sporont, filling almost the whole oocyst (Dubey and Frenkel, 1972).
Following excretion into the environment, they are non-infectious until sporulation
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occurs (1-5 days depending on aeration and temperature) with three cellular divisions
that results in eight infective sporozoites. Infectious oocyst (subspherical or ellipsoid,
11x13pm) contains two ellipsoid sporocysts (6x8pm), each of those containing four
sporozoites ultrastructurally similar to the tachyzoites (2x6 to 8pm) (Dubey et al.,
1970a, b) (Figure 2. 4).
Figure 2. 4 T. gondii oocysts in a suspension of cat faeces
Photograph courtesy of Dr. D. Buxton
When ingested, oocysts are disrupted by the host digestive enzymes and the
sporozoites are liberated into the intestinal lumen, commencing a new asexual cycle
in the intermediate host. It has been reported that the time to shedding of oocysts in
cats is 3-5 days after ingestion of tissue cysts and they are shed for 1-2 weeks and as
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many as 10 million may be shed in a single day (Dubey et al., 1970b; Dubey and
Frenkel, 1972).
Oocysts are resistant to most ordinary environmental conditions and can live
in the environment for months to years. The viability of oocysts is extended by higher
humidity (Dubey at al., 1970a, b; Frenkel and Dubey, 1972). In moist soil, infectivity
has been shown to last for over a year (Frenkel et al., 1975). Unsporulated oocysts
are more sensitive to adverse temperatures than are sporulated oocysts. Exposure of
unsporulated oocysts to 60-70°C for 10 seconds, 4°C for 90 days, -5°C for 14 days or
-20°C for 1 day result in failure of the oocysts to sporulate, whilst sporulated oocysts
retain their infectivity at -5°C for 120 days (Jackson and Hutchison, 1989).
2.3 Mechanisms of acquisition
2.3.1 Acquisition via tissue cysts
Ingestion of bradyzoites within the tissue cysts in meat from infected animals,
alongside ingestion of oocysts from cat faeces contamination, are the main cause of
postnatally acquired T. gondii infection in humans (Zuber and Jacquier, 1995).
Weinman and Chandler (1954) first suggested that undercooked meat from
infected animals might be the source of T. gondii infection in people. The first
definitive demonstration of Toxoplasma cysts in the tissues of sheep, swine and cattle
took place in 1960 (Jacobs et al., 1960a). They showed evidence that man can
acquire the infection by consuming undercooked meat containing T. gondii
bradyzoites within tissue cysts. The importance of this mode of transmission was
demonstrated by a study of the seroconversion rates of children admitted to a
tuberculosis hospital in Paris who were fed undercooked meat (Desmonts et al.,
1965). Cured pork has recently been shown to also be a source of Toxoplasma
infection (Buffolano et al., 1996).
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Seroepidemiological studies provide evidence for the importance of
undercooked meat from infected farm animals as a source of T. gondii infection as
the highest seroprevalence of T. gondii among the human population is reported in
countries like France, where undercooked meat is traditionally eaten (Zuber and
Jacquier, 1995). Seroprevalence surveys of meat animals in many parts of the world
indicate that the T. gondii infection rates vary considerably (Jackson and Hutchison,
1989). The actual presence of tissue cysts in the meat of food animals is the
important factor in transmission. The parasite has been isolated only rarely from
naturally infected bovine tissues although there have been occasional reports from
Japan, Czechoslovakia, Italy and Argentina of successful isolation (Dubey, 1986b).
Thus the actual role of beef in the epidemiology of T. gondii infection in the human
population has been disputed. Whereas viable T. gondii tissue cysts have been
isolated frequently from the tissues of naturally and experimentally infected sheep
(Dubey, 1996), pigs (Dubey et al., 1995), goats (Dubey, 1980) and wild game
(Dreesen, 1990). It has been detected from soft tissues such as brain, skeletal muscle,
small intestine, liver and diaphragm.
Tissue cysts have been found to persist in edible tissues of live animals for
months (Dubey, 1986a). This chronic stage of the parasite is not resistant to
conventional cooking at 67°C (temperature at the center of the piece of meat)
(Garnham and Lainson, 1960). The ability of tissue cyst to survive for up to two
months at 4°C (Jacobs et al., 1960b) indicates that they are likely to survive the
normal refrigeration process but they should be killed by commercial or domestic
freezing procedures (Jacobs et al., 1960b). Microwaving does not kill all T. gondii
because of uneven cooking (Lunden and Uggla, 1992).
2.3.2 Acquisition via oocysts
Ingestion of oocysts is the only mode of transmission to herbivores, beside
congenital infection, and one of the ways of infection in omnivores and carnivores
(Hutchison, 1965; Hutchison et al., 1969; Frenkel et al., 1970; Hutchison et al.,
1970; Sheffield and Melton, 1970). The sole source of infection for sheep, cattle and
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horses are oocysts. This stage of the parasite is also the major source of infection for
pigs although it is possible for them to be infected by the ingestion of tachyzoites or
bradyzoites present in meat (Dubey, 1986a).
The importance of ingestion of oocyst contaminated food and water as a route
of infection in humans was confirmed by demonstration of the presence of antibodies
to stage-specific oocyst/sporozoite antigens in the acute and convalescent sera of
individuals infected in an outbreak associated with water contaminated with T. gondii
oocysts (Wong and Remington, 1993).
Cats become infected as a result of ingesting infected tissues of intermediate
hosts, such as small birds and rodents. A cat may shed millions of oocysts, and they
are very hardy, capable of surviving in the soil for a year or more, increasing the
likelihood of infection. They are resistant to most ordinary environmental conditions
and can survive in cold climates but are less viable in arid environments (Dubey et
al., 1970b). Invertebrates like flies, cockroaches and earthworms can mechanically
spread oocysts (Dubey et al., 1970b).
Transplacental infection in cats rarely occurs and infection by ingesting
oocysts is an unlikely source of infection in cats (Dubey and Frenkel, 1976). The
prevalence of infection is highest in kittens and occurs when they begin to hunt small
birds and small mammals such as rodents, particularly the latter since they can pass
T. gondii infection from generation to generation without causing clinical disease
(Beverley, 1959). Many cats will have seroconverted to T. gondii by adulthood
(Wallace, 1971). It is unknown what percentage of previously infected cats repeat
oocyst shedding on further exposure to T. gondii. Recent studies indicate that
immunity against oocyst shedding is not life-long and oocyst shedding occurs in
approximately 40% of the cats infected six years prior to a secondary challenge
(Dubey, 1995). Oocyst shedding occurs in chronically infected cats
immunosuppressed with extremely high doses of glucocorticoids (Dubey and
Frenkel, 1974; Lappin, 1994). Whether other concomitant infections can induce re-
shedding of T. gondii oocysts is not well known. It has been shown that coinfection
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with feline immunodeficiency virus (FIV) does not affect the repeat shedding of
oocysts (Lappin et al., 1992).
Infection from direct contact with fresh faeces is very unlikely as oocysts
have to sporulate to become infectious and fresh faeces cannot cause infection
(Lappin, 1994). Domestic and barn cats in farm environments tend to nest and
defecate in hay and straw mows and in grain stores thus providing the potential for
direct infection of livestock feed with T. gondii. It has been demonstrated that sheep
are frequently maintained in an environment significantly contaminated with oocysts.
Certainly, fertilized fields with manure and bedding from building where cats live
can be a source of infection (Blewett and Watson, 1983; Faull et al., 1986).
2.3.3 Acquisition via tachyzoites
Tachyzoites are delicate organisms unable to survive outside the body of the
host and are easily destroyed by gastric secretions (Jacobs et al., 1960b). Although
they are eukaryotic cells, they require an intracellular habitat for survival and
multiplication. The parasites in this form are capable of infecting phagocytic and
non-phagocytic, nucleated and non nucleated cells (Werk, 1985). The only ways in
which tachyzoites can infect the host are by transplacental transmission from mother
to foetus: inoculation of packed leukocytes during a blood transfusion or transplants
or because of laboratory accidents (Dubey and Beattie, 1988).
During acute Toxoplasma infection, tachyzoites are distributed throughout the
host tissues. Tachyzoites have been detected in several body fluids such as tears,
nasal secretions, saliva, milk, vaginal secretions, semen, urine and faeces (Fayer,
1981) and isolated from the milk of cows, goats, sheep, pigs, dogs, cats, rabbits,
guinea pigs and mice either naturally or experimentally infected with T. gondii
(Jones, 1973). Although there is little danger of infection from milk because it is
generally pasteurized or even boiled, unpasteurized goat milk has been reported as a
source of human infection (Fayer, 1981).
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Venereal transmission of T. gondii infection through infected rams is unlikely
to be significant in the spread of the infection. The recovery of tachyzoites of T.
gondii from the semen of experimentally infected rams was reported (Spence et al.,
1978), although the production of T. gondii infected semen appears to be restricted to
a brief period shortly after infection (Teale et al., 1982). Epidemiological evidence
suggests that sexual transmission does not play a role in human toxoplasmosis,
although organisms have been isolated from semen of seropositive men (Fayer,
1981).
2.3.3.1 Congenital infection
A case of congenital infection was first recorded in man in 1937 (Wolf et al.,
1939). It was not until early 1950's when transpacental transmission of T. gondii was
described in sheep for the first time with the discovery of Toxoplasma-like organisms
in placentas and foetuseses of several abortions (Hartley et al., 1954).
Transplacental infection to the foetus occurs when mothers acquire
Toxoplasma infection for the first time during pregnancy. However, in some hosts
such as women, ewes, sows and nanny goats immunity following primary infection
will protect the host sufficiently to prevent foetal infection or abortion occurring in
subsequent pregnancies (Dubey and Beattie, 1988; McColgan et al., 1988; Frenkel,
1990). However, repeated congenital infection occurs for ten or more generations in
mice, rats, guinea pigs, and hamsters (Beverley, 1959; Dubey and Beattie, 1988).
Thus, by passing T. gondii from generation to generation through congenital
infection, rodents can provide a reservoir of infection in an area for a long time with
the potential for infection of cats and the triggering of massive oocyst contamination
of the environment (Buxton, 1990).
Infection with T. gondii is a major cause of abortion in important sheep-
rearing areas such as New Zealand and the British Isles (Buxton, 1993b). Following
initial multiplication of tachyzoites in the mesenteric lymph nodes (Dubey, 1984),
there is a parasitaemia disseminating the infection to many tissues (Dubey and
21
Sharma, 1980; Reid et al., 1982). In the pregnant ewe a progressive infection may
establish in the gravid uterus. As a result of this parasitaemia tachyzoites are able to
reach and parasitize the caruncular septa, the maternal tissue of the placentome. They
then invade adjacent trophoblast cells of the foetal villi and from there, the rest of the
foetus (Buxton and Finlayson, 1986). This is similar to human infection, in which the
consequences of contracting T. gondii infection early in pregnancy may have the
most severe consequences (Frenkel, 1990).
Although sporadic reports from several countries of neonatal deaths in cattle
have been attributed to congenital T. gondii infection because of finding
Toxoplasma-like structures in fetal bovine tissues, it is doubtful if T. gondii is a
primary cause of bovine abortion (Munday, 1978; Stalheim et al., 1980a, b; Dubey,
1984). Recent studies would suggest that perhaps these Toxoplasma-like structures
reported in fetal tissues from cases of bovine abortion may be the closely related
coccidian parasite Neospora caninum. N. caninum is now thought to be one of the
major causes of infectious bovine abortion (Dubey and Lindsay, 1996).
2.4 Clinical toxoplasmosis and species vulnerability
Toxoplasma gondii is an obligate intracellular parasite, with an unusually
wide range of intermediate hosts (Dubey and Beattie, 1988). The outcome of the
infection is different depending upon the species (Table 2. 1). There is a wide
spectrum of host/parasite relationships ranging from unapparent infection to fatal
disease with various intermediate cases (Dubey and Beattie, 1988; Innes, 1997).
The evolution of Marsupials, such as kangaroos (Macropus fuliginosus) and
koalas (Phascolarctos cinereus) as well as NewWorld Monkeys like marmosets
(.Marikina geoffroyi), nightowl monkeys (Aotus zonalis), and squirrel monkeys
(,Saimiri sciureus) have taken place largely separated from the presence of the
definitive host of T. gondii, the cat (Araujo et al., 1973; Dubey et al., 1988c; Hartley
22
et al., 1990; Miller et al., 1992; Cunningham et al., 1992). When these species do
come into contact with T. gondii, mainly in zoos, infection is often fatal. Toxoplasma
infection has been reported to be fatal in penguins (Mason et al., 1991), which would
not be expected in their natural environment to come in contact with the cats, and
therefore the oocysts.
In less susceptible species such as humans or sheep, infection is generally
unapparent in the adult host, but primary infection during pregnancy can cause
serious disease or death in the foetus (Aparicio Garrido, 1978; Buxton, 1990).
Toxoplasma infection has serious consequences in immunocompromised individuals
such as the immunologically immature foetus, AIDS patients or people undergoing
organ transplant and are therefore in receipt of immunosuppressive drugs (Luft and
Remington, 1992). Whereas species, such as cattle, in which infection readily occurs
but no disease is provoked are comparatively more resistant (Dubey, 1986b).
2.4.1 Postnatally acquired infection in immunocompetent individuals
When T. gondii infection is acquired by any immunocompetent host (with the
exception of the very vulnerable species mentioned previously), acute infection
usually results in a mild febrile response, dyspnea and anorexia, detected within two
weeks of infection (Remington, 1974; Aparicio Garrido, 1978; Dubey and Towle,
1986). The parasite elicits a strong and persistent cell-mediated immune response,
resulting in a stalemate situation mutually beneficial to the parasite and the host
(Gazzinelli et al., 1993). The parasite encysts and remains in the tissues, it is thought,
for the life time of the host (Dubey, 1977; Dubey and Towle, 1986), but the apparent
exception to this is cattle. Several workers have indicated that tissue cysts do not
persist in bovine tissue, and that they are quickly eliminated or markedly reduced in
number following infection (Beverley et al., 1977; Costa et al., 1977; Fayer and
Frenkel, 1979; Stalheim etal., 1980b; Dubey, 1983).
There are several situations in which the lack of an effective immune
response against the parasite can result in serious consequences.
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Table 2.1 Comparative species vulnerability to T. gondii infection in intermediate hosts











2.4.2 Reactivated toxoplasmosis in immunocompromised individuals
The most prevalent form of T. gondii-induced disease reported currently in
people is recrudescence of a chronic Toxoplasma infection often encountered in
individuals who are immuno suppressed due to chemotherapy to permit tissue
transplantation, for cancer treatment or in human immunodeficiency virus (HIV)
infected patients (Luft et al., 1984; Luft and Remington, 1992). Reactivated
toxoplasmosis has emerged as the most common opportunistic infection in AIDS
patients. The numbers of people at risk are high because of the prevalence of
seropositive individuals in the population (Chang, 1996).
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During chronic infection, it is likely that bradyzoites are slowly liberated from
cysts, without complete cyst wall disruption, into the surrounding host tissue. In the
immunocompetent host, these released parasites will provoke an influx of
inflammatory cells during the early stages of the liberation process and development
of microglial nodule at the site, that will readily destroy the parasite. Thus, the
original stalemate situation will be restored (Wong and Remington, 1993). However,
a defective immune response, will permit bradyzoites freed from cysts to behave like
the fast replicating tachyzoites resulting in rapid parasite proliferation and severe
tissue damage (Gazzinelli et al., 1993). Consequently, Toxoplasma encephalitis in
AIDS patients has been described, almost always, as the result of reactivation of a
previous infection (Frenkel and Escajadillo, 1987). Recently, several authors have
postulated that brain lesions are the result of reactivation in the peripheral organs
with subsequent haematogenous spread of the tachyzoites to the CNS (Wong and
Remington, 1993).
In nearly all the AIDS patients, TE was characterised by bilateral severe and
persistent headache responding poorly to analgesics, alongside confusion, lethargy,
ataxia and finally coma.
2.4.3 Prenatally acquired toxoplasmosis
Another situation where the parasite can prove a dangerous opportunistic
pathogen is to the developing foetus due to its immunological immaturity, as has
been described in woman and sheep (Dubey and Beattie, 1988).
When acquired by a T. gondii naive individual during pregnancy, T. gondii
can invade and cross the placenta to the immunologically immature foetus leading to
severe tissue damage and in extreme cases abortion. As pregnancy advances the risk
of clinical toxoplasmosis due to congenital Toxoplasma infection decreases as a
consequence of the relative development of the fetal immune system (Buxton and
Finlayson, 1986).
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If the woman or ewe becomes infected in the first trimester of pregnancy, it is
less likely that the parasite will be transmitted to the foetus but if transmission occurs
the result is very severe, resulting even in death of the foetus. Infection later in
pregnancy is more likely to result in fetal infection due to an increased blood supply
to the foetus via the placenta, but the consequences of infection will be less severe
due to the relative maturity of the foetal immune system. A triad of characteristic
symptoms has been described in prenatal toxoplasmosis: hydrocephalus or
microcephalus, intracraneal calcification and retinochoroiditis. This latter symptom is
one of the most common clinical signs of human toxoplasmosis; usually results from
a congenital infection, although it is generally not detected until much later in life
(Aparicio Garrido, 1978; Frenkel, 1990).
Primary T. gondii infection in the ewe early in pregnancy is rapidly fatal to
the foetus. Subsequent resorption of the foetus may be mistaken for infertility
(Johnston, 1988; Buxton, 1990). It has been indicated that foetal death is due to the
absence of an effective immune response able to control parasite multiplication
(Buxton and Finlayson, 1986). Infection for the first time in late pregnancy generally
has no clinical effect, the lamb will be born alive and immune although may be
infected with T. gondii (Buxton and Finlayson, 1986; Buxton, 1990). A primary
T. gondii infection of ewes in mid gestation can also result in stillborn, mummified,
and /or weak lambs (Figure 2. 5).
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Figure 2. 5 Ewe with stillborn lamb and weak live lamb following primary infection with T. gondii in mid
pregnancy
Photograph courtesy of Dr. D. Buxton
Both in women and ewes, the mothers are not known to abort in subsequent
pregnancies, either because of recrudescence of a chronic infection or as a result of a
secondary infection. Therefore the host immunity induced by the parasite is sufficient
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to protect against congenital toxoplasmosis in future pregnancies (Aparicio Garrido,
1978; McColgan et al., 1988).
Unlike the situation in sheep, Toxoplasma infection does not appear to cause
abortion or neonatal mortality in cattle under natural conditions (Dubey, 1986b)
(Figure 2. 6). In 1953, what was thought to be clinical toxoplasmosis in cattle was
reported for the first time in USA (Sanger et al., 1953).
Figure 2. 6 Cow with healthy calf
Photograph courtesy of Dr. D. Buxton
The findings reported then have since been challenged as further
examinations of the tissues failed to reveal T. gondii or related protozoan parasites
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(Dubey, 1986b). Several studies of natural and experimental toxoplasmosis in cattle
carried out since 1953 have shown that toxoplasmosis does not appear to cause
abortion or neonatal mortality in cattle under natural conditions (Koestner and Cole,
1961; Dubey, 1986b), although in several cases the parasite has been isolated in mice
inoculated with colostrum or unpasteurized milk (Dubey, 1986b). When pregnant
cattle are inoculated with T. gondii oocysts or tissue cysts, transient fever and
anorexia is detected and they give birth to healthy calves. The parasite was not
isolated from the tissues of the newborn calves or placentas (Munday, 1978).
2.5 Pathogenesis of T. gondii infection
Since T. gondii was recognised in the early 1950's as a significant cause of
abortion in sheep, extensive research has been carried out in sheep in order to
understand the disease pathogenesis.
As it is beyond the scope of this thesis to review the pathogenesis of T. gondii
in all hosts species, this section will be restricted to the pathogenesis of T. gondii
infection and pathological findings in sheep and cattle.
2.5.1 Pathogenesis in non-pregnant animals
Immunocompetent non-pregnant sheep and cattle show only very mild
clinical symptoms following Toxoplasma infection (Sanger et al., 1953; Munday,
1978; Dubey and Towle, 1986; Dubey and Thulliez, 1993). Toxoplasma gondii is
able to elicit a strong and persistent immune response which protects the host against
rapid tachyzoite growth and consequent pathology (Gazzinelli et al., 1993). As a
consequence there are few lesions observed at post mortem examination in infected
but otherwise healthy adults. Thus, much of the information on disease pathogenesis
has come from experimental infections.
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Following ingestion, sporulated oocysts are disrupted by the host digestive
enzymes and the sporozoites are liberated into the small intestinal lumen of the host.
Four days later the organisms (tachyzoites) will be found actively multiplying in the
mesenteric lymph nodes causing marked enlargement, sometimes with focal necrosis
(Dubey, 1984). They progress via the bloodstream and parasitize multiple tissues. In
this early phase of the infection, the tachyzoites (the rapidly multiplying stage of the
parasite) can be found in many different tissues (Dubey and Beattie, 1988). The
parasite is found accompanied by mononuclear inflammatory reactions leading to
small necrotic foci (Frenkel, 1988). The parasitaemia, which coincides with a febrile
response of at least 41°C (Buxton et al., 1988), has been detected from the fifth to the
twelfth day following infection (Dubey and Sharma, 1980; Reid et al., 1982;
Wastling etal., 1993).
In normal immunocompetent individuals, the parasite and the host immune
system reach a compromise situation in which the tachyzoites are cleared from the
hosts tissues and the necrotic foci regenerated, and no significant lesions are
produced. The parasite differentiates to bradyzoites which are contained within cysts,
where they are normally harmless to the host and serve to maintain the chronic
infection. Because of their location within cysts, bradyzoites are less vulnerable to
immune attack than tachyzoites. There is evidence that individual bradyzoites may
escape from cysts without complete wall disruption, and in this way stimulate the
immune response, which may be responsible for the long-lasting immunity induced
by such chronic infections (Wong and Remington, 1993; Gazzinelli et al., 1993).
Unlike the situation in sheep, cattle are thought to harbour fewer T. gondii tissue
cysts which do not necessarily persist for the life time of the host (Dubey, 1986b).
2.5.1.1 Pathological findings in Toxoplasma infected sheep and cattle
The lesions following experimental Toxoplasma infection of adult
immnocompetent sheep and cattle occur most commonly in the nervous system, and
lymph nodes. Where there is visceral involvement, pneumonitis, hydrothorax, ascites,
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lymphadenitis, intestinal ulceration and necrotic foci in the myocardium, liver, spleen
and kidneys may be observed (Radostits et al, 1994).
2.5.1.1.1 Neuropathology of ovine and bovine Toxoplasma infection
Koestner and Cole (1961) observed that findings at post mortem examination
in the ovine and bovine CNS, following T. gondii infection, were similar in both
species, although the lesions in cattle are less severe. They reported a higher
incidence of cerebral lesions in sheep than in cattle. The infection is characterised by
focal necrosis and vascular damage in animals undergoing acute infection. Lesions
comprise endothelial swelling, perivascular oedema, and proliferation of adventitia
cell elements. Proliferating Toxoplasma organisms were present alongside numerous
foci of necrosis, characterised by microglial proliferation. When chronic infection
was studied, findings were identified as glial nodules, with mineralization of vascular
walls. The lesions of the CNS were equally distributed and no preferred site was
found.
2.5.1.1.2 Pathology of the lymph nodes
Buxton and colleagues (1981) outlined the findings in ovine popliteal lymph
nodes after subcutaneous inoculation of sheep with tissue cysts of T. gondii. Severe
pathological changes were described. Gross enlargement, loss of architecture,
haemorrhages, some necrosis and the sinuses were full of plasma cells and numerous
blast cells. In immune sheep, the changes provoked in lymph nodes by T. gondii were
similar but less striking, with persistence of architecture and neither haemorrhages
nor necrosis.
Essentially similar changes were described by Dubey (1984) in mesenteric
lymph nodes after oral infection of sheep with oocysts. As early as four days post
infection, the nodes were necrotic, infiltrated by neutrophils and there was lymphoid
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depletion in the cortex. As the infection was progressing, histocytic infiltration was
detected in the cortex and medulla.
2.5.2 Pathogenesis and clinical pathology of congenital toxoplasmosis in sheep
In naive, pregnant sheep, following ingestion of sporulated oocysts, the
parasite will follow the same route as described in the previous section in a
immunocompetent healthy adult. The parasite is disseminated via the blood stream to
numerous tissues. In the pregnant ewe the infection will reach the gravid uterus.
Tachyzoites can cross the placenta, parasitize the caruncular septa of the placentome,
invading then the adjacent trophoblast cell of the foetal villi and from there the rest of
the foetus, leading to severe tissue damage and in extreme cases death. On the uterine
side, the maternal immunological response is suppressed, while the ability of the
foetus and its placenta to recognize and respond to T. gondii develops progressively
throughout gestation period (Buxton and Finlayson, 1986).
However, the outcome of infection will be influenced by the stage of
gestation at which the infection takes place. Toxoplasma gondii infection in early
gestation will have more severe consequences than infection late in pregnancy, when
foetal immunity is relatively well developed (Blewett and Watson, 1983; Buxton and
Finlayson, 1986; Johnston, 1988). Toxoplasma abortion in sheep usually occurs as a
consequence of infection in early to mid pregnancy resulting in stillborn, mummified
foetus, and/or weak lambs (Buxton, 1990).
2.5.2.1 Pathological findings in aborted material
2.5.2.1.1 Placenta
In general, the lesions described in the placenta vary depending on the time of
the death of the foetus which will depend upon the transmission of infection from
mother to foetus. Multiplication of tachyzoites in the cells of the caruncular septa of
the placentome, causes focal inflammation and necrosis, allowing the parasite to
32
spread and invade the trophoblasts. When foetal death has taken place early in
pregnancy, often no gross abnormality other than autolysis has been described
(Hartley and Kater, 1963). The characteristic lesions consist of macroscopically
visible multiple white spots present in the cotyledons. These correspond with foci of
necrosis (2 to 3 mm in diameter). No lesion other than mild oedema was seen in the
intercotyledonary area (Hartley and Kater, 1963; Beverley et al., 1971b).
On histological examination, the earliest lesion seen consisted of edematous
foetal villi with often the presence of a focal or diffuse mononuclear hypercellularity
alongside hyperplasia and hypertrophy of the trophoblastic epithelium. Groups of
Toxoplasma have been described in this area (Hartley and Kater, 1963; Buxton and
Finlayson, 1986). Longer-standing lesions have been described as focal coagulative
necrosis, desquamation of the hypertrophic trophoblast, necrosis of the contiguous
maternal villi often with the presence of degenerating Toxoplasma (Hartley and
Kater, 1963; Beverley et al., 1971b; Buxton and Finlayson, 1986). In older lesion
there are foci of caseous necrosis involving fetal and maternal villi, which often may
be mineralized (Hartley and Kater, 1963). Tachyzoites may be seen at the edge of
caseous necrotic lesions where they are often undergoing degeneration (Hartley and
Kater, 1963).
2.5.2.1.2 Foetus
The pathological changes found in lambs born to Toxoplasma infected ewes
vary depending upon the stage of gestation at which the dam acquires the infection.
Hartley and Kater (1963) estimated that 35% of infected foetuses die before birth,
60% at the time of birth and 5% within a few hours of birth.
Infection in early gestation is rapidly fatal resulting in subsequent resorption
of the foetus (Buxton and Finlayson, 1986; Johnston, 1988). However, a small
mummified foetus often alongside still born and/or weak lambs will be found if the
dam acquires the infection for the first time during mid gestation. Nonspecific gross
lesions, such as anasarca and excessive fluids in cavities, will be found at
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postmortem examination, possibly due to impaired nutrition and intrauterine death
(Beverley et al., 1971a, b).
Buxton and collaborators (1982) concluded, after examination of lambs born
to ewes experimentally infected with T. gondii, that intrauterine infection of the
foetus causes characteristic neuropathological changes in the foetus and that anoxia
due to cotyledonary damage plays a significant role in the cause of death. The
commonest pathological finding consists of perivascular cuffing by lymphoid cells
and distinctive focal inflammation in the brain, a possible indication of a foetal
immune response to the infection (Hartley and Kater, 1963; Buxton et al., 1982).
Extensive foci of leukoencephalomalacia mainly in the anterior cerebral
periventricular white matter, and often associated with haemorrhages, are described
in more than 50% of the examined cases. They consist of focal myelin loss, axonal
swelling and degeneration. In older lesions, peripheral gliosis may be present, with
central calcification (Hartley and Kater, 1963; Buxton et al., 1982). In the foetal brain
the parasite is seen in clumps attached to the vascular endothelium or associated with
microglial nodules, as well as large non-encapsulated apparently extracellular clumps
or cysts (Hartley and Kater, 1963).
Pathological changes have been reported in other organs. In the liver, there
are focal granulomas, which may have central areas of necrosis, as well as large
accumulations of lymphoreticular cells in portal triads and foci of extramedullary
haemopoietic cells (Beverley et al., 1971a; Buxton et al., 1982). The adrenal gland
shows infiltration of eosinophils which are often associated with macrophages
(Hartley and Kater, 1963; Buxton et al., 1982). Scattered small foci of mononuclear
cells have been seen in lungs as well as pulmonic necrosis associated with T. gondii
infection. In the heart interstitial myocarditis with infiltration by mononuclear cells
between muscle fibers has been seen in some cases (Beverley et al., 1971a).
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2.6 Host-parasite relationship
In most cases infection with T. gondii induces a rapid and effective immune
response which will protect the host but does not eliminate the parasite. A stalemate
situation occurs where the host remains persistently infected with T. gondii
bradyzoites within tissue cysts but generally the hosts suffers no ill effects from this
situation. However, any change in the immune status of the persistently infected
individual, e.g. any of the forms of immunosuppression discussed in 2.4.2, would
result in reactivation of the parasite which would proceed to freely multiply until the
host is overwhelmed and dies. Perhaps in species most vulnerable to T. gondii
infection, such as marsupials and New world monkeys, the immune response is less
efficient than in more resistant hosts such as sheep or cattle.
2.6.1 Host resistance to T. gondii
One important feature of T. gondii infection is the strong and persistent cell-
mediated immune response elicited by the parasite, which protects the host against
rapid tachyzoite growth and consequent pathology. Bradyzoites due to their protected
location within tissue cysts, are therefore able to resist the immune response.
Spontaneous release of bradyzoites from the protective environment of the cysts will
stimulate the immune system maintaining a long-lasting immunity able to control the
chronic Toxoplasma infection (Gazzinelli et al., 1993). It is interesting to highlight
that the strong immune response induced by the parasite is harmless to the host, and
does not cause immunopathology in the immunocompetent host.
A review of host immune responses demonstrates the extensive research
using murine models of T. gondii infection (Beaman et al., 1992; Gazzinelli et al.,
1993; Subauste and Remington, 1993).
This section will focus on the host immune responses to T. gondii from
studies using mice, sheep and cattle.
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2.6.1.1 Immune responses in infectedmice
Mice are very susceptible to Toxoplasma infection. Inoculation of mice with
tissue samples is often used to help diagnose cases of toxoplasmosis. The mouse is a
convenient and inexpensive animal model which has been extensively employed in
studying various aspects of the immune response to T. gondii (McLeod et al., 1993).
2.6.1.1.1 Mucosal immunity
The oral route is the natural site of entry of T. gondii (Frenkel et al., 1969).
The local tissues, underlying the intestinal epithelium are heavily populated with
lymphoid cells from the mucosal immune system (Kraehenbuhl and Neutra, 1992)
which are able to rapidly come into contact with the parasites during intestinal
invasion (Chardes et al., 1993).
Recent studies have been carried out to investigate mucosal immunity in the
gut following T. gondii infection in mice. Evidence suggests that intraepithelial
lymphocytes (IEL), (mainly CD8 a/p+ Thy-1+) play a major role at the mucosal
surfaces as a first line of defence (Chardes et al., 1994). Chardes and collaborators
demonstrated the importance of IEL showing a decrease in the number of T. gondii
tissue cysts in the brains of Toxoplasma infected mice when primed IEL cells were
transferred to naive mice before infection. It has been reported that the effector
mechanisms of this cell population is based on IFNy production which limits the
amount of iron available to the parasite and in this way inhibits T. gondii replication
(Chardes et al., 1994).
A local intestinal IgA response following T. gondii infection has been
reported (Chardes et al., 1990; Chardes and Bout, 1993). It has been established that
a strong mucosal IgA response is induced against major surface T. gondii antigens
(SAG-1, P30) following T. gondii oral infection of mice (Chardes et al., 1990; Mineo
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et al., 1993). IgA has been shown to inhibit the infection of host cells by T. gondii
parasites (Mack and McLeod, 1992; Mineo et al., 1993)
2.6.1.1.2 Innate resistance
Hauser and collaborators (1982, 1983) reported the ability of T. gondii to
directly activate macrophages and natural killer (NK) cells. This activation occurs
during the early stages of Toxoplasma infection before specific T cell induction
occurs. NK cells have been identified as an important source of IFNy and other
cytokines produced by macrophages are involved in the initiation of the immune
response (Sher et al., 1993).
The production of IFNy by NK cells has been attributed to the synergic
activity of tumor necrosis factor alpha (TNFa) and interleukin 12 (IL-12 or NK
stimulatory factor) produced by macrophages activated by T. gondii (Gazzinelli et al.,
1993).
Interestingly, it has recently been demonstrated that cell invasion is not the
only method to activate macrophages, both live parasite and secretory/excretory
antigens from T. gondii can induce the appropriate cytokine response resulting in
IFNy production by NK cells (Gazzinelli et al., 1993).
The early activation of both macrophages and NK cells plays a very important
role in establishing an early resistance against the rapidly dividing tachyzoites. The
early production of IFNy is also thought to provide the correct cytokine environment
to induce the T helper 1 (Thl) subset of CD4+ T cells which are also thought to be
important in immunity to T. gondii (Gazzinelli et al., 1993)
2.6.1.1.3 Cell-mediated immunity (CMI)
Acquired resistance to the obligate intracellular parasite T. gondii has been
demonstrated to be mainly dependent on CMI. Transfer of large quantities of serum
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from chronically infected animals fails to protect naive mice against intraperitoneal
(i.p.) challenge with virulent parasite strains (Pavia, 1986). Studies with IgM-
suppressed mice, which lacked B lymphocytes and therefore failed to make
antibodies, but had intact T cell functions, were able to control Toxoplasma infection
(Frenkel and Taylor, 1982). Moreover, athymic nude mice which lack functional T
cells were shown to be extremely susceptible to the parasite (Lindberg and Frenkel,
1977; Gazzinelli et al., 1993).
Adoptive transfer studies using inbred strains of mice showed that both CD4+
and CD8+ T cells are relevant in the development of protective immunity (Suzuki and
Remington, 1988; Gazzinelli et al., 1991) and moreover that CD8+ subset is the
major effector population in controlling the infection (Suzuki and Remington, 1988;
Parker et al., 1991; Khan et al., 1994).
2.6.1.1.3.1 T cells subsets involved in resistance to T. gondii
CD4+ T lymphocytes are thought to be important in establishing immunity
during early stages of infection (Araujo, 1991) or vaccination (Gazzinelli et al.,
1991) and it has been suggested that although CD8+ T cells are the major effector T
lymphocyte, their induction and optimal activity is dependent upon CD4+ helper
function (Chardes et al., 1993; Denkers et al., 1993) probably through the production
of Thl cytokines such as IL-2, IFNy, TNF and granulocyte-macrophage colony
stimulator factor (GM-CSF).
Two basic effector mechanisms by which CD8+ T lymphocytes could limit
Toxoplasma infection have been described. The first involves the production of IFNy
by the CD8+ T cells, the activity of which is enhanced in the presence of IL-2
(Gazzinelli et al., 1991; Denkers et al., 1993). An adoptive transfer study showed
that CD8+ T cells were no longer protective if the recipient mice were treated with
monoclonal antibodies to IFNy (Suzuki and Remington, 1990). The second effector
function involves direct lysis T. gondii infected host cells by MHC class I restricted
CD8+T cells (Hakim et al., 1991; Subauste et al., 1991). The generation of these
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effector cells seems to be dependent upon CD4+ lymphocytes and IL-2 (Hakim et al.,
1991). It has been suggested that the releasing of soluble Toxoplasma antigen is
important in maintaining CD8+ lymphocytes in a primed state during long-term
chronic infection via antigen presentation on bone marrow macrophages (Denkers et
al., 1992).
2.6.1.1.3.2 Interferon gamma
Interferon gamma plays a crucial role in host resistance to T. gondii (Subauste
and Remington, 1991). If this cytokine is depleted from previously vaccinated mice
they become vulnerable to Toxoplasma challenge (Gazzinelli et al., 1991). Depletion
of IFNy in chronically infected mice using specific monoclonal antibodies has lead to
the reactivation of previously dormant tissue cysts in the brain causing similar
pathology to that described in AIDS patients with TE (Suzuki et al., 1989). IFNymay
also be important in the effector function of activated CD8+ cells by activation of
other cell types, e.g. macrophages, to destroy tachyzoites released from the lysed
target cells (Subauste and Remington, 1991). Interferon gamma is also known to be
involved in the maturation of the CD8+ cells into effector cytotoxic cells (Zanovello
et al., 1988).
2.6.1.1.4 Humoral immunity
Although cell mediated immunity is generally thought to be more important
in recovery from a primary T. gondii infection, humoral immunity also has an
important role. It is known that specific antibodies can destroy tachyzoites in the
presence of complement (Sabin and Feldman, 1948; Schreiber and Feldman, 1980).
Tachyzoites opsonized by antibody or complement are unable to prevent fusion of
their parasitophorous vacuole with the host cell lysosomes and thus are unable to
evade the normal killing mechanisms of macrophages (Joiner et al., 1990). It has
been also suggested that Toxoplasma specific antibodies may inhibit the invasion of
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cells by blocking the activity of secretory-excretory substances responsible of
promoting the host cell penetration (Schwartzman, 1986).
The passive administration of immune sera containing polyclonal antiserum
confers little or no protection against T. gondii challenge to mice (Krahenbuhl et al,
1972; Pavia, 1986). Moreover, transfer of monoclonal antibodies against the major
surface protein of T. gondii P30 to naive recipients has conferred some protection
against challenge infection (Johnson et al., 1983; Sharma et al., 1984). It has also
been demonstrated that immune serum conferred partial immunity to B-cell-deficient
mice (Frenkel and Taylor, 1982). It is important to mention that specific IgA
responses in the gut mucosa are thought to be an important barrier to oral infection
(McLeod and Mack, 1986).
In summary antibodies are important in resistance to T. gondii, in particular
during a secondary infection, acting together with CMI.
2.6.1.2 Immune response in infected sheep
Congenital toxoplasmosis in the sheep is very similar to congenital human
toxoplasmosis. Tansplacental transmission of the infection will only occur if the ewe
acquires the infection for the first time during pregnancy, and the parasite is not
transmitted to the foetus in chronically infected immunocompetent animals
(McColgan et al., 1988). Consequently the use of sheep to study T. gondii infection is
not only of direct relevance to control the disease in this species but may be a more
relevant model for studying human congenital Toxoplasma infection than relying
entirely on mouse models where repeat vertical transmission is known to occur
(Beverley, 1959).
Early reports suggested that infection with T. gondii induces an immune
response in sheep (Olafson and Monlux, 1942; Wickman and Carne, 1950). In both
experimental and natural infection with Toxoplasma specific seroconversion occurs
(Hartley and Marshall, 1957; McColgan et al., 1988). Antibody levels in sheep
infected with a complete strain of T. gondii may remain steady for 5 months after
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infection (McColgan et al., 1988). In a primary infection Toxoplasma specific IgM
antibodies are initially detected, followed by specific IgG antibody (Miller et al.,
1982; Blewett et al., 1983).
Studies carried out at Moredun Research Institute (Edinburgh, UK), using
experimentally infected sheep, have focused on the study of the immune response in
sheep with the incomplete S48 strain of T. gondii (Wilkins et al., 1987). The S48 T.
gondii parasites lack the ability to differentiate to bradyzoites and hence cannot form
tissue cysts (and therefore to establish persistent infection). Following subcutaneous
inoculation of naive sheep with S48 tachyzoites, the in vivo immune response elicited
by the parasite in a peripheral lymph node draining the site of challenge was
monitored (Figure 2. 7).
The humoral response was dominated by antibody recognizing a 30-32 kDa
band, probably corresponding to the major surface glycoprotein of T. gondii
tachyzoites designated P30 or surface antigen 1 (SAG1) (McLeod et al., 1991). The
antibodies were detected from day 9 following a primary T. gondii infection.
However, secondary challenge resulted in a immunological memory response with
antibody being detected 3-4 days after infection compared with 7-8 days after
primary infection (Wastling et al., 1995).
Examination of cell output from the lymph node showed an initial decrease,
presumably due to the phenomenon called cell shutdown which takes place in lymph
nodes following antigenic challenge (Hall and Morris, 1965; Buxton et al., 1994).
Then the cell output from the lymph node increased and largely comprised
lymphoblast cells responding to the parasite infection. Phenotypic analysis of
lymphoblast cells in the efferent lymph showed that the cells responding to infection
were mainly T cells. Initially those with a CD4+ phenotype producing EFNy ,were
more numerous than CD8+ T cells but at around day 9 to 10 after infection the latter
became predominant. The disappearance of the parasite from the lymph also occurred
at this time (Innes andWastling, 1995).
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Figure 2. 7 Host-parasite relationship detected in efferent lymph from a peripheral lymph node draining
the site of subcutaneous challenge in a sheep undergoing primary infection with tachyzoites of the S48
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IFNy was detected in cell-free lymph supernatant from days 3 to 10 after
primary infection but appeared in lymph as early as 24 hours after secondary
challenge (Innes et al., 1995b). Both CD4+ and CD8+ T cell subsets have the
potential to produce IFNy after appropriate stimulation (Morris et al., 1982;
Mosmann and Coffman, 1987). It has been demonstrated that CD8+T cells from
responding efferent lymph are able to inhibit Toxoplasma multiplication in vitro
1 From Innes and Wastling, 1995.
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(Innes et al., 1995a). These observations suggest that a T cell response combined
with IFNy production plays a major role in immunity to T. gondii infection in sheep.
It is generally thought that the CD4+ T cell subset is required for optimal induction of
the CD8+ T cells (Suzuki and Remington, 1988; Gazzinelli et al., 1991; Parker et al.,
1991; Innes et al., 1995a). These in vivo observations are further supported by in
vitro studies which have shown that recombinant ovine IFNywill inhibit the growth
of T. gondii in ovine cells (Oura et al., 1993).
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Anti-Toxop/osmoimmuneecha isms T.gondii tachyzoites
2.6.1.3 Immune response in infected cattle
The reasons for the existing diversity in vulnerability to Toxoplasma infection
among different species are not well understood, although it is likely that the host
immune system plays an important role.
There is very little published data on immune responses in T. gondii infected
cattle. The majority of information is on studies of seroprevalence and
seroconversion in experimentally infected animals.
In cattle, seroprevalence rates are difficult to establish due to problems of
specificity with the serological tests used (Dubey, 1986b). The Sabin-Feldman dye
test (DT), thought to be the most reliable test for human sera was found to be
unsuitable for use in cattle as it can give a false positive reaction due to a naturally
occurring globulin, thought to be IgM. This globulin can be partially inactivated by
heating the sera to 60°C for 60 minutes (Dubey et al., 1985). Furthermore, in
experimentally infected cattle DT titres increase briefly during the first month after
inoculation before returning to baseline levels. There have been a number of reports
indicating that the indirect fluorescent antibody test (IFAT) may be as sensitive as the
dye-test (Munday and Corbould, 1971; Munday, 1978; Uggla, 1986).
Cattle experimentally infected with T. gondii develop specific antibodies
within four weeks of infection (Beverley et al., 1977; Costa et al., 1977; Dubey et al.,
1995; Fayer and Frenkel., 1979; Munday, 1978). In cattle there is an age effect in
antibody development with calves producing higher and longer lasting antibody titres
than adult cattle, following experimental challenge with the same dose of T. gondii
(Dubey et al., 1985; Dubey, 1986b).
Under natural conditions it has been shown that sheep grazing on a pasture
alongside cattle developed significant antibody titres to T. gondii as measured by
IFAT while none of the calves became sero-positive (Munday and Corbould, 1979)
corroborating once more the different susceptibility existing between these two
species.
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There have been no studies of CMI in T. gondii infected cattle, to my
knowledge.
2.7 Diagnosis of T. gondii infection
Diagnosis of Toxoplasma infection can be made using a variety of methods
including histopathology, serology, isolation of the parasite and amplification of
specific deoxyribonucleic acid (DNA) by polymerase chain reaction (PCR).
2.7.1 Clinical signs
Diagnosis of Toxoplasma infection by clinical signs or macroscopic
pathological changes is difficult since these are nonspecific and the symptoms are
common to other infections.
2.7.1.1 Clinical signs of Toxoplasma infection in man
In the immunocompetent person T. gondii only rarely causes illness.
Symptoms of infection include listlessness, fatigue, headache, muscle and joint pains,
and slight fever. Because these symptoms are common to other diseases,
toxoplasmosis is often unrecognized.
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2.7.1.1.1 Postnatally acquired toxoplasmosis in human
2.7.1.1.1.1 Lymphoglandular toxoplasmosis
Lymphadenitis is the most frequently observed clinical sign in
immunocompetent persons. The most frequently involved nodes are deep cervical
ones. When infected the nodes are tender, discrete but not painful (Dubey, 1977).
2.7.1.1.1.2 Toxoplasma encephalitis
The most serious complications of toxoplasmosis have been described in
patients whose immunity is suppressed, e.g. patients undergoing immunosuppressive
therapy for tissue transplantation or cancer therapy, or in people who are
immunocompromised as a result of HIV infection (Luft and Remington, 1992).
Clinically, patients may have a severe headache, disorientation, drowsiness,
hemiparesis, reflex changes, convulsions, and may become comatose, developing
encephalitis and brain abscesses (Navia et cil., 1986).
2.7.1.1.2 Congenital toxoplasmosis
When a pregnant woman acquires the infection for the first time during
pregnancy, she may transmit it transplacental^ to her foetus, sometimes resulting in
death of the foetus. Very often signs and symptoms are not apparent until weeks,
months, or even years after birth.
While the mother rarely has symptoms of infection, she does have a
temporary parasitaemia (Dubey and Beattie, 1988). Severely diseased children may
have the full triad of signs proposed by Sabin et al. (1952): hydrocephalus or
microcephalus, intracraneal calcification and retinochoroiditis. However, the most
common consequence of congenital toxoplasmosis is ocular disease, affecting mainly
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the posterior chamber and causing retinochoroiditis. The punctate lesions described
on the retina are usually harmless and may not be detected until adulthood (Perkins,
1973).
2.7.1.2 Clinical signs of Toxoplasma infection in sheep
It has been generally reported that postnatal acquired Toxoplasma infection in
adult immunocompetent sheep only provokes a mild clinical response, accompanied
by temperature response and moderate diffuse symptoms, most often remaining
unnoticed (Blewett etal., 1982; Miller etal., 1982; Dubey, 1984; McColgan etal.,
1988; Buxton etal., 1991).
2.7.1.2.1 Congenital toxoplasmosis
When a pregnant ewe becomes infected for the first time during pregnancy,
only a mild febrile response and dyspnoea may be detected. Much of the pathology is
found in the foetus.
The outcome of the infection is influenced by the stage of gestation when it
occurs (Blewett and Watson, 1983).
2.7.1.3 Clinical signs of Toxoplasma infection in cattle
A review of the relevant literature demonstrates that although cattle can
readily become experimentally infected with T. gondii (Costa et al., 1977; Munday,
1978; Dubey, 1986b), they show very mild clinical symptoms which include pyrexia,
nervous and respiratory signs.
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2.7.2 Demonstration of T. gondii in infected tissues
Diagnosis of the infection can be aided by demonstrating the presence of the
parasite in host tissue and by the histological appearance of the tissues removed by
biopsy or at necropsy (details of the characteristic lesions are described in 2.5). The
finding of the rapidly multiplying stage of the parasite, tachyzoites, indicates an
active infection is occurring and the presence of tissue cysts may indicate latent
infection.
2.7.2.1 Haematoxylin and eosin stain
A rapid but inconclusive diagnosis can be made by microscopic examination
of tissue sections stained with haematoxylin and eosin (H&E). Crescent-shaped
tachyzoites and spherical tissue cysts can be located in stained sections. However a
more specific test is often required as degenerating host cells may resemble
degenerating Toxoplasma and because of the close morphological similarities with
related cyst-producing coccidia like Sarcocystis spp. and Neospora sp. (Lindsay and
Dubey, 1989;Dubey etal., 1989).
2.7.2.2 lmmunohistochemical labelling
Conventional histological examination of tissue from infected animals or
people is often difficult if the samples are badly decomposed. Moreover, it may be
difficult to distinguish T. gondii in sections because of the sparse distribution of
organisms in the tissues and the close morphology with other related protozoa.
A peroxidase antiperoxidase technique (PAP) adapted to specifically stain
microorganisms in tissues has been used to demonstrate T. gondii in sections of
formalin-fixed, paraffin-embedded tissues from different species (Conley et ai,
1981; Uggla et al., 1987). Although Toxoplasma antigen can be detected even after
one year of fixation in 10% formalin, fixation for shorter periods is recommended.
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2.7.2.3 Amplification of specific nucleic acid sequences
Recent advances in molecular biology have devised methods to amplify
specific nuclei acid sequences using the PCR technique. This technique has been
applied to T. gondii by amplification of the Bl, p30, TGR1 or the 18S ribosomal
DNA (rDNA) targets (Burg et al., 1989; Savva et ai, 1990; Dupon et al., 1995). PCR
amplification has been successfully used on various clinical specimens from different
species (Holliman et al., 1990; Turner and Savva, 1991; Wastling et al., 1993).
Toxoplasma gene amplification has been found to agree closely with mouse
inoculation techniques and shows a high degree of specificity (Hitt and Filice, 1992;
Wastling et al., 1993), although as a method of diagnosis it is relatively expensive
and requires specialized laboratory facilities.
2.7.3 Isolation of T. gondii
Isolation of T. gondii from infected tissues is considered to be a conclusive
and specific test to determine active infection. This is usually achieved by inoculation
of tissue samples into laboratory mice. The choice of inoculum (secretions,
excretions, body fluids and tissues) will depend upon the case. Cerebral spinal fluid
from a child with a possible congenital infection, or lymph node material from a
patient with lymphadenopathy or cerebral spinal fluid from a patient with AIDS, can
be good sources of Toxoplasma parasites. At necropsy, the tissues selected often
include brain in TE, cardiac muscle, skeletal muscles and placenta.
Mice are readily infected by intraperitoneal inoculation of tachyzoites or
bradyzoites or infected tissue samples. Because other related coccidia like Neospora
sp. and Sarcocystis spp. can appear morphologically similar, isolates should be
distinguished by animal inoculation. T. gondii has been proved to be highly infective
to mice, whereas Sarcocystis spp. is not infective and Neospora sp. is rarely infective
to immunocompetent mice (Dubey et al., 1989; Dubey and Lindsay, 1996). Although
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most strains of mice are susceptible to Toxoplasma infection, outbred albino female
adult mice are recommended when attempting parasite isolation.
Depending on the virulence of the T. gondii strain, mice will develop either
an acute infection with parasite-rich ascites in 7 to 14 days after inoculation or a
chronic infection with presence of bradyzoites within tissues in brain (Derouin et al.,
1987). Failure to demonstrate T. gondii in mice does not necessarily prove that the
mice are not infected. Therefore mice should also be tested for the presence of
specific antibodies. Following infection with T. gondii mice will develop
Toxoplasma antibodies by 28 days after infection (Buxton et al., 1979). The
experimentally infected mice are monitored for up to 8 weeks after challenge.
Larger samples of tissues can be fed to Toxoplasma naive cats which will
produce oocysts in their faeces if the tissue samples contains T. gondii. Cats are a
very sensitive and specific host for the parasite, but are not a very convenient animal
model as it is very difficult to obtain Toxoplasma naive cats (Dubey and Thulliez,
1993). The faeces are collected for a period of 3 to 15 days after feeding of the test
material and are examined for T. gondii oocysts microscopically.
2.7.4 Demonstration of specific antibodies in body fluids
Following infection with T. gondii, most animals seroconvert. While
demonstration of specific T. gondii antibodies does not prove active infection, it does
establish whether the host has previously been infected with the parasite. Specific
serological assays have therefore been a useful aid to diagnosis, being relatively
inexpensive and reasonably reliable (Dubey et al., 1987; Arthur and Blewett, 1988;
Munday et al., 1987).
Since the development of the "dye test" by Sabin and Feldman in 1948, many
serological tests have been described for the detection of antibodies against T. gondii.
These tests may be divided into those which use the intact parasite as antigen and
those which use a fractionated antigen preparation.
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In order to be of use the tests must be both specific and sensitive and capable
of differentiating between acute and chronic infection, since it has been proved that
high antibody levels can still be detected in serum from infected animals years after
infection (Dubey and Beattie, 1988). The onset of the infection can be estimated by
sequential analysis of samples or by the monitoring of specific IgM antibodies
(Remington et ai, 1968).
2.7.4.1 Whole parasite antigen
2.7.4.1.1 Dye test
The cytoplasm modifying or "dye test" of Sabin and Feldman (1948) is still
considered very reliable. The test has been standardized (Beverley and Beattie, 1958)
and adapted to microscale (Feldman and Lamb, 1966; Waldeland, 1976; Balfour et
al., 1982).
The test involves mixing live T. gondii tachyzoites with the serum sample and
complement and adding a methylene blue dye. If there are antibodies to Toxoplasma
present, the cell wall of the parasite is lysed by the effect of the antibody and
complement and cannot take up the dye. The titre reported is the serum dilution at
which more than 50% of the parasites remain live and by comparison with a World
Health Organization (WHO) international reference serum (Lyng and Simm, 1982),
may be expressed in international units per millilitre. Most hosts develop DT
antibodies within 4 weeks and titres may remain stable for months or even years.
Although the DT is not species specific, a natural globulin in bovine serum
can cause false-positive results. This globulin is not inactivated at 56°C for 30
minutes but is inactivated to some extent at 60°C for 1 hour (Dubey, 1986b).
The DT is highly specific and sensitive and is still considered the gold
standard by which all other serological test are compared. The main disadvantages of
this test are the high cost and the potential hazard of using live organisms.
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2.7.4.1.2 Indirect fluorescent antibody test
In this test, whole killed tachyzoites of T. gondii (either fixed in formalin or
air-dried onto slides) are incubated with serial dilutions of test serum and specific
antibody is detected by adding fluorescent-labelled antispecies IgG (or whole
immunoglobulin). Numerous workers have found good agreement between the IFAT
and the DT (Suzuki et al, 1965; Munday and Corbould, 1971; Munday, 1978;
Hughes, 1985).
Figure 2. 9 Whole killed T. gondii tachyzoites fixed in formalin and air dried onto slides, incubated with T.
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Photograph courtesy of Dr. D. Buxton
A modification of the IFAT was developed for the demonstration of
immunoglobulin M Toxoplasma antibodies and has proved useful in establishing the
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diagnosis of congenital and acute acquired infection in which the presence of IgM
signifies an active or recently acquired infection (Remington, 1969).
The drawbacks of this test are that a microscope with ultraviolet (UV) light is
required, reading of the results is subjective and false positive responses may occur in
individuals with antinuclear antibodies (Araujo et al., 1971) and rheumatoid factor
present in their serum (Hughes, 1985).
2.7.4.1.3 Agglutination test
This test was first described by Fulton and Turk (1959) but because of its low
specificity and the need for a large number of tachyzoites in each test, it was not a
favoured test. The reproducibility and sensitivity of this assay has been increased by
growing Toxoplasma tachyzoites within mouse sarcoma cells (Desmonts and
Remington, 1980).
In this test, formalin-preserved whole parasites are incubated with serum
samples at 37° C for 2 hours and at 2°C overnight. The presence of specific IgG
antibody is assessed from the nature of the agglutination pattern found. This test is
free from cross reactivity with other parasites but is very sensitive to IgM antibodies
and these may frequently cause nonspecific agglutination in samples which are
negative when tested with other methods (Desmonts and Remington, 1980). This
problem can be avoided by treating sera with 2-mercaptoethanol. Titres in this test
parallel those in the DT and IFAT, both in human sera and animal sera (Dubey and
Beattie, 1988).
The method is accurate, simple to perform, inexpensive and is widely used
for screening pregnant women (McCabe and Remington, 1983). It has also been
modified to detect IgM antibodies (Dubey and Beattie, 1988).
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2.7.4.2 Soluble antigen preparations
In this case the water soluble antigens (both membrane and cytoplasmic
antigens) are prepared following water lysis of Toxoplasma organisms (Hughes and
Balfour, 1981).
2.7.4.2.1 Enzyme-linked immunoabsorbent assay (ELISA)
This technique has become the most widely used test to detect specific T.
gondii antibodies in many species. This method works on the principle that soluble
antigen can be bound to polystyrene or polyvinyl surfaces and that specific antibody
bound to the antigen can be detected by an enzyme linked specific antiserum. The
resulting colour development is read visually or spectrophotometrically. The ELISA
has advantages over the IFAT test of objectivity, quantification and automation and
provides quantifiable data (Voller et al., 1976; Buxton et al., 1988). This test uses a
crude, sonicated lysate of T. gondii tachyzoites as antigen and shows a good
correlation with other serological test (Walls et al., 1977; McCabe and Remington,
1983; Buxton et al., 1988; Seefeldt et al., 1989).
2.7.4.2.2 Latex agglutination test
A latex agglutination test (LAT) for use in microtitre plates is commercially
available (Eiken Chemical Company®, Japan). In this test, soluble antigen is coated
on latex particles. If Toxoplasma-specific antibodies are present in the serum to be
tested, agglutination takes place. LAT titres from human and animal samples
generally correspond with those of DT and IFAT (Wilson et al., 1990). Because this
test is simple, easy to perform, inexpensive and does not require any species specific
reagent, it has been very useful for screening purposes in different animal species.
2.7.5 Antigen induced cell proliferation
In this test, cultures of primed lymphocytes will proliferate in the presence of
specific T. gondii antigen quantified by differential uptake of tritiated thymidine
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compared to the response in unprimed cells. However, proliferative responses have
been observed in some nonimmune individuals, and this may indicate that the assay
is not entirely specific (Hughes et al., 1984; Lunden, 1995). Therefore, the
significance of antigen specific stimulation of cells can only be evaluated within the
context of a wider examination of the immune status of the individual.
2.8 Methods of disease control
2.8.1 Drug treatment
The increasing number of patients with TE due to the AIDS pandemic, has
stimulated much interest in new effective drugs against T. gondii (Araujo and
Remington, 1992). Current drugs are only active against the tachyzoite stage of T.
gondii, however the majority of cases of TE in immunocompromised patients result
from a reactivation of a previous latent infection, characterised by the presence of
bradyzoites within the resistant tissue cysts. There are few effective drugs currently
available that are effective against T. gondii tissue cysts.
This section will discuss some of the chemotherapeutic agents with
demonstrable in vivo activity against T. gondii.
2.8.1.1 Drug therapy in human toxoplasmosis
2.8.1.1.1 Inhibitors of dihydrofolate reductase (DHFR)
These substances have been investigated because T. gondii is dependent on
the host for purines (Schwab et al., 1995).
Pyrimethamine is a widely used therapy for toxoplasmosis and has been
administered in combination with other agents, such as sulfadiazine. These two drugs
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are the combination of choice for patients with TE (Fung and Kirschenbaum, 1996).
They act synergistically by blocking the metabolic pathway involving
paraminobenzoic acid and the folic-folinic acid cycle.
Trimethoprim is active against T. gondii but less so than pyrimethamine.
Trimetrexate and piritrexim are two of the inhibitors of the DHFR with
activity against T. gondii and significant protection against Toxoplasma infection
(Araujo and Remington, 1992).
2.8.1.1.2 Sulfonamides
These substances, namely sulfadiazine, sulfamethazine, sulfamerazine, act
against T. gondii by inhibiting the dyhidrofolic acid synthetase. Thus interfering with
the parasite's ability to use paramonobenzoic acid. As mentioned before, these
substances are widely used in combination with pyrimethamine. They are generally
well tolerated although sometimes thrombocytopenia and/or leukopenia may develop
(Fung and Kirschenbaum, 1996).
2.8.1.1.3 Clindamycin
In experimental models of acute and chronic infection, treatment with
clindamycin has been shown to reduce mortality as well as reduce tachyzoite
numbers and inflammation of the brain. The combination of pyrimethamine and
clindamycin was comparable to the widely used pyrimethamine-sulfadiazine for the
treatment of TE in AIDS (Remington and Vilde, 1991).
2.8.1.1.4 Macrolides and azalides
Roxithromycin, a derivative of erythromycin, has been reported to protect
mice against lethal infection with T. gondii. Azithromycin, has been proved to be
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more active than other macrolides, although the protection depends on the strain of T.
gondii used (Araujo and Remington, 1992).
2.8.1.1.5 Tetracyclines
Both doxycicline and minocycline have in vitro and in vivo activity against
the infection in mice, although their mechanism of action is unknown for the moment
(Wong and Remington, 1993).
2.8.1.1.6 Hydroxynapthoquinones
The hydroxynapthoquinone, atovaquone, has a potent activity against both the
tachyzoite and tissue cysts of T. gondii (Huskinson-Mark et ai, 1991). In murine
experimental models, atovaquone has significantly reduced mortality (Wong and
Remington, 1993).
2.8.1.1.7 Spiramycin
It has been shown that early treatment with spiramicyn may prevent
transmission of infection to the foetus but most probably cannot interrupt an existing
brain infection, which is the most severe outcome of congenital toxoplasmosis in
humans (Schoondermark et al., 1993).
2.8.1.1.8 Others
Several other agents have been experimentally tested for activity against the
parasite. Eimycine an inhibitor of DNA (deoxyribonucleic acid) and RNA
(ribonucleic acid) synthesis; arprinocid which inhibits hypoxantine transmembrane
transport and dapsone an inhibitor of T. gondii dihydropteroate syntheses.
58
2.8.1.2 Drug therapy in sheep
2.8.1.2.1 Monensin
The anticoccidial monensin was the first chemoprophylactic agent shown to
be effective against toxoplasmosis. When fed to the ewes daily during pregnancy at a
rate of 15mg per animal, treatment with monensin would control a subsequent
infection with T. gondii (Buxton et al., 1987; Buxton et al., 1988).
2.8.1.2.2 Decoquinate
The anticcocidial drug decoquinate fed daily to pregnant ewes (2mg per Kg
bodyweight) can also significantly reduce the effect of a Toxoplasma oocyst
challenge during pregnancy (Buxton et al., 1996).
2.8.1.2.3 Pyrimethamine and sulphamethazine
Buxton and coworkers (1993a) tested an effective treatment in human
medicine (pyrimethamine and sulphamezathine) to treat Toxoplasma infection in
sheep after infection had become established within the placenta and foetus. The
results showed that this combination suppressed the parasite in sheep, with no
lambing losses in the treated ewes.
2.8.1.2.4 Baquiloprim and sulphadimidine
This combination of agents which also blocks the folate synthesis has given
promising results in a controlled pilot study in non pregnant sheep (Buxton, 1993a).
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2.8.2 Vaccination against T. gondii infection
Unlike many other parasitic diseases, infection with T. gondii induces a life¬
long protective immunity and therefore offers the possibility of controlling the
disease by vaccination.
It is generally agreed that a vaccine to prevent oocyst shedding in cats would
be very desirable to prevent T. gondii oocyst shedding. However, this would only be
practical if all the cats would be vaccinated. This is extremely difficult because of the
stray and wild cat population. Currently there is a vaccine available in the USA to
prevent oocyst shedding in cats. This is a live vaccine which involves a strain of T.
gondii bradyzoites unable to form oocysts in the gut of the cat (Toxoplasma-263)
(Frenkel et ai, 1991). However, because it is a live vaccine and has to be grown in
mice, the production is problematic and it has a very short self life.
A more realistic aim would be the prevention of abortion both in woman and
ewes and prevention of tissue cysts formation in intermediate hosts. An effective
vaccine to reduce tissue cysts would be of great benefit in reducing transmission of
the disease to people via consumption of tissue cysts from infected animals.
A potential vaccine must afford long-term protection, be safe, cost-effective
and easy to deliver.
2.8.2.1 Live vaccines
Temperature-sensitive (Ts) mutants of the RH strain have been recently
described (Pfefferkorn and Pfefferkorn, 1976). One of these, which grew normally at
37°C but persisted for only 40 hours at 38°C and 39°C and 20 hours at 40°C, was
shown to be non-lethal to mice and hamsters. Organisms were not isolated from
infected mice two months after the initial inoculation and an effective and sustained
immunity developed (Waldeland and Frenkel, 1983; McLeod et al., 1988; Suzuki
and Remington, 1990). The Ts-4 mutant would appear to combine the advantages of
both live and killed vaccines, with its ability to proliferate for only a short period in
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vivo and to stimulate an effective CMI response. Because the Ts-4 mutant is a live
vaccine, it is not suitable for use in people.
In the USA, a vaccine to prevent cyst formation in pigs is being tried using
RH strain of T. gondii. Parasites of this strain are highly virulent in mice but cause
only mild disease in pigs and the parasites do not persist as tissue cysts in the
animals. When pigs that recover from the infection are re-infected with parasites of
cyst-forming strains, they do not show any signs of disease and have fewer cysts in
their tissues (Dubey et al., 1991).
In 1988, a live vaccine for the control of toxoplasmosis was launched on the
market in New Zealand (O'Connell et al., 1988; Wilkins et al., 1988) and in 1992 in
the United Kingdom and Eire (Buxton, 1993b). The vaccine comprises tachyzoites of
the S48 strain of T. gondii which is a short-lived, incomplete strain of the parasite
that exists only as the tachyzoite stage and is unable to form tissue cysts (Wilkins and
O'Connell, 1992). S48 T. gondii was originally isolated from an ovine abortion in
New Zealand and then passaged in laboratory mice about 3000 times before it was
shown to have lost the ability to develop bradyzoites in tissue cysts and initiate the
sexual life cycle of the parasite in cats (Buxton and Innes, 1995). When administered
to sheep by subcutaneous injection, S48 tachyzoites afforded a high degree of
protection against Toxoplasma induced abortion following challenge with oocysts
(O'Conell et al., 1988; Buxton et al., 1991). Live S48 tachyzoites now form the basis
of the first commercially available veterinary vaccine for toxoplasmosis (Buxton and
Innes, 1995). However, this vaccine is potentially hazardous for man and has a short
shelf-life making commercial production and distribution problematic.
2.8.2.2 Killed vaccines
Several attempts to induce protective immunity in sheep by inoculation of
whole killed Toxoplasma parasite preparations have been unsuccessful (Beverley et
al., 1971a, b; Wilkins et al., 1987; Buxton et al., 1989), and although many live
lambs were born, placental and fetal infection were not eliminated.
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Toxoplasma surface antigens combined with Quil A (immunostimulating
complexes or ISCOM) have been shown to elicit good humoral and cellular immune
responses and to provide protection against a lethal challenge in mice (Uggla et al.,
1988). However, while good titres of antibody were stimulated by the vaccine, only
moderate protection with reduction in abortion rate (not statistically significant) was
detected when the same preparations were use to prevent congenital infection and
abortion in pregnant sheep (0vernes et al., 1991; Lunden, 1995).
Good protection against acute infection in mice has been observed after
immunization with the major surface protein of T. gondii tachyzoites, P30 or SAG1,
either incorporated into liposomes (Biilow and Boothroyd, 1991) or in conjunction
with Quil A (Khan et al., 1991).
The search for an effective and safe vaccine against toxoplasmosis continues.
The main problem in using killed vaccines is the difficulties of inducing an
appropriate cell mediated immune response. Therefore there has been much interest
in studying different routes of antigen delivery to the host. Mucosal immunity (IgA
and CMI) can be elicited following oral T. gondii infection (Chardes et al., 1990;
Huskinson et al., 1990; Chardes and Bout, 1993). Vaccines are commonly
administered by a parenteral route, but the mucosal route is attractive for both
logistical and conceptual reasons. Professor Bout and colleagues in Tours (France)
have shown that mucosal vaccination of mice against toxoplasmosis using SAG1
antigen and cholera toxin (CT) as an adjuvant was very effective (Chardes et al.,
1993).
Nasal vaccination against T. gondii represents a novel approach to
vaccination against infectious diseases and has the advantage over oral administration
that the degradation of the antigen is minimal. A vaccine using killed antigenic
material, administrated nasally and effective after one dose which would induce both
mucosal and systemic immune responses against T. gondii infection and would be
very desirable (Bourguin et al., 1993; Chardes et al., 1993).
Preliminary studies have shown that the native 30 kDa protein SAG1 of T.
gondii coupled to CT has a great potential as a protective vaccine, affording 85%
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protection in mice (Darcy et al., 1992; Bourguin et al., 1993). However it remains to
be seen whether such a vaccine preparation would afford any protection against
congenital toxoplasmosis and abortion in sheep.
As recently stated by the WHO Veterinary Public Health Working group on
Toxoplasmosis Vaccine Development and Technology, there is a need for a vaccine
for meat producing animals. The general aims of such vaccine development are to
reduce abortion and neonatal mortality in sheep and to reduce the number of tissue
cysts in meat for human consumption and in this way reduce disease transmission to
people. Successful development of a killed vaccine for use in sheep would permit its
wider use and bring a vaccine for the prevention of human toxoplasmosis very much
closer.
2.8.3 Management practices to reduce T. gondii infection
There are two main targets in the control of toxoplasmosis. The first is
prevention of congenital Toxoplasma infection and the second is to reduce the risk of
transmission of T. gondii through the consumption of infected meat.
2.8.3.1 Oocyst infection
To prevent infection in cats and shedding of oocysts in cats faeces, control
programs should attempt to reduce infection of cats. When young cats start hunting
for the first time they eat T. gondii infected small rodents and birds. Following a
primary infection with T. gondii the cats will excrete high numbers of oocysts which
can persist in the environment for up to one year (Dubey and Frenkel, 1972). The risk
for contamination of animal feeds is high when litters of cats inhabit and defecate in
hay, grain or other feed store areas of the farm. Fecal contamination of pasture areas
can also be a significant cause of infection in grazing livestock.
Elimination of cats from farm areas is very difficult, therefore it is advised
that where possible feed should be stored in cat-proof areas, particularly feed for
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pregnant sheep. Cats should never be fed undercooked meat, viscera or bones.
Moreover, dead animals should be removed promptly from the farm area to prevent
scavenging by cats and foetal membranes and dead foetuses should be buried or
incinerated to prevent infection of felids and other animals on the farm.
Because oocysts can survive in the environment for several months up to one
year, contact with sporulated oocysts is likely to occur most frequently when working
with soil or when drinking contaminated water. Although human infection occurs
commonly by ingestion of tissue cysts in infected meat, to avoid oocysts infection,
individuals at high risk should avoid feeding pet cats undercooked meat, prevent the
cat hunting as far as possible, clean the litter box daily with scalding water and
incinerate or flush the faeces, wear gloves when working with soil and keep sand pits
covered.
2.8.3.2 Consumption ofT. gondii cysts
People are commonly infected following the ingestion of tissue cysts present
in undercooked infected meat. Veterinarians, farm workers, especially if pregnant,
and AIDS patients, should take precautions to avoid infection when handling raw
meat. Meat should be cooked to at least 66°C for 20 minutes (Dubey et al., 1990).
Hands should be cleansed thoroughly after handling raw meat. Freezing meat at
-20°C greatly reduces the viability of tissue cysts (Dubey, 1988). Microwaving does
not kill all T. gondii because of uneven cooking (Lunden and Uggla, 1992).
2.9 Neospora caninum and neosporosis
Neospora caninum is a recently recognised protozoan parasite of livestock
and companion animals. The disease was first recognised in Norwegian dogs with
encephalomyelitis and myositis (Bjerkas et al., 1984). The new genus, Neospora was
not proposed until 1988 following isolation of the parasite into tissue culture (Dubey
et al., 1988a).
64
Neosporosis has been described as a major cause of abortion in cattle in many
countries and an important cause of neuromuscular paralysis in dogs. Neospora
caninum is very closely related to T. gondii and unlike T. gondii is a major cause of
disease in cattle. Therefore a brief summary of current knowledge of the parasite and
the disease it causes in cattle may be pertinent to the understanding of T. gondii
infection in cattle.
2.9.1 Neosporosis in cattle
Thilsted and Dubey (1989) first reported N. caninum-Uke, organisms in the
brain of aborted bovine foetuses. Toxoplasmosis was excluded as the cause of
abortion because aborting cows did not show Toxoplasma-specific antibodies and T.
gondii is not recognised as abortifacient in cattle.
Abortion is the only clinical sign observed in infected cows (Anderson et al.,
1991). Dairy and beef cows of any age (Anderson et al., 1991; Wouda et al., 1995)
may abort from 3 months of gestation to term. Foetuses may die in the uterus, be
resorbed, mummified, autolysed, stillborn, born alive, but diseased, or born clinically
normal but chronically infected. There have been reports on abortions occurring
sporadically or in groups within a few weeks or abortions persisting in a herd (Dubey
and Lindsay, 1996). Neospora caninum seems to be able to cause repeated abortion
in the same cow although the rate of repeat abortion in low (<5%) (Obendorf et al.,
1995; Anderson et al., 1995). Degenerative and inflammatory lesions are most
common in CNS, heart, skeletal muscle and liver of the foetus (Wouda et al., 1996).
Examination of maternal and foetal sera for Neospora specific antibodies can aid
diagnosis, which is based mainly on detection of the parasite by immunohistology of
infected tissues. Neosporosis in congenitally infected calves is mainly characterised
by neurologic signs (Parish et al., 1987).
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2.9.2 Life cycle and transmission
Neospora caninum has been found in dogs, cattle, sheep, goats, horses and
deer (reviewed by Dubey and Lindsay, 1996). The complete life cycle of N. caninum
is not well understood and as yet the definitive host remains to be determined.
Transplacental infection, which may occur repeatedly in the same animal (Barr et al.,
1993), is the only natural route of transmission to date. Neospora caninum is
infective by experimental subcutaneous, intraperitoneal, intramuscular, intravenous
and oral routes (reviewed by Dubey and Lindsay, 1996). Bradyzoites within the tissue
cysts are resistant to HCl-pepsin solution, which may indicate that like T. gondii
carnivorism is part of the life cycle (Lindsay and Dubey, 1990).
2.9.3 Immunity to N. caninum
While the host immune response to T. gondii has been well studied, little is
known regarding the induction of the immune response following infection with N.
caninum. Seroconversion in cattle has been demonstrated following experimental and
natural infection with Neospora (Conrad et al., 1993). Detection of Neospora-
specific antibodies in the sera of cows by both IFAT (Dubey et al., 1988b) and
ELISA (Bjorkman et al., 1997; Williams et al., 1997), can be useful in the diagnosis
of bovine abortion and to study the seroepidemiology of the disease. Although
morphologically Toxoplasma and Neospora are very similar, they are genetically
distinct (Marsh et al., 1995). Moreover, there are antigenic differences between these
two parasites, demonstrated by the lack of cross reactivity between N. caninum and
T. gondii when examining specific antibodies. Neospora lack both of the major
surface proteins of T. gondii namely SAG1 (P30) and SAG2 (P22) (Brindley et al.,
1993). Little is known regarding the induction of the cellular immune response
during Neospora infection. It has been reported that IFNymay be involved in the host
immunity as the cytokine is able to inhibit intracellular multiplication of N. caninum
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in vitro (Innes et al. 1995c). Recent studies on experimentally infected mice have
demonstrated a cellular response to N. caninum. It can be characterised by the
induction of T cells and is mediated by the production of IL-12 and IFNy as the
administration of antibodies to these cytokines reversed natural protection in mice





3. Materials and Methods
3.1 Animals
All the animals involved in this study were kept in an environment considered
to offer minimal risk of T. gondii infection.
3.1.1 Sheep (Ovis auries)
Twenty-two sheep seronegative by ELISA for antibodies to T. gondii were
infected orally with different doses of T. gondii oocysts.
Figure 3. 1 Welsh Mountain ewe and lamb (Ovis auries)
Photograph courtesy of Dr. D. Buxton
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3.1.2 Cattle (Bos taurus)
Ten cattle seronegative by IFAT for antibodies to T. gondii and Neospora
caninum were orally infected with two doses of T. gondii oocysts.
Figure 3. 2 Young Ayrshire bulls (Bos taurus)
Photograph courtesy ofMr. J. McCracken
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3.1.3 Mice (Mus musculus)
Mature female Swiss White mice (inbred) were used to passage and maintain
T. gondii tachyzoites of the S48 strain as well as to study the viability of T. gondii
cysts in tissues. Females were used to avoid fighting and tail biting among competing
male mice. Porton mice were used to maintain the M3 isolate of T. gondii.
Figure 3. 3 Strain Porton (Mus musculus)
Photograph courtesy of Mr. S. Wright
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3.1.4 Cats (Felis catus)
Cats of both sexes, under six-months of age and seronegative for antibodies to T.
gondii, were obtained from a Toxoplasma free colony in the University of Newcastle
(UK).They were used to obtain viable T. gondii oocysts of the M3 isolate.
Figure 3. 4 Felis catus





The complete M3 isolate of T. gondii was originally isolated from the brain of
a stillborn lamb at Moredun Research Institute (Edinburgh, UK) on the 25th of April
1986, following i.p. inoculation of 2 female Swiss White mice with foetal tissue. It
was passaged for the first time 3 months later, and maintained by once yearly passage
in Porton mice (minimally inbred). The brains were aseptically removed and
homogenized in Hank's balanced salt solution (HBSS) by passage through a 16
gauge (G) needle. Between 40-100 tissue cysts were inoculated i.p.
The M3 isolate was chosen for this project because it has been proved to be a
complete isolate, capable of causing clinical toxoplasmosis in sheep and bradyzoites
of this isolate can induce oocysts formation in seronegative cats. This isolate was
experimentally used for the first time in 1991 (Buxton et al., 1991).
3.2.1.2 M3 tissue cysts
Brains from chronically infected Porton mice (4 on average) were removed
and homogenized in an equal volume of phosphate buffered saline (PBS), using an
18G needle and a syringe. Suspensions containing an estimate 10" T. gondii tissue
cysts were prepared.
3.2.1.3 Oocysts
Cats used as T. gondii donors were maintained in a negative pressure isolator
to minimize contamination of the environment with infective oocysts
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After a short period of acclimatization, each cat was infected with
approximately lCf M3 T. gondii tissue cysts, mixed with a little food. Faeces were
collected daily and screened for the presence of oocysts. Oocyst shedding
commences approximately 5 days post infection, and continues for 7-10 days. After a
3 day period when no oocysts were detected in the faeces, the animals were removed
from the isolator, which was then sterilized using a peroxide based disinfectant.
Cats were fed using a proprietary tinned food, and water was available ad-lib.
Moist, oily food was given in the event the animal became constipated (a not
infrequent occurrence during T. gondii infection in cats). Oocysts delayed in the gut
of the animal due to constipation usually fail to sporulate, and so are useless for
infection studies.
Sporulated T. gondii oocysts of the M3 isolate were obtained from infected
cat faeces using the Saturated Salt Flotation Technique described by Buxton et al.
(1988). Briefly, a small amount (0.5 to lg) of infected faeces was suspended in 10ml
of water and then centrifuged for 5 minutes at lOOOg. The pellet was resuspended in
10ml of saturated sodium chloride (NaCl) and the mixture centrifuged at lOOOg for
other 5 minutes. The meniscus was removed and transferred to an improved
Neubauer haemocytometer for microscopic examination (Vickers M75, x40
objective) for the presence of oocysts. If the sample contained oocysts the remainder
of the faeces was processed in similar manner.
Faeces were diluted 1:10 in water, homogenized thoroughly and then the
suspension was sieved through 1mm mesh. Aliquots of 50ml were centrifuged for 10
minutes at lOOOg (relative centrifugal force), the supernatant was discarded, and the
pellet resuspended in 50ml of saturated NaCl. After 10 minute centrifugation at
lOOOg, the meniscus was removed (approximately 5ml) and diluted 1:10 with water
and then centrifuged for 10 minutes at lOOOg. The pellet was resuspended in small
volume of water and counted using an improved Neubauer haemocytometer. Oocysts




Inoculum for sheep and cattle were made up by serial dilution, administered
as a 2ml aliquot by gavage, and washed down with 50ml water.
3.2.2 S48 strain
T. gondii strain S48 was originally isolated at Wallaceville (New Zealand)
from an aborted sheep foetus (Hartley and Marshall, 1957). This strain was passaged
twice-weekly in laboratory mice, about 3000 times before being shown to have lost
the ability to develop bradyzoites (Wilkins et al., 1987). The S48 strain has lost its
capacity to form oocysts in cats and is, therefore, referred to as an incomplete strain
(Wilkins et al., 1987; Frenkel et al., 1986). These parasites were used to prepare
antigen for the Antigen induced proliferation assay on peripheral blood mononuclear
cells and for the IFAT.
3.2.2.1 Maintenance
T. gondii tachyzoites of the S48 strain were maintained by passage in female
Swiss White mice. Mice were killed with carbon dioxide (CCF) and parasites were
harvested with a 26 G needle and syringe from the peritoneal cavities of mice that
had been infected three days earlier with 106 tachyzoites by i.p. injection (cellular
contamination below 2%).
3.2.3 RH strain
T. gondii complete strain RH was originally isolated at Cincinnati (USA)
from mice inoculated with a tissue sample from the CNS of a 6 year old boy with a
fatal acute nonsupurative encephalitis (Sabin, 1941). These parasites were used to
prepare antigen for the ELISA.
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3.2.3.1 Maintenance
T. gondii tachyzoites of the RH strain were maintained by passage in female
Swiss White mice. Mice were killed with C02 and parasites were harvested with a
26G needle and syringe from the peritoneal cavities of mice that had been infected
three days earlier with 106 tachyzoites by i.p. injection (cellular contamination below
2%).
3.3 Antigen preparation
3.3.1 Water soluble fraction of T. gondii antigen
The water soluble fraction of both T. gondii strains, RH and S48, antigen was
obtained based on the method described by Voller et al. (1976). RH strain was used
for the ELISA and S48 strain for the antigen induced proliferation assay on
peripheral blood mononuclear cells described later.
RH and S48 strains of Toxoplasma tachyzoites were obtained as described
previously (3.2.2 and 3.2.3). The peritoneal washings collected from infected mice
were given a minimum of six alternate 15 minute washes in 0.3M PBS and HBSS
(pH 7.4) to remove the host cell contamination to below 2%. After the final wash, the
supernatant was discarded and the pellet containing the tachyzoites was lysed by
resuspension in distilled water (10 times its volume). In order to rupture the
tachyzoites, the pellet was freeze-thaw three times followed by 6x30 seconds cycles
of sonication at 4°C. Particulate matter was then removed by centrifugation at
lOOOOg for 30 minutes at 4°C and the water soluble extract (supernatant fluid) was
stored in aliquots of 50(ig/ml at -20°C until required. Protein concentration was
assayed using BCA reagent (Sigma Chemical, UK) and read using a
spectrophotometer.
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3.3.2 Whole killed T. gondii antigen
T. gondii antigen using the S48 strain was prepared by modification of the
method described by Goldman (1957) and Munday and Corbould (1971) to be used
in the IFAT.
T. gondii tachyzoites of the S48 strain were harvested from mice infected 3 or
4 days previously by the peritoneal route (see 3.2.2). The peritoneal washings
collected were given a minimum of six alternate 15 minute washes in 0.3M PBS and
HBSS (pH 7.4) to remove the host cell contamination to below 2%. Suspensions of
formalinised tachyzoites (Formaldehyde solution 37/40%w/v, with 10-14% methanol




Blood samples were taken periodically from the jugular vein of sheep and
cattle (see Chapter 4 and Chapter 6 for further details) into preservative-free
evacuated blood collection tubes, Vacutainer®(Becton Dickinson Ltd., UK) and
allowed to clot. Following retraction of the clot, the serum was obtained after
centrifugation at 500g for 15 minutes and then stored at -20° C until required.
Blood samples were taken from the tail of Swiss White mice, 8 weeks after
inoculation with tissue samples from sheep and cattle, into heparinized haematocrit
tubes (Harsaw Chemicals Ltd., UK). The serum was obtained by centrifugation for
10 minutes and then stored at -20°C until required.
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3.4.2 Cell free peripheral blood plasma
Blood samples were taken periodically from the jugular vein of sheep and
cattle (see Chapter 7 for further details) into preservative-free heparinized (103U/ml
of Heparin sodium salt, Sigma Chemical, UK) evacuated blood collection tubes,
Vacutainer®(Becton Dickinson Ltd., UK) and centrifuged at 400 g for 20 minutes and
the plasma removed and stored at -20°C until required.
3.4.3 Peripheral blood mononuclear cells (PBMC)
Blood samples were taken periodically from the jugular vein of sheep and
cattle (see Chapter 7 for further details) into preservative-free heparinized (10 U/ml
of Heparin sodium salt, Sigma Chemical, UK) evacuated blood collection tubes,
Vacutainer®(Becton Dickinson Ltd., UK). Ten ml of each sample were mixed with
10ml of sterile PBS and placed into a sterile 20ml Universal, centrifuged at 400g for
20 minutes with the brake off in a GS-6R Beckman centrifuge® and the buffy coat
removed to a sterile 20ml Universal. The PBM cells were resuspended in HBSS
supplemented with 2% fetal bovine serum (FBS), lOOIU/ml of penicillin, 100pg/ml
of streptomycin (Northumbria Biologicals, UK), gently layered onto Lymphoprep
(Nycomed, Norway) in a 10ml conical centrifuge tube and centrifuged at 500g for 40
minutes in a GS-6R Beckman centrifuge® with the brake off. PBM cells from the
interface were then collected in a 20ml Universal® and washed twice with HBSS
supplemented with 2% FBS, lOOIU/ml of penicillin and 100p,g/ml of streptomycin.
3.4.3.1 Isolation ofperipheral blood mononuclear cells for Polymerase Chain
Reaction
The peripheral blood mononuclear cells obtained as described in 3.4.3, were
placed into a 1.5ml UV sterilized eppendorf. The remaining red blood cells (RBC)
were lysed by the addition of 1ml of lOmM Tris ammonium chloride followed by
centrifugation at 13000g for 30 seconds. The cells were then washed three times by
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resuspension in PBS and centrifugation at 13000g for 30 seconds. The cell pellet was
stored at -20°C until ready for use.
3.4.3.2 Peripheral blood mononuclear cells for antigen inducedproliferation
assay
The peripheral blood mononuclear cells obtained as described in 3.4.3, were
resuspended at 4xl06 cells/ml in culture medium comprising Iscove's Modified
Dulbecco's medium (IMDM) (Gibco, UK) supplemented with 10% FBS, lOOIU/ml
of penicillin, lOOpg/ml of streptomycin and 5 x 10~5M 2-Mercaptoethanol (Sigma
Chemical, UK).
3.4.3.3 Peripheral blood mononuclear cells forphenotypic analysis
Peripheral blood mononuclear cells were collected as described in 3.4.3.2 and
aliquots of 2xl06 cells per monoclonal antibody were used.
3.4.4 Cytokine analysis
Supernatants from short term cultures of PBM cells were collected after 96
hours of stimulation with specific antigen and stored at -20°C until required (see
Chapter 7 for further details).
3.4.5 Tissue samples
Either 6 weeks or 6 months after challenge of sheep and cattle postmortem
examinations were carried out. Carcasses of the killed animals were first inspected
for external lesions and then opened for gross examination of the internal organs.
During the postmortem examination, tissues were collected for histopathological
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examination, bioassays in mice and PCR (see Chapter 4 and Chapter 5 for further
details).
Tissue samples for histopathological examination were fixed in 10% formal
saline (40% formaldehyde and 0.9% sodium chloride) until processed. The samples
to be inoculated in mice were collected aseptically and those analyzed by PCR were
collected in sterile conditions and stored at -20°C until required.
3.5 Clinical response
3.5.1 Rectal temperatures
Rectal temperatures of sheep and cattle were recorded daily for the 3 days
before and 14 days after oral dosing with a clinical electronic thermometer (Solex,
UK).
3.5.2 Detection of parasitaemia by B1 Polymerase Chain Reaction
3.5.2.1 Detection of T. gondii DNA in PBM cells by the B1 PCR
Peripheral blood mononuclear cells were analysed by the B1 PCR to detect
and amplify T. gondii DNA following the procedure described by Wastling and
collaborators (1993). Method modified from that of Burg and co-workers (1989).
3.5.2.1.1 Peripheral blood mononuclear cell preparation
The peripheral blood mononuclear cells were obtained as described in 3.4.3.1
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3.5.2.1.2 DNA extraction from peripheral blood mononuclear cells
The cell pellet was defrosted and resuspended in K buffer containing
proteinase K (100 pg/ml) (Sigma Chemical, UK) and Tween 20 (polyoxyethilene
(20) sorbitan monosaturate) (Fison, UK) (0.5%). After incubating the mixture at
55°C for 1 hour, proteinase K was inactivated by boiling and the samples were stored
at -20°C.
3.5.2.1.3 Preparation of T. gondii tachyzoites of the S48 strain
Toxoplasma tachyzoites were passaged in Swiss White mice every three days
by intraperitoneal inoculation (106 tachyzoites)as described in 3.2.2. Peritoneal
exudate was removed and the parasite cleaned by washing with PBS followed by
HBSS and then centrifuged at 500g for 5 minutes. Parasites were counted using a
haemocytometer and preparations containing 98% tachyzoite suspension were used.
3.5.2.1.4 T. gondii DNA extraction for use as a positive control
DNA was extracted from 109 T. gondii tachyzoites for use as positive control
material. Parasites were lysed in 50mM Tris (pH 8.0), 50mM EDTA, 1% sodium
dodecyl sulphate (SDS), containing lOOjig/ml proteinase K. After incubation at 50°C
for three hours, the nucleic acid was extracted with an equal volume of
phenol/chloroform followed by an equal volume of chloroform. DNA was then
precipitated with 2 volumes of ethanol (100%) and 0.1 volume of 3M sodium acetate
at -20°C for 1 hour, followed by centrifugation at 10000 g. The pellet was washed in
70% ethanol and then resuspended in Tris-EDTA solution (lOmM Tris, EDTA, pH
7.6) and the DNA quantified by measuring UV absorption at 260 nm.
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3.5.2.1.5 Quantification of T. gondii DNA
The concentration of DNA preparations was assessed by taking readings of
Optical Density (OD)26o using a spectrophotometer (OD26o equal to 1 corresponds to
50p,g/ml double stranded DNA). Readings were also taken at OD280. DNA
preparations free from protein possessed an OD260: OD280 ratio approaching 2.0.
3.5.2.1.6 The B1 polymerase chain reaction
The polymerase chain reaction was carried out in a thermal cycler (Hybaid
Ltd., UK) over 25 cycles in 50|il volumes which were overlaid with 30|ll of mineral
oil. The B1 PCR system required the use of nested primers (see Figure 3. 5).
The method of Burg et al. (1989) was modified to amplify the multi-copy B1
gene. The reaction mixture contained lOmM Tris (pH 8.3), 2.5 mM MgCl2, 40mM
KC1, 0.01% gelatin, O.lmM d-NTPs (deoxy nucleotide triphosphate) (Pharmacia
Biosystem Ltd., UK), 0.2|iM of each oligonucleotide primer (Oswell DNA Services,
Edinburgh, UK) and 2.5 units of Taq DNA polymerase (Boehringer Mannheim,
Germany). Primers PI, P3 and P4 were as described by Burg et al., (1989) but P2
consisted of only 20 bases corresponding to nucleotides 757-776 of the B1 gene.
Figure 3. 5 Primers for detection of the multi-copy gene B1
PI (external), annealing to nucleotides 694-714
P2 (internal), annealing to nucleotides 757-776
P3 (internal), annealing to nucleotides 853-831
P4 (external), annealing to nucleotides 887-868
GGA ACT GCA TCC GTT CAT GAG
TGC ATA GGT TGC AGT CAC TC
GGC GAC CAA TCT GCG AAT ACA CC
TCT TTA AAG CGT TCG TGG
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Amplification was performed with PI and P4 to give a 193 base pair (bp)
product over 25 cycles of denaturation at 93°C for 20 seconds, annealing at 50°C for
20 seconds and extension at 70°C for 40 seconds. The final cycle was extended by 4
minutes at 70°C. Amplification products were then diluted 1: 20 in distilled water to
reduce amplification of non-specific products and amplified again with nested
primers P2 and P3 over 25 cycles in the same conditions to give a 96 bp product.
With this method, 0.05 pg ofDNA could be seen on 2% agarose gel.
Negative controls consisting of distilled water were run for each set of tests to
monitor cross-contamination.
A DNA ladder of 50-1000 bp (Amersham, UK) with a concentration in each
band of approximately 50ng/5pl of DNA ladder loaded, was used to estimate the
band size of the amplified product.
3.5.2.1.7 Agarose electrophoresis of DNA
Amplification products were analyzed on 2% agarose gels (w/v) (nucleic acid
grade ultrapure agarose, Bio-Rad Laboratories Ltd., UK) in Loening E buffer
(900mM Tris, 750mM NaPLPCL, 25mM EDTA, pH 7.6-7.8) using agarose "sub-
cell" gel tanks (Pharmacia, UK). Ethidium bromide (2,7-diamino-10-ethyl-9-phenyl-
phenanthridinium bromide; homidium bromide; 500p/ml, Sigma Chemical, UK) was
added to molten agarose at a final concentration of 0.2 pg per ml. DNA loading
buffer (0.1% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol, 75mM EDTA,
25% sucrose) was added 1:9 (v/v) to samples prior to loading, and electrophoresis
was carried out at 60 volts per cm in Loening E buffer until required resolution was
achieved. DNA was then visualized using ultraviolet translumination on a Hybaid
Crosslinker (Hybaid, UK).
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The detected product was confirmed to be T. gondii DNA by transfer of the
agarose gel to nitrocellulose membrane and detection of bound digoxigenin (DGI)
labelled probes to T. gondii DNA.
3.5.2.1.8 Southern Blotting of DNA to nitrocellulose membrane
DNA was then transferred from agarose gel to nitrocellulose membranes
using a modification of the method described by Smith and Summers (1980). The gel
was denaturated in 0.5M NaOH, 1.5M NaCl for 30 minutes, and then neutralized in
1.5M ammonium acetate, 0.02M NaOH for 30 minutes. The membrane was then
placed on top of the gel followed by 3 sheets of Whatman 3MM chromatography
paper (Whatman, UK) soaked previously in neutralizing solution for 20 minutes
(1.5M NH4 acetate, 0.02M NaOH). Finally a 3cm stack of paper towels and lKg
weight were placed on top of the membrane. Transfer was carried out over 3 to 18
hours. The filter was then washed in neutralizing solution for 20 minutes, blot dried
with 3MM paper and incubate at 37°C for 10 minutes. The DNA was then fixed to
the membrane in a vacuum oven at 80°C for 1 hour.
3.5.2.1.9 Preparation of Digoxigenin labelled DNA probes
PCR products were labelled with DIG using the DIG DNA labelling and
detection kit (Boehringer Mannheim, Germany). A fragment of 96 bp (using P2 and
P3) was used. The DNA was denatured by boiling for 10 minutes, incubated with 1
pi random hexanucleotide mix, lpl dNTP labelling mix and 1 unit of Klenow
enzyme for 2-16 hours at 37°C. This labelling reaction results in the random
incorporation of DIG-11 -dUTP (deoxy uracil triphosphate) every 20-25 nucleotides
in the newly synthesized DNA (Feinberg and Volgenstein, 1983).
3.5.2.1.10 Hybridization of DIG labelled probes
Hybridizations were carried out as described by Boehringer Mannheim
(Germany). Filters were prehybridized by incubating in hybridization solution
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(5x SCC (sodium chloride and sodium citrate buffer), 5% (w/v) blocking solution,
0.1% (w/v) N-lauroylsarcosine Na-salt, 0.02% (w/v) SDS, 50%v/v formamide) for 1
hour at 42°C. Freshly denaturated probe was added (2-5|ll) and hybridization was
carried out for 2-16 hours at 42°C. Filters were washed twice in 2xSCC, 0. l%w/v
SDS for 5 minutes at room temperature and then twice in 0. lxSCC, 0.1%w/v SDS
for 15 minutes at 42°C.
3.5.2.1.11 immunological detection of bound DIG labelled probes
All the incubations in this method were carried out at room temperature and,
except for the colour reaction, with shaking.
Filters were washed briefly in Buffer 1 (lOOmM Tris, 150mM NaCl) and then
blocked in Buffer 2 (Buffer 1 with 0.5% (w/v) blocking solution) for 30 minutes.
After washing the filters were incubated in 10-20ml Buffer 1 containing 1:5000 (v/v)
dilution of anti-DIG alkaline-phosphatase conjugate for 30 minutes. The unbound
conjugate was removed by washing twice in Buffer 1 for 15 minutes. The filters were
equilibrated in Buffer 3 (lOOmM Tris-HCl, lOOmM NaCl, 50mM MgCh, pH 9.5)
and a colour solution was added which consisted of 45(0.1 nitroblue tetrazolium (NBT)
solution (75mg /ml nitroblue tetrazolium salt in dimethylformamide), and 35(il X-
phosphate (50mg/ml in 5-bromo-4-cloro-3-indolylphosphate, toludinium salt in
dimethylformamide) in 20ml Buffer 3. The filters were then incubated in the dark for
1-24 hours until the colour developed and the reaction stopped by washing briefly in
Tris-EDTA solution. Finally the filters were air dried.
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3.6 Humoral immune response
3.6.1 Indirect fluorescent antibody test
An IFAT was used to quantify T. gondii specific antibodies in test sera from
challenged sheep and cattle, based on that described by Munday and Corbould
(1971).
3.6.1.1 Serum samples
Samples were collected as described in 3.4.1 Serum samples.
3.6.1.2 Antigen preparation
Whole killed T. gondii antigen using the S48 strain was prepared as described
in 3.2.2 S48 strain.
3.6.1.3 Conjugate
Rabbit anti bovine IgG (whole molecule) FITC conjugate and pig anti sheep
IgG (whole molecule) FITC conjugate were supplied by Sigma Chemical (UK).
3.6.1.4 Assay procedure
Five microlitres of a suspension of formalinised (0.2% v/v) tachyzoites
(107per ml) were layered onto each well of 15 well HTC autoclavable slides (Cell-
Line Ltd., USA) and left to dry overnight in a dust free area. The slides were fixed in
methanol for ten minutes and then washed twice in PBS for 10 minutes each time.
After washing, 5pl of diluted test sera and hyperimmune serum (diluted in PBS) as a
positive control, were added to each well. The sera were tested at dilutions of 1:16,
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1:32, 1:64, 1:128, 1:256, 1:512, 1:1024, 1:2048, 1:4096, 1:8192, 1:16384, 1:32768
and 1:65536. One well contained 5pl of a non immune serum acting as a negative
control and one well with PBS only as a background control for the FITC conjugated
second antibody. The slides were incubated in a moist atmosphere at 37°C for 30
minutes and then washed in PBS for two ten minute periods.
All the wells were layered with 5|il of either rabbit anti bovine IgG (whole
molecule) FITC conjugate (1/256 working dilution) or pig anti sheep IgG (whole
molecule) FITC conjugate (1/40 working dilution) diluted in PBS containing 0.2%
Evan's Blue. After incubation for another half an hour at 37°C in a moist atmosphere
the slides were washed with PBS (3x10 minutes washes) and finally the slides were
mounted using Citifluor (glycerol/PBS solution, Citifluor Ltd., UK) and viewed with
UV light under an Olympus BX50 microscope using a U-MNB filter cube with a x40
objective.
Values up to 1/32 were considered negative and values over 1/32 considered
positive for ovine samples.
3.6.2 Enzyme-Linked Immuno-Sorbent assay
An ELISA to quantify IgG antibody to T. gondii on ovine and murine serum
samples was used based on that described by Voller and collaborators (1976) and
Buxton and co-workers (1988).
3.6.2.1 Serum samples




Water soluble fraction of T. gondii antigen using the RH strain was prepared
as described in 3.3.1 Water soluble fraction of T. gondii.
3.6.2.3 Assay procedure
Dynatech 96 flat bottom plates (Dynatech Ltd., UK) were coated with 150(il
of T. gondii antigen (estimated protein: 3|J.g/ml) diluted at 1:500 in 0.1M
carbonate/bicarbonate buffer (pH 9.6) and incubated overnight at 4°C. Plates were
then washed three times in PBS containing 0.05% Tween 20 (pH 7.4) (PBST).
Serial doubling dilutions (1:800 to 1:102400) of a standard high titre sheep
antiserum to T. gondii were included, and 150 |il of test serum diluted 1:500 in
PBS/1% BSA (Bovine Serum Albumin-99% albumin, BSA) (Sigma Chemical, UK)
was added to the appropriate well and the plates incubated for 2 hours at 37°C in a
moist atmosphere. After three washes with PBST, 150|il of conjugate (either pig IgG
anti sheep IgG conjugated to horseradish peroxidase (1/500) or rabbit IgG anti mouse
IgG conjugated to horseradish peroxidase (1/20000)) (Sigma Chemical, UK) diluted
in PBST containing 1% BSA were added and incubated for a further 2 hours at 37°C
as described above.
The plates were then washed three times with PBST and 150jil of ortho-
phenylenediamine substrate (OPD, Sigma Chemical, UK) was added and incubated
for 30 minutes in the dark at room temperature. The substrate consisted of 40mg
OPD in 100ml phosphate/citrate buffer (0.02M citric acid, 0.05M sodium hydrogen
phosphate, pH 5) plus 40|il H202. The enzyme-substrate reaction was stopped by the
addition of 50pl of arrestor (2.5M IUSO4) to each well. The resulting colour changes
were read on an ELISA plate reader measuring OD with a 492nm filter.
The OD of the standard high titre serum dilutions were used to construct a
standard curve. The OD at a dilution of 1 in 500 was read and given the arbitrary
value of 100% and all subsequent OD values within the experiment were expressed
as a percentage of this with the following equation (Buxton et al., 1988):
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(exp erimental OD) - (negative antigen OD)
^^
(standard OD) - (negative antigen OD)
A positive result was taken to be any reading above 25% for sheep and above
10% for the mice.
3.7 Cellular immune response
3.7.1 Antigen induced proliferation assay on peripheral blood mononuclear
cells
A proliferation assay using PBM cells was set up to analyse the response of
the cells to T. gondii antigen as described by Innes and collaborators (1995a).
3.7.1.1 PBMCpreparation
PBM cells from challenge sheep and cattle were collected as described in
3.4.3.2 and resuspended at 4xl06cells/ml.
3.7.1.2 Antigen preparation
Water soluble extract of T. gondii was prepared as described in 3.3.1 Water
soluble fraction of T. gondii.
3.7.1.3 Concanavalin A
Concanavalin A (Con A) (Sigma Chemical, UK), the lectin of the jack bean
0Canavalia ensiformis), was used as positive control for the test, as it has been
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described to selectively stimulate T lymphocytes (Janossy and Greaves, 1971; Rouse
and Babiuk, 1974). In contrast untreated cells were used as a negative control.
3.7.1.4 Radiolabelling
All the cultures were pulsed with [3H]-thymidine (The Radiochemical Centre,
Amersham, Buckinghamshire, UK).
3.7.1.5 Assay procedure
Aliquots each of 100 pi of PBM cells and 100 pi of diluted T. gondii antigen
were added to a 96 well round bottomed plate (Nunc, Denmark) in quadruplicate.
Cells and antigen were cultured for five days at 37°C in a humidified 5% CO2
incubator and pulsed for the final 18h with 0.5pCi (18.5 KBq)/ well of [3H]-
Thymidine, prior to harvesting onto filters. Cell associated radioactivity was
quantified in a beta scintillation counter.
3.7.1.6 Determination ofStimulation index
The results reported as counts per minute (cpm) are the mean value of
"3
quadruplicate cultures. The differential incorporation of [~H]-Thymidine between
treated and untreated cultures was used as a measure of proliferation expressed as
stimulation index (SI):
cpm of test culture
cpm of negative control culture
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3.7.2 Phenotypic analysis of peripheral blood mononuclear cells
An indirect immunofluorescence test was used to stain PBM cells from sheep
and cattle as described by Innes and collaborators (1995a).
3.7.2.1 PBM cells preparation
PBM cells from challenge sheep and cattle were prepared as described in
3.4.3.3 Peripheral blood mononuclear cells for phenotypic analysis.
3.7.2.2 Monoclonal Antibodies
Appropriate monoclonal antibodies (MoAb) at a pre-determined optimal
dilution were used to stain the different population of cells.
Table 3. 1 Monoclonal antibodies specific for distinct sheep and cattle leukocyte molecules
Antibody specificity
Species CD2+ CD4+ CD8+
sheep 36F 17D 7C2
cattle CC42 CC8 CC63
The monoclonal antibodies specific for distinct sheep leukocyte molecules
were obtained from the Basel Institute for Immunology (Switzerland) and the
monoclonal antibodies specific for cattle leukocyte molecules were obtained from
Institute for Animal Health (IAH) in Comptom (UK).
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3.7.2.3 Conjugate
Fluoroscein isothiocyanate (FITC) conjugated anti-mouse immunoglobulin
(Dakopatts, Denmark) was used.
3.7.2.4 Assay procedure
Aliquots containing 2xl06 washed PBM cells were resuspended in 50p.l of
fluorescence-activated cell sorter (FACS) medium (HBSS supplemented with 2%
FBS and 0.01M sodium azide) and mixed with 50pl of the appropriate MoAb at a
predetermined optimal dilution. Cells and MoAbs were incubated at 4°C for 30
minutes and washed three times by repeated resuspension and centrifugation for 3
minutes at lOOg. The supernatant fluid was removed and 50pl of a 1:50 dilution of a
FITC conjugated anti-mouse was added to the cells. After a further 30 minute
incubation the cells were washed as described above before fixing in PBS containing
1% paraformaldehyde.
3.7.2.5 Determination of stained cells
The percentage of stained cells was determined for each MoAb and a sample
stained only with the FITC conjugate was used as a control. Ten thousand cells were
analyzed per sample using flow cytometry (FACScan).
3.7.3 Cytokine analysis
Cell free peripheral blood plasma and supernatant from short-term cultured
PBM cells were tested for the presence of IFN, either biologically active IFN using a
bioassay described by Entrican and collaborators (1989, 1992) or IFNy using an
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enzyme immunoassay (EIA) test (CSL Veterinary, Australia) as described by the
manufactures.
3.7.3.1 Peripheral bloodplasma collection
Cell free peripheral blood plasma was collected as described in 3.4.2 Cell free
peripheral blood plasma.
3.7.3.2 Supernatants from short term PBMC cultures
Supernatants from short term cultures of PBM cells were collected as
described in 3.4.4 Cytokine analysis.
3.7.4 Bioassay for detection of biologically active IFN
This assay was performed as described by Entrican and co-workers (1989,
1992). Samples were tested for their ability to inhibit the replication of Semliki
Forest virus (SFV) in ovine fibroblast cells.
3.7.4.1.1 Ovine fibroblast cells
ST-6 cells, cultured from an ovine adenocarcinoma of the small intestine by
repeated passage in vitro, were used as the target cell in the assay. The derivation and
characterization of these cells have already been described by Norval and co-workers
(1981).
3.7.4.1.2 Semliki Forest virus
Semliki Forest virus (kindly provided by Dr. Entrican, MRI) was added to the
cultures in order to measure the cytopathic effect (CPE) provoked.
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3.7.4.1.3 Assay procedure
ST-6 cells were plated out in 96-well flat-bottomed microtitre plates (Costar,
UK) at a density of 5xl03 cell per well in lOOpl of IMDM supplemented with 5%
FBS. When the cells formed a confluent monolayer (3-4 days), neat test samples
were added to quadruplicate well in 100|il volumes. ST-6 cells cultured with medium
alone were used as a negative control and ST-6 cells cultured with SFV alone were
used as positive control. Following a further 24 hour incubation the medium in the
wells was removed and replaced with 100 tissue culture infective dose (TCID)5o of
SFV in 200jll1 of IMDM supplemented with 2% FBS. The plates were then incubated
with the virus for 48 hours before the CPE was measured.
A sample was considered to be negative for interferon if the fibroblast cells
have rounded up due to viral replication. Cells were protected from viral replication
if biologically active IFN was present in the test samples. The assay was read visually
and the % of CPE was estimated for each test sample.
3.7.4.2 Enzyme immunoassay for detection of IFNy
This enzyme immunoassay was performed as described by manufacturers.
This test consisted of a sandwich enzyme immunoassay able to detect IFNy. This test
is capable of detecting less than 50pg/ml of recombinant IFNy, the approximate
equivalent of less than 1 unit of IFNy.
3.7.4.2.1 Assay procedure
Diluted samples were loaded onto microtitre plates coated with antibody to
IFNy and incubated at room temperature (22° ± 5°C for 60 ± 5 minutes). Unbound
material was then removed by washing (six times) with wash buffer. After the sixth
wash the plates were placed face down on clean filter paper and allowed to drain in
order to remove as much remaining wash buffer as possible. Then freshly prepared
conjugate, comprising horseradish peroxidase labelled anti-bovine IFNy, was added
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to react with IFNy bound to the antibody coated to the solid support, incubated as
above and unreacted conjugate was removed by washing as previously described.
Enzyme substrate containing FECF was added and incubated for 30 minutes at room
temperature. The reaction was finished when enzyme stopping solution with 0.5M
H2SO4 was added.
The rate of conversion of substrate is proportional to the amount of bound
IFNy. The amount of colour development was estimated spectrophotometrically.
3.8 Parasite detection in tissue samples
To determine the presence of T. gondii within the tissues of the challenged
animals, half of the animals in each group were killed at six weeks and at six months
after challenge and post-mortem examination was carried out. Samples of the several
tissues were collected in order to be analyzed for the presence of T. gondii (see
Chapter 4 and Chapter 5 for further details).
3.8.1 Histopathology examination
3.8.1.1 Samples collected
Tissue samples were taken from animals necropsied either six weeks or six
months after infection for microscopic examination. Samples of the following tissues
were collected: brain, spinal cord, cardiac muscle, skeletal muscles (psoas, gracillis),
liver, mesenteric lymph node, lung and kidney immediately fixed in 10% formal
saline and processed for microscopically examination.
3.8.1.2 Tissue section preparation
Tissues were fixed in 10% formal saline (40% formaldehyde and 0.9%
sodium chloride) for 2 to 4 hours, then post-fixed for lh using modified Bouin
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(saturated aqueous picric acid 1%, 40% formaldehyde and glacial acetic acid). The
tissues were processed routinely in a Hypercenter-XP (Shandon, UK) and embedded
in paraffin wax. Sections 4jj.m thick were cut, placed on poly-l-lysine coated slides,
and dried overnight at 37°C.
3.8.1.3 Haematoxylin and eosin stain
Sections were dewaxed in xylene, rehydrated by a graded series of alcohol
and washed in tap water. They were stained in Mayers haematoxylin for 5 minutes,
differentiated by 1% HC1 in 70% alcohol and blued up in Scott's Tap Water
Substitute. A counterstain of eosin was used before dehydration through a graded
series of alcohol into xylene. The slides were mounted permanently using
CoverBond-Mounting Media (xylene based mountant). Nuclei were stained blue and
the cell cytoplasm was stained pink.
3.8.2 Bioassay in mice
To define the presence of viable T. gondii, tissue samples of brain, cardiac
muscle and skeletal muscle (psoas and gracillis) were collected from the challenged
sheep and cattle, processed and intraperitoneally inoculated into three mice.
3.8.2.1 Sample preparation
Approximately 1 to 3 gr. of infected tissue was removed and placed in a
sterile container. The sample was homogenized with 10ml of 0.25% trypsin in PBS
and incubated with gently agitation for 60 minutes at 37°C. The large particles were
removed by filtering with fine mesh gauze and then pelleted at lOOOg for 15 minutes.
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3.8.2.2 Assay procedure
Once the samples were processed, three female Swiss White mice were each
inoculated with 0.5ml of the processed sample by i.p. injection. The animals were
inspected daily for signs of a febrile response that may indicate acute toxoplasmosis.
Mice which showed signs of illness (tottering gait, hunched appearance alongside
evidence of emaciation and dehydration) were culled immediately and a sample of
peritoneal exudate removed and inspected for tachyzoites by microscopic
examination. Mice which survived were bled at 8 weeks post inoculation and the
presence of specific T. gondii antibodies detected by IgG ELISA as described on
3.6.2 Enzyme-Linked Immuno-Sorbent assay.
A group of mice from a Toxoplasma free colony which received no inoculum
was used as negative controls.
3.8.3 Detection of T. gondii DNA by the B1 polymerase chain reaction
A B1 PCR technique was used to detect and amplify specific T. gondii DNA
from tissues of orally challenged sheep and cattle.
3.8.3.1 Samples collected
Tissues were taken from animals necropsied either six weeks or six months
after challenge. Tissue samples of brain, cardiac muscle and skeletal muscles (psoas,
gracillis), were removed, placed in a sterile container and stored at -20°C until
required.
3.8.3.2 DNA extraction from tissue samples
Each tissue was finely chopped and processed as described in 3.5.2.1.2 DNA
extraction from peripheral blood mononuclear cells.
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3.8.3.3 S48 T. gondii preparation and DNA extraction
DNA was extracted from S48 tachyzoites as described on 3.5.2.1.3
Preparation ofT. gondii tachyzoites of the S48 strain and 3.5.2.1.4 T. gondii DNA
extraction.
3.8.3.4 Quantification ofDNA from T. gondii
The concentration of DNA was assessed by taking readings of Optical density
as described in 3.5.2.1.5 Quantification of T. gondii DNA.
3.8.3.5 TheBlPCR
The nested B1 PCR was carried out in a Hybaid thermal cycler over 25 cycles
in 50pl volumes as described in 3.5.2.1.6 B1 polymerase chain reaction.
3.9 Statistical analysis
A Student's t-test was calculated, using the mean values in each group to








To examine parasitaemia and host humoral immune response in sheep given a
titrated dose of T. gondii oocysts of the M3 isolate.
To establish the dose of oocysts required to produce a detectable amount of
T. gondii parasites within sheep tissues.
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4. Oral infection of sheep with a titrated dose of
T. gondii oocysts
4.1 Introduction
In the early nineteen seventies the identification of the cat as the definitive
host of T. gondii occurred with the discovery of oocysts in its faeces (Hutchison et
al., 1969, 1970, 1971; Work and Hutchison, 1969a, b; Frenkel et al., 1970; Dubey et
al., 1970a, b; Sheffield and Melton, 1970; Jackson and Hutchison, 1989).
Transmission of infection by ingestion of T. gondii oocysts is the main cause
of infection in herbivores, along with congenital transmission. This was confirmed in
several reports on natural outbreaks of clinical toxoplasmosis in sheep where the
source of infection was T. gondii oocysts (Plant et al., 1974; Dubey et al., 1986; Faull
et al., 1986).
Infection with T. gondii usually results in the formation of parasite cysts in
the host tissues, characterizing subclinical chronic infection (Frenkel et al., 1970). In
the majority of intermediate hosts, such as sheep, this parasite stage may persist for
the life time of the host (Lainson, 1959; Jacobs et al., 1960a, b; Remington and
Cavanaugh, 1965; Robertson, 1966; Conley and Jenkins, 1981; Dubey and Beattie,
1988).
The first study of experimentally induced toxoplasmosis in sheep orally
infected with 104 oocysts was reported in 1975 by Beverley and collaborators. The
objective of this study was to investigate the possibility of oocyst formation in sheep
as well as the development of T. gondii infection in sheep following oral infection
with oocysts. No evidence was found that Toxoplasma oocyst formation occurs in
sheep, and it was stated that a primary infection with T. gondii oocysts in pregnant
sheep can be just as harmful to the foetus as an infection using T. gondii tissue cysts
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(Beverley et al., 1975). Since then, several research groups have used T. gondii
oocysts to conduct experimental infections of sheep. Dubey and Sharma (1980)
showed that after oral infection of naive 4- to 6-year-old sheep, with either 102 or 105
oocysts of the GT-1 strain, there was a transient and low parasitaemia. Toxoplasma
was isolated from numerous tissues of orally infected animals by mouse inoculation.
It was stated that the persistence of the parasite in skeletal muscle of sheep indicates
that this may be a favoured site of T. gondii in sheep and the difference in the doses
administered did not affect the distribution of the parasite in the tissues (Dubey and
Sharma, 1980).
In 1988, McColgan et al., carried out a titration experiment in which fifty-
nine ewes, seronegative to T. gondii, were allocated into four groups which received
20, 2xl02 or 2x103Ml Toxoplasma oocysts. It was demonstrated that 2xl02 oocysts
given orally to sheep was the threshold infective dose, defined by febrile response
and seroconversion. During this experiment, sheep given 2xl03 Ml oocysts
developed a significant febrile response and seroconverted with significantly higher
%OD by IgG ELISA than the animals which received the lower doses.
Garnham and Lainson (1960) first reported the persistence of T. gondii cysts
in ovine tissues after parenteral inoculation of sheep with tissue cysts. The infected
animals were killed at either 112 or 150 days after infection and the parasite was
isolated from brain, skeletal muscle, heart, liver and kidney by intraperitoneal
inoculation of 1ml of the tissue suspension into pairs of multimammate rats
(Mastomys concha).
The aims of the present study were to describe the parasitaemia and humoral
response in sheep experimentally infected with a titrated dose of T. gondii oocysts
and to ascertain the dose of oocysts which would produce detectable levels of
parasite in sheep tissues.
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4.2 Materials and methods
4.2.1 Animals
Twelve 9-month-old male Greyface sheep shown to be seronegative to
T. gondii by ELISA were used in this study.
Mature Swiss White mice of both sexes from Toxoplasma free colonies were
used to passage and maintain the S48 strain of T. gondii tachyzoites as described in
Chapter 3 (3.1.3, 3.2).
Cats of both sexes, under six months of age and seronegative for antibodies to
T. gondii, obtained from a Toxoplasma free colony in the University of Newcastle
(UK) were used to produce M3 isolate T. gondii tachyzoites (Chapter 3, 3.1.4).
4.2.2 Toxoplasma gondii
To produce sporulated oocysts of the M3 isolate of T. gondii, cats were fed a
suspension of approximately 10 tissue cysts mixed in a small amount of food and
their faeces were collected daily and analyzed for the presence of oocysts (Chapter 3,
3.2.1.3).
Toxoplasma gondii tachyzoites of the S48 strain were prepared as described
in Chapter 3 (3.2.2), and used as antigen in the serological analysis. Tachyzoites were
counted using a haemocytometer and preparations with less than 2% cellular
contamination were used as antigen for the IFAT (Chapter 3, 3.3.2).
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4.2.3 Experimental design
Sheep were allocated into three groups as described in Table 4. 1. On day 0
suspensions containing 103, 104 and 105 sporulated T. gondii oocysts of M3 isolate
were administrated to the sheep by gavage (Table 4. 1).
Table 4.1 Experimental design
Group Species Animal numbers M3 Oocysts dose
1 sheep SI, S2, S3, S4 105
2 sheep S5, S6, S7, S8 104
3 sheep S9, S10, SI 1, S12 103
s: sheep
4.2.4 Clinical analysis
Rectal temperatures were recorded daily from 3 days before and until 14 days
after oral infection with a clinical electronic thermometer.
Blood samples were taken daily from the jugular vein from 3 days before and
until 14 days after infection, PBM cells were separated and examined using the B1
PCR to detect any specific T. gondii DNA (Chapter 3, 3.4.3).
4.2.5 Serology
Blood samples were collected from the jugular vein of sheep into preservative
free evacuated blood collection tubes and allowed to clot. Following retraction of the
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clot and centrifugation at 500g for 15 minutes, serum was removed, and stored at
-20°C until required. Serum samples were collected every second day from 3 days
before and until 14 days after infection to examine for the presence of specific
antibodies (see Appendix Chapter 4 for further details).
An IFAT was used to quantify T. gondii specific antibodies in test sera, based
on the method described by Munday and Corbould, 1971 (Chapter 3, 3.6.1).
An ELISA was used to detect IgG antibody to T. gondii. The method was
described by Voller and collaborators (1976) and Buxton and co-workers (1988)
(Chapter 3, 3.6.2).
4.2.6 Parasite detection
All the animals were killed 6 weeks after infection.
4.2.6.1 Histopathology
Samples of brain, cardiac muscle, skeletal muscle (gracillis and psoas), lung,
liver, kidney and mesenteric lymph node were removed and immediately fixed in
10% formal saline, then processed using the method described in Chapter 3 (3.8.1).
Sections 4jim thick were cut from the paraffin wax embedded tissues, placed on
poly-l-lysine coated slides, and stained following the method outlined in Chapter 3
(3.8.1.3) prior to microscopic examination.
4.2.6.2 Polymerase chain reaction
Samples of brain, cardiac muscle, and skeletal muscle (gracillis and psoas)
were taken for specific DNA detection using the B1 PCR. To address the problem of
sampling error four large samples of approximately lOOg were taken from different
sections of each organ and stored at -20°C prior to extraction ofDNA for PCR
analysis. Approximately two grams of each sample were analysed and when a
105
positive result was obtained the remainder of the sample was not tested. The PCR
product was confirmed to be T. gondii DNA by Southern blotting and immunological





The rectal temperature data were analysed by taking the mean of the
temperature values for all the animals, recorded before infection on day 0, as a base
line value. A dose dependent febrile response was observed when rectal temperatures
were recorded daily for 14 days following infection. All three groups showed rectal
temperatures below 40°C before infection. The febrile response, which reached
values of greater than 42°C, lasted for five days (P<0.01) (Figure 4.1). Details of the
individual animals are displayed in Appendix Chapter 4 (Table 2 to Table 4).
Group 1(105 oocysts) showed a significant response (P<0.01 Student's t-test)
compared to base line value on day 4 after infection which reached a peak on day 5
before starting the return to base line value by day 8. However, the other two groups
(Group 2: 104 oocysts and Group 3: 103 oocysts) had a significantly later response
(,P<0.01 Student's t-test) compared to group 1, starting the return to base line values
on day 9 post infection. Group 2 reached the peak temperature on day 5 and group 3
peaked on day 6 after infection.
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Figure 4.1 Mean (+se) rectal temperatures of sheep following primary oral infection with T. gondii oocysts
of the M3 isolate
°C
days after infection
The mean base line value is represented by a continuous line at 39.75°C. se: standard error
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4.3.1.2 Parasitaemia
The results obtained from the analysis of PBM cells for the presence of T.
gondii are illustrated in Table 4. 2. Using the B1 PCR T. gondii DNA was not
detected in any of the sheep before infection on day 0. T. gondii specific DNA was
detected and amplified in the PBM cells of each of the four animals infected with 105
oocysts. No T. gondii was detected in any of the animals from Group 2 and only one
animal from Group 3 gave a positive result on day 9 after infection. These results
show that the high-dose animals had a greater parasitaemia than the medium and
low-dose.
Table 4. 2 Detection of T. gondii DNA in the PBM cells of sheep orally infected with 10s, 10J and 103
Toxoplasma oocysts of the M3 isolate
GrouD 1 Groun 2 Groun 3
Days after infection 10s oocysts 104 oocysts 103 oocysts
SI S2 S3 S4 S5 S6 S7 S8 S9 S10 Sll S12
0
1
2 ■> - - - -
3
4 ■fr ■fr . - - -
5
6 - ■fr <r - - -
7 - ■ <r . -
8
9 <r - ■ - ■>





■>: detection and amplification of T. gondii DNA in PBM cells by the B1 PCR
no detection of T. gondii DNA in PBM cells by the B1 PCR
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4.3.2 Serology
4.3.2.1 Indirectfluorescent antibody test
All the animals in this experiment manifested specific seroconversion after
oral infection with 105, 104 or 103 T. gondii oocysts of the M3 isolate using the IFAT
to detect T. gondii specific IgG. Serum samples from these animals were analysed
using doubling dilutions starting from 1:16. The results are illustrated in Figure 4. 2.
Details of individual animals are shown in Appendix Chapter 4 (Table 5 to Table 7).
Animals infected with either 105 or 104 oocysts show a 6-fold increase in
specific antibody titre from base line values on day 12 after infection. Animals given
the lowest dose (10 oocysts) show a 5 -fold increase from base line values on day
12 after infection.
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4.3.2.2 Enzyme-linked immunosorbent assay
The results from the analysis of serum samples using the IgG ELISA are
illustrated in Figure 4. 3. The data were expressed as a percentage of a standard high
titre positive serum. Experience has shown that adult ewes with a 25 % or less OD
using the ELISA are seronegative (Buxton et al., 1991) (Chapter 3, 3.6.2).
Seroconversion was demonstrated in all the animals when the serum samples were
analysed by ELISA for the presence of T. gondii specific IgG. Details of individual
animals are shown in Appendix Chapter 4 (Tables 8 to 10).
Group 1 (105 oocysts) had a mean % OD greater than 25 on day 14 after
infection while group 2 (104 oocysts) did so on day 12, although a statistically
significant increase in the %OD was not detected in both groups until day 14 after
infection (p<0.01 Student's t-test). Although in group 3 (103 oocysts) a % OD just
greater than 25 was recorded on day 14 after infection, there was no statistically
significant increase in the level of IgG antibodies until day 19 after infection.
Ill
Figure 4. 3 Mean (+se) % of OD IgG antibody in sheep orally infected with T. gondii oocyst of the M3
isolate measured by ELISA
%OD





The data were expressed as a percentage of a standard high titre positive serum. An OD below 25 % is considered





No tissue cysts or histopathological changes were observed in any of the 12
animals after examination of tissues (brain, cardiac muscle, skeletal muscle (gracillis
and psoas), lung, liver, kidney and mesenteric lymph node) stained with H&E.
4.3.3.2 PCR
The result from the analysis of tissue samples using the B1 PCR are
illustrated in Table 4. 3. Specific DNA was detected in 8 of the 12 sheep. It was more
readily detected in samples from group 1 (105 oocysts) than from groups 2(104
oocysts) and 3 (103 oocysts) and was mainly detected in brain and heart. Only one
sample of gracillis muscle from the sheep in group 1 (105 oocysts) gave a positive
reaction.
Table 4. 3 Detection of T. gondii DNA in tissues of sheep orally infected with 10s, 104 or 101 Toxoplasma








SI S2 S3 S4 S5 S6 S7 S8 S9 S10 Sll S12
brain ■fr "fr ■fr <■
cardiac muscle ■fr -fr . -fr -fr ■fr -fr
skeletal muscle psoas
skeletal muscle gracillis
■fr: detection and amplification of T. gondii DNA in PBM cells by the B1 PCR
no detection of T. gondii DNA in PBM cells by the B1 PCR
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4.4 Discussion
The M3 isolate of T. gondii used in this study is a complete isolate, tissue
cysts from infected mice result in oocyst production if ingested by seronegative cats
(Chapter 3, 3.2.1).
The study demonstrates that infection of sheep with the M3 isolate results in
parasites being present in the tissues, but detection appears dependent on the number
of oocysts ingested by the sheep. Parasites were more consistently detected in the
c o
group of sheep given 10 oocysts compared to 10 , brain and cardiac muscle being
the best candidate tissues for detection.
There are conflicting reports in the literature concerning the favoured tissue
for detection of T. gondii parasites. Various workers have reported the presence of
T. gondii in tissues following experimental infection of sheep using several infection
routes and different parasite stages (Jacobs et al., 1963; Jacobs and Hartley 1964;
Dubey and Sharma 1980; Dubey, 1984). When Dubey and Sharma (1980) orally
dosed seronegative ewes with 105 sporulated T. gondii oocysts of the GT-1 strain,
they were consistently able to isolate of the parasite from skeletal muscle of sheep
killed between day 7 and 119 after infection, indicating that this may be a favoured
site of T. gondii persistence in sheep. A similar result was reported by Jacobs and
collaborators (1963) where they also detected T. gondii more frequently in muscle.
However, the results from this study would suggest that the brain and heart are the
favoured site for detection of T. gondii and indicate that a 10-fold and a 100-fold
difference in oocyst dose affects the frequency of detection of T. gondii in the tissues.
These results agree with those reported by Dubey and Sharma (1980) where a 1,000-
fold difference in oocyst dose from 102 to 105 influenced the frequency of detection
of parasite cysts in the tissues from infected sheep. In the study reported by Dubey
and Sharma (1980) only one animal was killed at each time point and therefore it is
difficult to draw definitive conclusions from their study.
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While in the study reported here the sheep were killed 6 weeks after infection,
and Garnham and Lainson (1960) reported the presence of parasite for at least 9
months after infection, it is generally assumed that sheep infected with a complete
isolate of T. gondii will remain persistently infected for life (Uggla and Buxton,
1990). However, the size of the tissue sample examined is crucial to detection, and a
negative result from any sample does not necessarily mean that the whole tissue is
free of parasite. The problem of sample error when working with large animal
species can only be avoided if the whole animal is examined, which is clearly
impractical.
There are various techniques available to detect T. gondii within tissues.
Methods for detecting or isolating T. gondii in body fluids or tissues offer a more
specific means of documenting active infection than serum antibody titre. In this
study T. gondii parasites were not observed on hematoxylin and eosin tissue sections
from the infected sheep. This may have been due to a combination of low density of
parasites within the tissue and the inevitable sample error. Also the sheep were killed
at 6 weeks after infection and therefore any T. gondii cyst present in the tissues
would be expected to be relatively immature. The detection of Toxoplasma parasites
in tissue sections of infected sheep by histology may prove difficult due to the
morphological similarities between T. gondii, N. caninum and Sarcocystis spp.
Therefore more specific tests are required to show the presence of T. gondii. Isolation
of Toxoplasma is usually carried out by inoculation of samples into susceptible
laboratory animals. Mice are most commonly used, since T. gondii is highly infective
to mice (Dubey et al., 1988b; 1989). Depending on the virulence of the strain, mice
develop either an acute infection with parasite-rich ascitic fluid or a chronic infection
characterized by the presence of T. gondii cysts in the brain (Derouin et al., 1987).
PCR test has been used to detect T. gondii specific DNA in a wide selection of body
fluids from several animal species: ocular fluid in horses (Turner and Savva, 1991),
lymph and blood from experimentally infected sheep (Wastling et al., 1993; Buxton
et al., 1994), placenta and foetal tissues from ovine abortions (Steuber et al., 1995)
and aqueous humor, cerebrospinal fluid, serum and blood samples from infected cats
and dogs (Stiles et al., 1996). Since a study reported by Wastling et al. (1993)
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elegantly demonstrated the very close agreement between the PCR technique and
mouse inoculation to detect parasitaemia in the same sample (Wastling et al., 1993),
the B1 PCR was used to analyse tissue samples in this study in preference to the
mouse inoculation assay. The B1 gene is reported to be highly conserved across
strains of T. gondii and has a high copy number in the T. gondii genome (Burg et al.,
1989). While the PCR test is extremely sensitive it only proves the presence of
specific T. gondii DNA within the samples; unlike the mouse inoculation technique,
PCR does not distinguish between live and dead parasites.
A febrile response around 4 to 6 days following infection of sheep with T.
gondii is a very consistent clinical finding (Smith, 1961; Spence et al., 1978; Miller
et al., 1982; Dubey, 1984; McColgan et al., 1988; Buxton et al. 1991, 1994). Similar
results to those obtained in the study reported here with group 3(10" oocysts) were
reported by Buxton and collaborators (1991) when they orally infected 14-month-old
Scottish blackface ewe-lambs with 2xl03 sporulated oocysts of the same isolate (M3)
with onset of pyrexia on day 5 after infection, and lasting for 5 days.
In 1984, Dubey published results recorded following oral infection of lambs,
rams and ewes with 104 infective oocysts of the GT-1 strain of T. gondii. He showed
that all sheep became febrile (greater than 40°C) between 3 and 7 days after infection
and the fever lasted 2 to 7 days. When the same dose was used in the present
experiment, statistically significant febrile response was not recorded until day 5 in
any of the animals from group 2 (104 oocysts). This may reflect the different
characteristics of the T. gondii strains used in each study. In the study reported here
the onset and duration of the febrile response appeared to correlate with the infective
dose. The highest dose (10 oocysts) induced the earliest and largest duration of
temperature response in the sheep. A similar effect of oocyst dose and resultant
temperature response in sheep was not observed by Buxton et al. (1988). However, in
their study a different T. gondii isolate was used, but perhaps more importantly the
dose range was narrower (2xl03 to 12xl03 oocysts) compared to the study reported
here (103 to 105 oocysts).
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In 1909, Nicolle and Manceaux discovered T. gondii by microscopic
examination of a blood smear from an African rodent. However, direct observation
of this parasite in blood is rare, and parasitaemia can usually be only demonstrated by
more sensitive techniques which include inoculation of blood into mice, tissue
culture or use of the PCR technique. Previous studies examining the presence of T.
gondii in blood have demonstrated the sensitivity of the PCR technique (Johnson et
al., 1990; Ho-Yen etal., 1992; Filice etal., 1993; Dupoy-Camet etal., 1993;
Wastling et al., 1993;Paugam etal., 1995).
Detection of parasitaemia following experimental infection of sheep appears
to correlate with the dose of oocysts used. In this study presence of parasite in blood
was more frequently detected when 105 oocysts were used to infect sheep. These
results correlated well with those reported by Dubey and Sharma (1980) who also
reported that detection of parasitaemia was dependent on the dose of oocysts used to
infect the sheep. In the study reported here parasitaemia was detected using PCR
technique whereas Dubey and Sharma (1980) used mouse inoculation.
A common feature of T. gondii infection is the development of specific
antibodies in the host (Dubey and Beattie, 1988). Detection of specific T. gondii
antibodies is frequently used as a diagnostic aid (Uggla, 1986). In the study reported
here the magnitude of the antibody response appeared to correlate with the dose of
oocysts used to infect the sheep. Similar responses were observed in sheep infected
with 105 and 104 but significantly less antibody was detected in the sheep infected
with 103 oocysts and the onset of seroconversion was significantly later. These results
corroborate those reported by McColgan and collaborators, (1988) where they
describe a similar correlation between oocyst dose and onset of specific
seroconversion.
The onset of seroconversion appeared to vary depending on the serological
test used. The IFAT showed a significant increase in specific T. gondii antibodies on
day 12 after infection, whereas this occurred on day 14 after infection using the
ELISA. The discrepancy between the two tests may reflect differences in the antigens
used to detect the antibodies. In the case of the IFAT whole fixed tachyzoites are
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used whereas the antigen in the ELISA is a crude water soluble fraction of
tachyzoites.
4.5 Conclusions
In conclusion, the results described here demonstrate that 103, 104 and 105 T.
gondii oocysts of the M3 isolate are capable of inducing symptoms of infection,
including pyrexia, seroconversion and detection of T. gondii in blood and tissues.
The sheep receiving the highest dose of oocysts showed the earliest onset of
pyrexia, parasites were detected most frequently in blood and tissues and showed an
earlier onset and greater magnitude of specific antibody response compared to the
■j
lowest dose group (10 oocysts).
Infection of sheep with 105 oocysts consistently produced a detectable level of
T. gondii within tissues and therefore may be a useful dose to conduct the








To examine the presence of T. gondii in various tissues taken from
sheep and cattle at six weeks and six months following oral infection with 10
or 105 sporulated oocysts
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5. Detection of T. gondii in sheep and cattle
following oral infection.
5.1 Introduction
Toxoplasmosis was first described in humans in 1923 in the retina of a
hydrocephalic child by Janku (cited Dubey and Beattie, 1988), although a
number of organisms reported earlier were later identified as Toxoplasma
gondii (Kean, 1972). Pikerton and Weinman (1940) reported the first case of
the disease in a patient who suffered a generalized and fatal illness with
enlarged lymph nodes and areas of necrosis in many organs. However it was
not until 1954 that the consumption of infected undercooked meat was
recognised as a major source of infection for people (Weinman and Chandelier,
1954). Years later T. gondii bradyzoites within tissue cysts were characterized
as the infective agents (Jacobs et al., 1960a).
Infection with T. gondii is the most common parasitic infection world¬
wide with an estimated prevalence of 1 to 2 billion people (Chang, 1996).
Transmission to people occurs following ingestion of sporulated oocysts, or
bradyzoites within the cysts, contained in the tissues of numerous food animals.
The frequency of infection is extremely variable in the different regions of the
world. The presence of feline population is considered an important factor
influencing the frequency of Toxoplasma infection as was demonstrated by
Wallace (1969) when he found human infection prevalent on Pacific atolls on
which there were cats, but virtually absent where there were none.
Seroprevalence in the human population ranges from 0 to 90% (reviewed by
Dubey and Beattie, 1988) and infection is more common in warm climates and
in low-lying areas than in cold climates and mountainous regions, where
conditions for sporulation and survival of oocysts are less favourable. The
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prevalence of T. gondii infection varies between ethnic groups, but this is due
to sanitary and cooking habits rather than to genetic differences. A
seroprevalence of 80% has been reported from Paris where undercooked meat
is often eaten (Desmonts, 1961). However, lower seroprevalences (10-40%)
have been reported in countries from South-East Asia where meat is cooked
thoroughly (Jacobs et al., 1960b; Zuber and Jaquier, 1995). There is evidence
supporting the hypothesis that cattle are not favoured host for T. gondii and that
in general infection is more likely to occur from consumption of pork, lamb
and goat's meat than beef (Dubey, 1980; Dubey, 1986a, b; Dubey and Towle,
1986, Dubey and Beattie, 1988). Consumption of cured pork has been recently
recognised as an important source of T. gondii infection (Buffolano et al.,
1996).
The presence of T. gondii cysts in the tissues of naturally and
experimentally infected sheep have been reported (Jacobs et al., 1960a, b;
Jacobs et al., 1963; Jacobs and Hartley, 1964; Dubey and Sharma, 1980).
Toxoplasma gondii has been detected from soft tissues such as brain, cardiac
muscle, skeletal muscle, small intestine, liver and diaphragm. The brain is the
most frequently infected tissue in either aborted foetuses or live animals born to
infected ewes and has been suggested as the organ of choice for isolating T.
gondii for diagnostic purposes (Uggla et al., 1987).
In contrast, the parasite has rarely been isolated from naturally infected
bovine tissues (reviewed by Dubey, 1986b).
Little is known of the density of T. gondii tissue cysts in organs of food
animals. It has been estimated that the number of T. gondii tissue cysts per
gram of tissue of food animals such as pigs may be low (less than 1 tissue
cyst/50gr). As a consequence, it is generally not practical to demonstrate the
presence of the parasite by histological examination of tissues (Dubey et al.,
1996). Therefore a concentration bioassay technique is often used to
demonstrate T. gondii in tissues of food animals. The most specific, but least
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practical, method of isolating the parasite from infected animals is by feeding
tissues to seronegative cats and subsequently demonstrating oocysts in the
faeces several days later (Dubey and Frenkel, 1976). Alternatively, viable
parasites can be detected in infected animals by inoculating mice with tissue
samples as they are extremely vulnerable to T. gondii infection (Araujo et al.,
1976; Williams et al., 1978).
Several studies have shown the sensitivity of the PCR for detection of
Toxoplasma DNA in various biological samples (Johnson et al., 1990; Wheeler
et al. 1990; Turner and Savva, 1991; Ho-Yen et al., 1992; Filice et al., 1993,;
Dupoy-Camet et al., 1993; Wastling et al., 1993). In addition, studies have
compared the traditional methods of Toxoplasma diagnosis, which include
detection of specific antibodies, mouse inoculation and immunohistochemistry,
with the PCR and have shown a good correlation between the different
techniques in the diagnosis of toxoplasmosis (Greig et al., 1993; Steuber et al.,
1995; Wastling et al., 1993). There is also a very good correlation between
PCR and mouse inoculation in the detection of parasitaemia (Wastling et al.,
1993).
Results from the previous study (reported in Chapter 4 of this thesis)
showed that the M3 isolate of T. gondii is able to cause infection of ovine
tissues and that 105 sporulated oocysts consistently produced a measurable
amount of T. gondii within the tissues of infected sheep.
The main objective of this study was to compare the presence of
T. gondii within tissues of sheep and cattle following oral infection with
sporulated oocysts. The parameters examined were whether oocyst dose
affected the frequency of T. gondii detection within tissues, the distribution of
T. gondii within ovine and bovine tissues and whether there was difference in
tissue distribution and frequency of parasite detection in tissues collected six
weeks or six months following infection.
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5.2 Materials and Methods
5.2.1 Animals
Ten adult sheep (ages ranging from 2 to 5 years) and ten calves (ages
ranging from 6 to 7 months) shown to be seronegative by IFAT to T. gondii and
N. caninum at the start of the experiment were used in this study.
Mature Swiss White mice of both sexes from Toxoplasma free colonies
were used for inoculation of tissues obtained from orally infected sheep and
cattle to determine the presence of viable T. gondii as described in Chapter 3
(3.8.2).
Cats of both sexes, under six months of age and seronegative for
antibodies to T. gondii, obtained from a Toxoplasma free colony in the
University of Newcastle (UK), were used to obtain oocysts (see Chapter 3).
5.2.2 Toxoplasma gondii
Toxoplasma gondii oocysts obtained from infection of seronegative cats
(Chapter 3, 3.2.1) were used to dose the experimental animals.
Tachyzoites of the S48 strain prepared as described in Chapter 3 (3.2.2)
were used as a source of T. gondii DNA for a positive control in the B1 PCR
and tachyzoites of the RH strain were used as source of specific antigen for the
serological analysis of infected mice in the ELISA (3.3.1).
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5.2.3 Experimental design
The sheep and cattle were allocated into four groups as illustrated in
3 5Table 5. 1. Suspensions containing 10 and 10 sporulated T. gondii oocysts in
PBS were administrated to the animals by gavage as described in Chapter 3
(3.2.1).
Table 5. 1 Experimental design
Group Species animal numbers M3 oocyst dose
1 sheep S,l, S,2, S,3, S,4 to3
2 cattle C21, C22, C23, C24 103
3 sheep S31, S32, S33, S34, S35, S36 to5
4 cattle C41, C42, C43, C44, C45, C46 to5
S„N: sheep number N from group n, C„N: cattle number N from group n
5.2.4 Parasite detection
To determine the presence of T. gondii within the tissues of the infected
animals, half of the animals in each group were killed six weeks and the
remainder six months after oral infection.
5.2.4.1 Examination of tissue sections by histopathology
Samples of brain, spinal cord, cardiac muscle, skeletal muscles (psoas,
gracillis), liver, mesenteric lymph node, lung and kidney were collected. All the
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samples were immediately fixed in 10% formal saline and processed as
described in Chapter 3 (3.8).
5.2.4.2 Detection of T. gondii from tissues by mouse inoculation
Approximately 1 to 3g of infected tissue samples of brain, cardiac
muscle and skeletal muscle (psoas, gracillis) were homogenized with trypsin in
PBS, incubated at 37°C for 60 minutes, large particulate matter removed and
then intraperitoneally inoculated into mice (Chapter 3, 3.8.3). Three mice were
inoculated per tissue sample. Mice were inspected daily for T. gondii infection
and those which appeared ill (symptoms described earlier in Chapter 3, 3.8.3)
were killed and a sample of peritoneal exudate removed to examine for the
presence of tachyzoites. Serum was collected from surviving mice 8 weeks
after inoculation and tested for the presence of Toxoplasma antibodies by IgG
ELISA as described in Chapter 3.
5.2.4.3 Detection ofT. gondii in infected tissues by polymerase chain
reaction
Approximately 5g (from animals given 103 oocysts) and lOOg (from
animals given 105 oocysts) of tissue samples of brain, cardiac muscle and
skeletal muscle (psoas and gracillis) were stored at -20°C prior to extraction of
DNA for PCR analysis. Approximately 2g of each sample were analysed and
when a positive result was obtained the remainder of the sample was not tested.
The PCR product was confirmed to be T. gondii DNA by Southern blotting and
immunological detection of bound DIG labelled probes to T. gondii DNA




Confirmation of infection following administration of oocysts was
defined by a febrile response and specific seroconversion. Details of the results
are described in Chapter 6: Clinical and humoral immune responses of sheep
and cattle to Toxoplasma gondii infection.
5.3.2 Examination of tissues at post-mortem
Post-mortem examination did not reveal macroscopic lesions in any of
the animals killed at either six weeks or six months following infection with
either 103 or 105 T. gondii oocysts.
5.3.3 Examination of tissues by histopathology
5.3.3.1 Oocyst dose: 103
5.3.3.1.1 Examination of tissue sections at 6 weeks after infection
by histopathology
Six weeks following infection, no obvious histopathological changes
were detected in samples of brain, heart and skeletal muscle taken from the
"2
i
cattle orally infected with 10' T. gondii oocysts of the M3 isolate. However,
cyst-like structures were detected in heart samples from sheep S i4 and in
skeletal muscle in sheep Si3. There was no evidence of any inflammatory
reaction around the cysts. Marked cuffing of many blood vessels was seen in
the brain (mesencephalo) of sheep Si3.
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As there was little evidence of infection in the tissues of either sheep or
cattle six weeks after infection, the tissues from the other animals were not
examined after six months.
5.3.3.2 Oocyst dose: 105
5.3.3.2.1 Examination of tissue sections at 6 weeks after infection
by histopathology
T. gondii-like cysts were seen in heart samples of two of the sheep
infected with 105 oocysts of the M3 isolate (S31 and S32) and in gracillis
muscle in sheep S31 and S33. There was no evidence of any inflammatory
reaction around the cysts in these samples. Disseminated nodules with no
necrotic center were seen in the brain in the sheep S3I, and an accumulation of
cells was located around blood vessels. Necrotic areas with glial cells were
described in the brain of one of the sheep (S33).
No histopathological changes were seen in cattle given 105 oocysts.
5.3.3.2.2 Examination of tissue sections at 6 months after
infection by histopathology
Cyst-like structures were seen in sections of skeletal muscles as well as
in heart samples from the three sheep (S34, S35 and S36). Again there was no
evidence of any inflammatory reaction around the cysts present in these
samples.
No histopathological changes were seen in sections of tissues from the
three cattle.
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5.3.4 Detection of T. gondii from tissues by mouse inoculation
5.3.4.1 Oocyst dose: 103
5.3.4.1.1 Examination of tissues at 6 weeks after infection
Table 5. 2 shows the results obtained from the bioassays in mice carried
out after i.p. inoculation of Swiss White mice with tissue samples from two
sheep (Si3 and Sj4) and two cattle (C2I and Ci3) killed 6 weeks after infection
with T. gondii oocysts.
Viable T. gondii was detected in the mice inoculated with heart sample
from one of the sheep (Si4). In this case the three mice inoculated with the
sample of heart tissue showed symptoms of acute infection but they recovered
and developed a high titre of specific IgG against T. gondii.
Acute infection was not detected in any of the mice inoculated with
cattle tissue samples.
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Table 5. 2 Viable T. gondii detected in tissue samples from sheep and cattle orally infected with 103
T. gondii oocysts and killed 6 weeks after infection
Animal Detection of infection Tissue samples
brain heart psoas gracillis
S,3 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
S,4 acute 0/3 0/3 0/3 0/3
ELISA 0/3 101%, 79%, 71% 0/3 0/3
C21 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
C23 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
Three mice were inoculated with each tissue sample. The term acute
refers to the mice culled due to acute toxoplasmosis defined by signs of febrile
response and presence of tachyzoites within peritoneal exudate. ELISA refers
to the mice which survived and were bled 8 weeks after inoculation. The
presence of specific T. gondii antibodies was determined by an ELISA
detecting specific IgG responses, and the data were expressed as a percentage
of a standard high titre positive serum. A positive result was taken to be any
reading above 10% OD (Chapter 3, 3.6.2). 0/3 means no reaction was detected
from any of the three mice tested.
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5.3.4.2 Oocyst dose: 105
5.3.4.2.1 Examination of tissues at 6 weeks after infection
Table 5. 3 shows the results obtained after i.p. inoculation of Swiss
White mice with tissue samples from 3 sheep (S3I, S32, S33) and 3 cattle (C4I,
C42, C43) killed six weeks following oral infection with 105 T. gondii oocysts
of the M3 isolate.
Viable parasites were frequently detected from tissue samples of the
sheep. The four different tissue samples taken from one of the sheep (S32)
resulted in an acute infection in mice and tachyzoites were seen in the
peritoneal fluid. Viable parasites were detected from the other two sheep (S31
and S33), in three different tissue samples taken (brain, heart and psoas).
Despite evidence that the mice were clearly infected with T. gondii, specific
IgG was only detected in two of the mice inoculated with tissue samples (brain
and psoas) from one of the sheep (S32).
It can be seen from Table 5. 3 that acute infection was not detected in
any of the mice i.p. inoculated with cattle tissues, but specific IgG against T.
gondii was detected using ELISA in one of the mice infected with brain tissue
of one of the cattle (C42).
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Table 5. 3 Viable T. gondii detected in tissue samples from sheep and cattle orally infected with 10s
T. gondii oocysts and killed 6 weeks after infection
Animal Detection of infection Tissues sample
Brain Heart Psoas Gracillis
s3i acute 2/3 3/3 2/3 0/3
ELISA 0/1 - 0/1 0/3
S32 acute 1/3 3/3 1/3 2/3
ELISA 38%/2 - 103%/2 0/1
S33 acute 1/3 3/3 1/3 0/3
ELISA 0/2 - 0/2 0/3
C41 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
C42 acute 0/3 0/3 0/3 0/3
ELISA 45%/3 0/3 0/3 0/3
C43 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
Three mice were inoculated with each tissue sample. The term acute
refers to the mice culled due to acute toxoplasmosis defined by signs of febrile
response and presence of tachyzoites within peritoneal exudate. ELISA refers
to the mice which survived and were bled 8 weeks after inoculation. The
presence of specific T. gondii antibodies was determined by an ELISA
detecting specific IgG responses, and the data were expressed as a percentage
of a standard high titre positive serum. A positive result was taken to be any
reading above 10% OD (Chapter 3, 3.6.2). 0/3 means no reaction was detected
from any of the three mice tested.
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5.3.4.2.2 Examination of tissues at 6 months after infection
Table 5. 4 illustrates the results obtained after i.p. inoculation of Swiss
White mice with tissue samples from sheep (S34, S35, S36) and cattle (C44,
C45, C46) killed six months following oral infection with 105 T. gondii oocysts
of the M3 isolate.
Viable parasites were detected from sheep samples of heart (3/3), brain
tissue (S34 and S35), and skeletal muscle (S34, S35). Specific IgG antibodies
were not detected in any of the mice inoculated i.p. with tissue samples.
There was no evidence of T. gondii in any of the tissues collected 6
months after infection in the group of cattle.
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Table 5. 4 Viable T. gondii detected in tissue samples from sheep and cattle orally infected with 10s
T. gondii oocysts and killed 6 months after infection
Animal Detection of infection Tissue samples
Brain Heart Psoas Gracillis
S34 acute 3/3 3/3 1/3 0/3
ELISA 0/3 0/3 0/2 0/3
S35 acute 2/3 3/3 0/3 1/3
ELISA 0/1 - 0/3 0/2
S36 acute 0/3 2/3 0/3 0/3
ELISA 0/3 0/1 0/3 0/3
C44 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
C45 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
C46 acute 0/3 0/3 0/3 0/3
ELISA 0/3 0/3 0/3 0/3
Three mice were inoculated with each tissue sample. The term acute
refers to the mice culled due to acute toxoplasmosis defined by signs of febrile
response and presence of tachyzoites within peritoneal exudate. ELISA refers
to the mice which survived and were bled 8 weeks after inoculation. The
presence of specific T. gondii antibodies was determined by an ELISA
detecting specific IgG responses, and the data were expressed as a percentage
of a standard high titre positive serum. A positive result was taken to be any
reading above 10% OD (Chapter 3, 3.6.2). 0/3 means no reaction was detected
from any of the three mice tested.
134
5.3.5 Detection of T. gondii in infected tissues by PCR
Table 5. 5 summarizes results obtained from PCR amplification of the
B1 gene of T. gondii from tissue samples taken from sheep and cattle, which
were infected either with 103 or 105 sporulated T. gondii oocysts. The samples
were taken at post-mortem examination either six weeks or six months after the
animals had been infected. Figure 5. 1 shows that the B1 gene of T. gondii was
amplified from tissue samples of sheep orally infected with T. gondii oocysts.
Figure 5. 2 shows the nitrocellulose membrane revealing the immunological
detection of bound DIG labelled probes to T. gondii DNA as specific
confirmation of the product detected.
Specific DNA was detected in tissue samples from sheep. Toxoplasma
gondii DNA was more frequently detected in tissues from sheep given the
5 3
higher infective dose of oocysts (10 ) compared to the 10' dose. Only the
-2
sample of heart tissue from one of the sheep (Si4) infected with 10' oocyst
gave a positive result with the B1 PCR.
Specific T. gondii DNA was not detected on any occasion from the
samples taken from cattle.
There was not much difference in the frequency of detection or tissue
distribution of T. gondii in sheep at six weeks compared to six months
following infection with 105 oocysts. Specific DNA was detected and amplified
from brain samples of all the sheep at six weeks and six months following
infection with 105 oocysts, from heart tissue sample of two sheep (S31 and S32)
killed six weeks after infection and from the heart sample of one sheep (S34)
killed six months after infection with 105 oocysts.
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Table 5. 5 T. gondii DNA detection and amplification of the B1 gene of T. gondii in tissue samples by
the B1 PCR from sheep and cattle undergoing primary oral infection with either 103 or 10s M3
T. gondii oocysts and killed either 6 weeks or 6 months after infection.
Animal M3 oocyst dose time after infection Tissue samples
brain heart psoas gracillis
103 6 weeks ...
Si4 103 6 weeks . -fr .
C21 103 6 weeks ...
C24 103 6 weeks ...
531 105 6 weeks <■ .
532 105 6 weeks ^ ^
533 105 6 weeks "5"
C41 105 6 weeks ...
C42 105 6 weeks ...
C43 105 6 weeks ...
534 10s 6 months ■> <■ -
535 10s 6 months +
536 105 6 months •> . .
C44 1 05 6 months ...
C45 105 6 months ...
C46 105 6 months ...
detection and amplification of T. gondii DNA in PBM cells by the B1 PCR
no detection of T. gondii DNA in PBM cells by the B1 PCR
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Figure 5. 1 T. gondii B1 gene detected and amplified by PCR from tissue samples of sheep
undergoing primary oral infection with T. gondii oocysts
Kb 123456789
kb: DNA ladder of 50-1000 bp with a concentration in each band of approximately 50 ng/ml
Lane 1: negative control consisting of UV sterilised distilled water
Lane 2: positive control consisting of 96 bp product of the B1 gene of T. gondii
Lane 3 to lane 9: B1 gene of T. gondii amplified from tissue samples of infected sheep using P2 and P3
primers
Lane 3: S3l-brain, Lane 4: S32-heart, Lane 5: S]4-psoas, Lane 6: S33-psoas, Lane 7: S35-gracillis, Lane 8:
S36-gracillis and Lane 9: S34- heart.
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Figure 5. 2 T. gondii B1 gene by Southern blot from agarose gel
987654321 Kb
Lane 1: negative control consisting of UV sterilised distilled water
Lane 2: positive control consisting of 96 bp product of the B1 gene of T. gondii
Lane 3 to lane 9: B1 gene of T. gondii amplified from tissue samples of infected sheep using P2 and P3
primers
Lane 3: S3l-brain, Lane 4: S32-heart, Lane 5: S,4-psoas, Lane 6: S33-psoas, Lane 7: S35-gracillis, Lane 8:
S36-gracillis and Lane 9: S34- heart.
kb ladder: DNA ladder of 50-1000 bp with a concentration in each band of approximately 50 ng/ml
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5.3.6 Comparison of bioassay in mice with B1 PCR
Table 5. 6 illustrates the results from the bioassay in mice compared
with the B1 PCR on samples taken from the infected animals at either six
weeks or six months after infection.
Using the mouse inoculation technique viable T. gondii parasites were
detected in 9 samples which were also positive by the B1 PCR technique. 43
samples analysed were negative by both techniques. T. gondii was detected by
mouse inoculation in 11 tissue samples but T. gondii DNA was not detected
from these samples when analysed by the B1 PCR. Only in one sample specific
Toxoplasma DNA was detected by PCR but T. gondii was not detected by
mouse inoculation.
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Table 5. 6 Comparison of bioassay in mice and the B1 PCR for detection of T. gondii in tissue






brain heart psoas gracillis
MI PCR MI PCR MI PCR MI PCR
S,3 103 6 weeks - - - -
S]4 103 6 weeks - fr fr - -
C21 103 6 weeks - - - -
C24 103 6 weeks - - - -
S31 105 6 weeks fr fr fr -J1 fr fr
S32 105 6 weeks fr fr fr fr fr fr
S,3 105 6 weeks fr ■}■ fr fr -
C41 105 6 weeks - - - -
C42 105 6 weeks fr - - -
C43 105 6 weeks - - - -
S,4 105 6 months ■0- fr ■fr fr fr -
S35 103 6 months fr fr fr - fr
S36 105 6 months fr fr - -
C44 105 6 months - - - -
C45 105 6 months - - - -
C46 105 6 months - - - -
1 MI: bioassay in mice (i.p. mouse inoculation)
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5.4 Discussion
The main finding from this study was that T. gondii could be detected in
the tissues of sheep whereas it was not possible, under the conditions of this
experiment, to detect T. gondii in the tissues of cattle.
Infection rates in food animals vary in many parts of the world as
indicated by serological surveys (Fayer, 1981; Dubey, 1986a, b; Dubey and
Towle, 1986). There are reports in the literature supporting the hypothesis that
cattle are not a favoured host for T. gondii and are able to reduce the number or
even to get rid of Toxoplasma cysts in their tissues (Sanger et al., 1953; Rawal,
1959; Jacobs et al., 1960b, Meyer, 1963; Zardi et al., 1964; Work, 1967; Catar
et al., 1969; Dubey and Streitel, 1976). The presence of T. gondii cysts in the
tissues of naturally and experimentally infected sheep have been reported
(Jacobs et al., 1960a, b; Jacobs et al., 1963; Jacobs and Hartley, 1964; Dubey
and Sharma, 1980). Toxoplasma gondii has been detected from soft tissues
such as brain, cardiac muscle, skeletal muscle, small intestine, liver and
diaphragm. The brain is the most frequently infected tissue in either aborted
foetuses or live animals born to infected ewes and has been suggested as the
organ of choice for isolating T. gondii for diagnostic purposes (Uggla et al.,
1987).
Confirming the findings of the experiment described Chapter 4 of this
thesis, T. gondii was more frequently detected in sheep given 105 compared to
3 510 oocysts. In sheep given 10 , T. gondii was more frequently detected in brain
and heart tissues and was not demonstrated to be present in skeletal muscle.
Examination of tissues at either 6 weeks or 6 months after infection did not
appear to affect the distribution of T. gondii within the tissue sampled.
As discussed in Chapter 4 the oocyst dose does affect the frequency of
T. gondii detection within ovine tissues (Dubey and Sharma, 1980). The results
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from the experiments described in Chapter 4 and 5 of this thesis suggest that
the brain and heart are the favoured site for detection of T. gondii in
experimentally infected adult sheep. It has been demonstrated that although
tissue cysts appear to have predilection for the CNS, they may also be found in
skeletal and cardiac muscle (Jacobs et al., 1960a) and that intact cysts may
persist for the life time of the host (Dubey, 1977). However, Dubey and Sharma
(1980) suggested that because in their experiment the parasite was isolated
consistently from skeletal muscle of sheep orally infected with Toxoplasma
oocysts, this may be a favoured site for T. gondii. It has been reported that brain
from congenitally infected sheep is the most heavily infected tissue (Watson
and Beverley, 1971; Dubey, 1984; Uggla et al., 1987).
Mature cysts will develop in chronically infected mice at 6-8 weeks
after infection (McHugh et al., 1994). During a chronic Toxoplasma infection,
similar to the present study, the parasite is not only in the form of encysted
bradyzoite but also individual bradyzoites which can escape from cysts without
complete cyst wall disruption (Santoro et al., 1985; Wong and Remington,
1993). Therefore it is not possible using the detection methods described in this
study to state the parasite stage detected. However, since the postmortem
examinations took place either at 6 weeks or 6 months after infection, it is
likely that the bradyzoite stage was detected.
Examination of animal tissues for the detection of T. gondii can be done
using various techniques which differ in their sensitivity and specificity.
There are few reports in the literature concerning pathological changes
following a primary infection of adult immunocompetent animals. The majority
of reports describe pathological changes following infection of the
immunologically immature foetus (Hartley and Kater, 1963; Beverley et al.,
1971; Buxton et al., 1982).
The lesions following Toxoplasma infection in adult animals occur
most commonly in the nervous system, and lymph nodes. In 1961 Koestner and
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Cole compared the central nervous system lesions from cases of both natural
and experimentally infected sheep and cattle. They reported that common
feature of Toxoplasma infection of the CNS in these species is characterized by
focal necrosis and vascular damage in animals with acute infection and by glial
nodules, repair and vascular mineralization in animals with chronic infection.
Buxton and colleagues (1981) outlined the pathological changes in ovine
popliteal lymph nodes after subcutaneous inoculation of sheep with tissue cysts
of T. gondii. These included gross enlargement, loss of architecture,
haemorrhaging, some necrosis and sinuses full of plasma cells and numerous
blast cells. The changes in lymph nodes from sheep immune to T. gondii were
similar but less striking.
Macroscopic lesions are difficult to find in immunocompetent adult
sheep (Garnham and Lainson, 1960; McErlan, 1974; Sharma and Dubey, 1981;
Dubey, 1984) or cattle (Sanger et al., 1953). Reports of cattle experimentally
infected with T. gondii (similar to the study discussed in this chapter) revealed
no macroscopic or histopathological changes at post mortem examination
(Costa et al., 1977; Beverley et al., 1977).
Tachyzoites begin to disappear from visceral tissues in the third week
following infection and may be localised as bradyzoites within cysts in neural
and muscular tissues (Dubey and Frenkel, 1974). Some residual cerebral
lesions have been described in brains of hosts which survived acute
Toxoplasma infection, consisting of microglial nodules alongside more
extensive hyperplasia of perithelial cells and perivascular fibrosis.
Inflammation is not usually associated with cysts and only in cases where cysts
have ruptured releasing parasites does, a severe inflammation occurs along with
local necrosis (Dubey, 1977). At this phase of Toxoplasma infection,
tachyzoites are rarely seen, and cysts 30pm diameter with a wall of acidophilic
material approximately 0.5pm thick, located in areas away from lesions, may
be the only form seen (Jubb et al., 1993).
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It may be difficult to find T. gondii in sections of animal tissues because
of the low number of organisms present specially when looking at tissues from
large animal species. Moreover, because tissue cyst-like structures from
Sarcocystis spp., N. caninum and T. gondii can appear morphologically similar
in sections stained with H&E, an immunohistochemistry technique may help to
specifically stain parasites in tissue section from infected animals (Uggla et ai,
1987; Lindsay and Dubey, 1989; Cole et al., 1993). In summary examination of
tissue sections by H&E is neither specific or sensitive enough as a technique to
examine for the presence of T. gondii which may be sparsely distributed within
tissues of large animal species (Dubey and Streitel, 1976; Beverley et al., 1977;
Sharma and Dubey, 1981; Dubey and Thulliez, 1993).
A more sensitive and specific technique involves the inoculation of
tissue samples into mice which are extremely susceptible to infection with T.
gondii, whereas Sarcocystis spp. is not infective and N. caninum is rarely
infective to immunocompetent mice (Dubey et al., 1988b; 1989). Larger
volumes of tissues (500g or more) can be fed to naive cats than can be used to
infect mice (Dubey and Thulliez, 1993). Therefore the former would be the
ideal animal for bioassay detection but this is clearly impractical as it is
extremely difficult and expensive to obtain T. gondii naive cats.
Inoculation of tissues into mice is a widely used method of bioassay due
to the sensitivity of mice to T. gondii infection. However, isolation of the
parasite by bioassay in mice is time consuming and potentially hazardous for
the operator. An increasingly popular detection method involving amplification
of the T. gondii B1 gene by PCR which is able to detect small amounts of DNA
(0.05 pg). This technique is known to be a sensitive method for the diagnosis of
Toxoplasma infection, and the results agree closely with those from mouse
inoculation (Wastling et al., 1993; Greig et al, 1993; Steuber et al., 1995). The
results from this study generally show good agreement between the two assay
systems, although the mouse inoculation assay detects live parasites only,
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whereas the PCR assay can detect specific DNA which may arise from either
live or dead parasite material.
One of the major difficulties in detection of T. gondii in tissue from
large animal species, such as sheep and cattle used in this study, is the
limitation of the size of sample able to be examined. While it was not possible
to detect T. gondii in cattle using the samples and detection methods described
in this study, it is possible that the parasite may be present in unexamined
tissues. The only way to demonstrate that T. gondii did not persist in cattle
tissues would be to examine the whole animal which would be clearly
impractical.
5.5 Conclusions
The results from this study show that T. gondii is more frequently
detected in the tissues of infected sheep compared to cattle.
It may also be inferred that an increase in the infective oocyst dose
augments the distribution of T. gondii within ovine tissues.
Finally, sample error is an important element to take into consideration
when attempting to detect T. gondii within tissues from large animal species.
Therefore the absence of macroscopic or histopathological alterations of
organs, no tissue cysts seen on histopathological sections and no parasite
detection by either bioassay in susceptible laboratory animals or PCR do not
exclude the possibility of infection in large animals such as sheep and cattle.
The reasons why cattle may be better able to control T. gondii infection
compared to sheep are unknown. A key factor could be the relative efficiency
of the host immune response provoked by T. gondii within sheep and cattle.
The following two chapters describe studies on the host immune
response in sheep and cattle following oral infection with T. gondii oocysts.
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Chapter 6
Comparison of clinical and humoral immune




To compare the clinical response, parasitaemia and humoral immune
response to a primary T. gondii infection in sheep and cattle
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6. Comparison of clinical and humoral
immune responses of sheep and cattle to a
primary Toxoplasma gondii infection
6.1 Introduction
Toxoplasma gondii infection in normal immunocompetent hosts is
generally asymptomatic (Dubey and Beattie, 1988).
However, it is known that Toxoplasma infection in non-pregnant
immunocompetent sheep (Dubey and Towle, 1986) and cattle can provoke a
febrile response, dyspnoea and anorexia within the first two weeks of infection
before returning to normal (Dubey, 1986b).
In sheep, following experimental infection with T. gondii, specific
antibody titres rise 2-3 weeks after infection, remaining elevated for several
years (Blewett et al., 1983). Under field conditions this antibody response is
often used as an aid to diagnosis (Munday and Corbould, 1971; Blewett et al.,
1983; Trees et al., 1989). It is interesting to note that reinfection of sheep with
either T. gondii tissue cysts (Blewett et al., 1983) or oocysts (McColgan et al.,
1988) does not elicit an increase in antibody titre.
There are few reports in the literature concerning detection of T. gondii
specific antibodies in cattle. This may be because T. gondii is not thought to be
a major cause of disease in cattle (Dubey, 1986b) but also there have been
reports that it is difficult to accurately determine specific antibody titres in
cattle due to a problem with non-specific activity in sera (Dubey and Streitel,
1976; Dubey, 1985; Dubey et al., 1985). Even so specific antibody responses
have been described in cattle experimentally infected with T. gondii (Costa et
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al., 1977; Beverley et al., 1977; Munday, 1978; Dubey, 1986b). However, is
seems likely that sheep are more susceptible to T. gondii infection than cattle as
research has shown that sheep grazing on a pasture alongside cattle developed
significant antibody titres to T. gondii as measured by IFAT while none of the
calves became sero-positive (Munday and Corbould, 1971).
Although a humoral immune response is clearly induced as a result of
T. gondii infection, its importance in protective immunity is unclear. Passive
transfer of immune serum (Krahenbuhl et al., 1972; Pavia, 1986) or
monoclonal antibodies (Johnson et al., 1983) only confer partial protection
against infection in mice. It is known that specific antibodies, in the presence of
complement, will lyse extracellular tachyzoites (Schreiber and Feldman, 1980)
and that they may also play a role in preventing invasion of host cells in two
ways. Antibody may block the activity of secretory-excretory substances which
are thought to aid parasite entry into host cells (Schwartzman, 1986) and
tachyzoites which are opsonized by antibody or complement are unable to
prevent fusion of their parasitophorous vacuoles with host cell lysosomes and
are therefore killed by normal macrophage destruction mechanisms (Joiner et
al., 1990).
The aims of the study described in this chapter were to compare the
temperature responses and specific antibody titres in sheep and cattle following
a primary oral infection with T. gondii oocysts.
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6.2 Materials and methods
6.2.1 Animals
Ten adult sheep (ages ranging from 2 to 5 years) and ten calves (ages
ranging from 6 to 7 months) shown to be seronegative by IFAT to T. gondii and
N. caninum at the start of the experiment were used in this study.
Mature Swiss White mice of both sexes from Toxoplasma free colonies
were used to passage and maintain the S48 strain of T. gondii tachyzoites as
described in Chapter 3 (3.1.3, 3.2).
Cats of both sexes, under six months of age and seronegative by IFAT
for antibodies to T. gondii, obtained from a Toxoplasma free colony in the
University of Newcastle (UK), were used in this study.
6.2.2 Toxoplasma gondii
Oocysts of the M3 isolate were prepared from the faeces of
seronegative cats which had been fed T. gondii tissue cysts as described in
Chapter 3 (3.2.1.3).
Tachyzoites of the S48 strain prepared as described in Chapter 3 were
used as antigen in the serological analyses of infected animals and to extract T.
gondii DNA as a positive control for the B1 PCR.
6.2.3 Experimental design
Sheep and cattle were allocated into four groups as described in Table
3 56. 1. Doses of either 10 or 10 T. gondii oocysts were administrated by gavage.
These are the same experimental groups used in Chapter 5 of this thesis.
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Table 6.1 Experimental design
Group Species Animal numbers M3 oocysts
1 sheep Sjl, S]2, S,3, S,4 103
2 cattle C21, C22, C23, C24 103
3 sheep S31, S32, S33, S34, S35, S36 105
4 cattle C4I, C42, C43, C44, C45, C46 105
SnN: sheep number N from group n, CnN: cattle number N from group n
6.2.4 Clinical response
6.2.4.1 Rectal temperatures
Rectal temperatures of sheep and cattle were recorded daily for the 3
days before and 14 days after oral dosing with a clinical electronic
thermometer.
6.2.4.2 Parasitaemia
Blood samples were taken from the jugular vein of sheep and cattle
daily from 3 days prior to infection until 14 days after infection. Peripheral
blood mononuclear cells extracted as described in Chapter 3: Materials and
Methods. These samples were analysed by the B1 PCR to detect and amplify
Toxoplasma specific DNA following the procedure described in Chapter 3:
(3.5.2.).
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6.2.5 Humoral immune response
Blood samples were collected from the jugular vein of sheep and cattle
into preservative-free evacuated blood collection tubes, and allowed to clot.
Following retraction of the clot and centrifugation at 500g for 15 minute serum
was removed, aliquoted and stored at -20° C until required. Serum samples
were collected from both sheep and cattle for 4 days prior to infection, and then
every two days for 3 weeks (animals given 103 oocysts) or 2 weeks (animals
given 105 oocysts). Thereafter samples were collected weekly and then monthly
for 1 year (animals given 103 oocysts) and 6 months (animals given 105
oocysts), (See Appendix Chapter 6 for further details).
6.2.5.1 Indirect FluorescentAntibody Test
Serum samples from experimental sheep and cattle were monitored for
the presence of T. gondii specific IgG antibodies using the IFAT (Chapter 3,
3.6.1).
In brief, a suspension of formalinised tachyzoites was layered onto
slides, air dried and fixed in methanol. After washing with PBS, diluted test
sera were added to the slides, incubated for 30 minutes and then washed with
PBS. The slides were incubated for further 30 minutes with a second antiserum
conjugated with FITC, washed and viewed with UV light under an Olympus





The first clinical signs in the sheep and cattle occurred during the first
week after infection when all the animals showed an increase in respiratory
rate, mild anorexia and a small febrile response when compared with pre-
infection observations. All the data corresponding to the rectal temperatures
were analysed taking the mean of the temperature values for each group
recorded before infection on day 0 as a base line.
Figure 6. 1 shows the mean rectal temperatures recorded from the
groups of sheep and cattle for a period of 14 days after oral infection. The
sheep infected with 10' oocysts showed a significant febrile response (P< 0.01
Student's t-test) compared to base line values on four, five, six and seven days
after infection. A maximum mean temperature was reached on day six and
values returned to normal by day eight. Cattle showed a rise in temperature on
day five, significantly later (PcO.Ol Student's t-test) than the sheep group. The
mean temperature in the cattle reached a peak on day 6 and returned to normal
values on day 9 (Figure 6.1.a).
When the infective dose was increased to 105 oocysts, the sheep
developed a significant pyrexia (P< 0.01 Student's t-test) compared to the base
line values on day three, four, five, six, seven and eight after infection. They
reached a peak on day four before returning to normal values by day eight. The
cattle also showed a febrile response on day three (P< 0.01 Student's t-test),
reaching a peak on day five post infection, and returning to base line values on
day 8 (Figure 6. l.b).
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In summary, although both 103 and 105 T. gondii oocysts induced
pyrexia in all the animals, the febrile response started earlier in the sheep and
lasted longer when compared to the cattle.
154
Figure 6.1 Mean rectal temperature response of sheep and cattle following primary oral infection
with sporulated T. gondii oocysts.
a) dose: 103 oocysts, base line represented with a continuous line (sheep: 39.81°C, cattle: 38.88°C)
• sheep n= 4
cattle n= 4
°C (± sem)
<2 sheep base line
37 H t 1 1 1 i 1 i 1 1 1 i i 1 1 1 r-
-3 -1 1 3 5 7 9 11 13
days of infection
b) dose: 10' oocysts, base line represented with a continuous line (sheep: 39.58°C, cattle: 38.39°C)
sheep n= 6
cattle n= 6




Specific T. gondii DNA was amplified by the B1 PCR from PBM cells
taken from sheep and cattle, both before and after infection. The results
obtained are summarised on Table 6. 2 and Table 6. 3. T. gondii DNA was not
amplified from any of the samples taken before infection (the samples on day 0
were taken before the infection was given).
Table 6. 2 illustrates the results from the sheep and cattle infected with
103 oocysts. T. gondii DNA was only detected in PBM cells from 2 of the
sheep infected with 103 oocysts on days 7 and 8 post infection. Positive results
were not recorded in any of the bovine samples.
Table 6. 2 Detection of T. gondii DNA by B1 PCR in the PBM cells of sheep and cattle infected with
103 T. gondii oocysts
Animal days of infection









■>: detection and amplification of T. gondii DNA in PBM cells by the B1 PCR




Table 6. 3 shows the results from the sheep and cattle infected with 105
oocysts. Specific DNA was detected and amplified in 4 of the 6 sheep and in
three sheep on day 7 after infection. The earliest detection of T. gondii was on
day 2 and the latest time of parasite detection was on day 14. In the group of
cattle Toxoplasma DNA was detected earlier with 5 of the 6 cattle being
positive on day 2 after infection and 3 positive on day 5 and one on day 13.
Table 6. 3. Detection of T. gondii DNA by B1 PCR in the PBM cells of sheep and cattle infected with
10s T. gondii oocysts
Animal days of infection









C43 <■ - - <r
C44 - +
C45 ■>
C46 - - -fr ■> -
■>: detection and amplification of T. gondii DNA in PBM cells by the B1 PCR
no detection of T. gondii DNA in PBM cells by the B1 PCR
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6.3.2 Humoral immune response
The mean titres of IgG antibody obtained by IFAT are shown in Figure
6. 2 to Figure 6. 5. All the sheep and cattle orally dosed with either 103 or 105
T. gondii sporulated oocysts of the M3 isolate seroconverted after infection.
The base line values are a mean of the IgG titres of all the animals in each
group before infection. Four samples were collected before infection.
6.3.2.1 Primary infection ofsheep and cattle with 103 T. gondii oocysts
The IgG IFAT titres for sheep and cattle infected with 103 oocysts for a
period of four weeks following infection are shown in Figure 6. 2. Neither the
"5
sheep nor the cattle seroconverted during the first week after infection with 10'
oocysts. During the second week the mean titre rose from 1/32 to 1/2048 in the
sheep, while the cattle mean antibody titre rose from 1/256 to 1/512. The latter
reached a maximum mean IFAT titre by the third week while the sheep reached
a maximum mean titre at the fourth week following infection.
The sheep showed a nine-fold increase in antibody titre following
infection compared with a three-fold increase in the cattle.
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Figure 6. 2 Mean (+ sem) Toxoplasma IgG IFAT titres in sheep and cattle following primary oral
infection with 103 oocysts of the M3 isolate
weeks of infection
The base line value for the sheep group is represented by the continuous line at 1/16 and for the cattle
group by a dotted line at 1/128
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Six weeks following infection, two sheep and two cattle were killed and
post mortem examinations carried out. The remaining animals were monitored
for specific antibody for 1 year following infection. The IgG IFAT titres of the
2 sheep and 2 cattle sampled every 4 weeks following infection for a period up
to 1 year are shown in Figure 6. 3.
The sheep reached a mean maximum titre (Si 1:1/16384, Si2: 1/4096)
by the end of the first month, after which titres started to decline until six
months after infection. Thereafter titres stabilized at 1/256-1/512 (Figure 6. 3).
The two cattle showed a peak IFAT titre of 1/4096 around 6 months
after infection. The titre fluctuated slightly around this value during the second
six month period.
In general the antibody titres remained fairly stable in both the sheep
and cattle from around 6 months after infection, although the antibody titres of
the cattle were greater than those of the sheep.
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The base line value for the sheep is represented by the continuous line at 1/16 and for the cattle
by a dotted line at 1/128.
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6.3.2.2 Primary infection ofsheep and cattle with 105 T. gondii oocysts
The IgG IFAT titres for sheep and cattle infected with 105 oocysts for a
period of four weeks and six months following infection are shown in Figure 6.
4 and Figure 6. 5 respectively. The base line values are a mean of the IgG titres
of all the animals in each group before infection. Four samples were taken
before infection.
Specific antibody was detected in both sheep and cattle following
infection. A rapid rise in the IFAT titres was observed in both groups during
the second week after dosing and both groups reached maximum titres
(1/16384) by the end of the fourth week (Figure 6. 4).
Three sheep and 3 cattle were killed and a postmortem examination
conducted at six weeks after infection. Three sheep and 3 cattle were monitored
for a period of six months following infection (Figure 6. 5). Both sheep and
cattle reached maximum mean antibody values (1/16384 and 1/8192
respectively) within the second month following infection, and titres then
started to decline until the fourth month after infection. Thereafter titres
stabilized for the remainder of the experiment (sheep: 1/4096-1/8192, cattle:
1/2048-1/4096).
In general the pattern of IFAT responses in sheep and cattle following
infection with 105 oocysts was very similar.
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Figure 6. 4 Mean (+ sem) Toxoplasma IgG IFAT titres in sheep and cattle following primary oral
infection with 105 oocysts of the M3 isolate
sheep n=6
weeks of infection
The base line value for the sheep is represented by the continuous line at 1/64 and for the cattle by a
dotted line at 1/128
163
Figure 6. 5 Mean (+ sem) Toxoplasma IgG IFAT titres in 3 sheep and 3 cattle following primary
oral infection with 10s oocyst of the M3 isolate
months after infection
The base line value for the sheep and cattle is represented by the continuous line at 1/128
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6.4 Discussion
The aims of this study were firstly to compare duration and severity of
the temperature response, parasitaemia and other clinical signs in sheep and
3 5cattle following primary oral infection with either 10" or 10 T. gondii oocysts
and secondly to compare IgG IFAT titres in the two groups.
In general in normal individuals, infection with Toxoplasma provokes a
mild febrile response, accompanied by moderate non-specific symptoms, often
remaining unnoticed in natural infection (Costa et al., 1977; Munday, 1978;
Blewett et al., 1982; Miller et al., 1982; Dubey, 1983, 1984; Buxton etai,
1988). A more detailed examination of clinical responses is possible when
carrying out experimental infections with animals.
After oral infection of sheep and cattle with either a low (103) or a high
(105) dose of T. gondii oocysts, it was shown that sheep developed an earlier
febrile response than cattle and the time of onset of the pyrexia was dependent
on the dose given. Furthermore, the pyrexia lasted longer in the sheep than in
the cattle. There was only sporadic detection of circulating T. gondii DNA in
sheep and cattle and it was more frequently detected in animals dosed with 105
■7
oocysts than with 10 . Both doses of T. gondii oocysts induced seroconversion
in sheep and cattle. A nine-fold increase in antibody titre was recorded in the
sheep compared with a three-fold increase in the cattle following infection with
103 oocysts. Whereas the patterns of IFAT responses in sheep and cattle
following infection with 105 oocysts were more similar. Thus it is concluded
that infection was established in all sheep and cattle.
A febrile response following experimental T. gondii infection is a
common feature in most experimentally infected animals. There are
comparatively few reports in the literature concerning clinical aspects of T.
gondii infection in cattle. Costa and collaborators (1977) described an elevation
of the body temperature in calves dosed orally with sporulated T. gondii
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oocysts (104, 105 or 3.5xl05). A rise in temperature was first detected around
day two after infection and lasted until day fifteen. The duration of the
temperature response was longer than in the experiment reported here, however
the authors only monitored one animal per dose of oocysts.
In another report of the experimental infection of cattle with T. gondii
(Munday, 1978) the onset of fever occurred at a similar time to the study
reported in this chapter.
Regardless of whether animals are dosed with T. gondii oocysts
(Buxton et al., 1988), tissue cysts (Miller et al., 1982) or tachyzoites (Buxton et
al., 1991) a temperature response will be elicited.
Buxton and co-workers (1988) reported no significant difference in the
onset or duration of the febrile response following oral infection of sheep with
two different doses of T. gondii oocysts. The main difference between their
experiment and the one reported in this chapter is that the oocyst dose ranged
from 2xl03 to 12xl03 in the former (Buxton et al., 1988) whereas in this
chapter the range of the dose administered was greater (10" to 10 ). These
results together with the findings described in Chapter 4 of this thesis, suggest
that the time to onset of a febrile response is dose dependent. The higher the
dose of oocysts the earlier the onset of temperature. An additional study
reported by Blewett et al. (1982) on the febrile response following
subcutaneous inoculation with either 75, 250 or 1000 T. gondii tissue cysts
would agree with the findings from the study reported in this chapter.
It is known that the cytokine IL-1 is an endogenous pyrogen and that
prostaglandin Et is involved in differentiation of immature B cells as well as
suppression of a variety of relevant immune functions (lymphocyte
proliferation, cytotoxic T lymphocytes, NK cells and cell to cell interaction).
Induction of both immune factors is associated with the quantity of antigen in
vivo which comes into contact with macrophages (Austyn and Wood, 1993).
Thus if a febrile response is elicited earlier in sheep than in cattle, it may reflect
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the parasites being present in greater number in the sheep compared to the
cattle.
When Toxoplasma infection occurs in cattle and sheep, ingested oocysts
encyst in the small intestines, each releasing eight sporozoites. Four days later
organisms, now defined as tachyzoites, may be present in the mesenteric lymph
nodes (Dubey, 1983, 1984). The tachyzoites then migrate to the blood stream
and in this way T. gondii is disseminated to many tissues (Buxton and Innes,
1995). It has been suggested that the cessation of parasitaemia coincides with
the onset of a protective immune response, resulting in the infection persisting
in the host as bradyzoites within tissue cysts (Wong and Remington, 1993).
Several studies have described parasitaemia in sheep after infection
with T. gondii, lasting from the fifth until the twelfth day after infection (Dubey
and Sharma, 1980; Reid et al., 1982; Wastling et al., 1993). Jacobs and Hartley
(1964) as well as Dubey and Sharma (1980) have described a transient
parasitaemia in sheep. Whereas in other hosts, such as goats, rabbits, mice and
pigeons, parasitaemias of longer duration have been observed (Jacobs and
Jones, 1950; Jacobs et al., 1953; Dubey et al., 1980).
Success in detecting parasitaemia in experimentally infected cattle has
been variable. In a study reported by Dubey (1983) where 16 calves and 6 cows
were infected with 105 oocysts, no parasitaemia was detected. In the study
reported here cattle infected with 105 oocysts did show a transient parasitaemia.
While the detection method used by Dubey (1983) was the inoculation of mice,
the B1 PCR technique was used in the study reported here. However studies by
Wastling and collaborators (1993) and Buxton and co-workers (1994)
demonstrated the very close correlation of the two techniques. It is important to
mention that whilst the mouse inoculation technique detects the presence of
viable parasites, the PCR would not be able to distinguish whether the parasite
DNA detected belongs to a viable organism.
In 1966 Rommel and co-workers (cited by Dubey, 1986b) detected
parasite in only 2 of 13 blood samples from cattle experimentally infected with
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Toxoplasma tissue cysts (on 2 days in one calf and 1 day in the other) (the dose
was not cited by Dubey, 1986b). Costa and collaborators (1977) also reported
the detection of T. gondii in the blood of 3 out of 3 calves orally infected with
104, 105 or 3.5x10s T. gondii oocysts, and in 2 out of 2 calves infected either
subcutaneously or orally, with 103 T. gondii tissue cysts. Parasite was
demonstrated as early as six days and as late as sixty-two days after infection .
On the contrary, Dubey (1983) described the lack of detectable parasite in the
blood of cattle orally dosed with 105 oocysts.
The results of the experiments presented in this chapter concur with
those of Rommel and collaborators (cited by Dubey, 1986b) and Costa and
collaborators (1977) in which the parasite was detected in the blood of cattle.
However, it is noticeable that parasite DNA was detected on only a few
occasions in animals dosed with the lower number of oocysts (103) but that
DNA was detected more frequently when the dose was increased to 105 oocyst
per animal. It is also interesting to note that parasite DNA was found as early as
forty-eight hours after infection in cattle dosed with 105 oocysts.
Evidence of the parasite in the blood was sporadic apart from the cattle
given 105 oocysts where 5 out of 6 animals were positive 48 hours after
infection. Previous studies employing the PCR, showed that detection of
parasite DNA after experimental infection of other animal species was also
sporadic. Joss and co-workers (1993) detected Toxoplasma DNA (Beverley
strain) in blood from Cotton rats and mice by means of B1 PCR from days 2 to
32 after intraperitoneal inoculation and Miedouge (1994) (cited by Paugam et
al., 1995) detected Toxoplasma (Beverley strain) in blood 7 to 28 days after
intraperitoneal inoculation in mice by PCR. Hitt and collaborators, (1992)
detected Toxoplasma DNA (C56 strain) by B1 PCR in blood of rabbits from
days 6 to 32 after subcutaneous inoculation. Schoondermark and collaborators,
(1993) detected Toxoplasma DNA (RH strain) by means of ribosomal PCR in
blood of pregnant monkeys for about 10 days after intravenous inoculation and
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Wastling and collaborators (1993) revealed specific DNA in the blood of sheep
subcutaneously injected with 105 T. gondii tachyzoites of the S48 strain.
In the study reported here DNA specific to T. gondii was detected as
late as 14 days after infection in one case but since the sampling period did not
extend beyond this time, it is not possible to say whether or not the parasite
would normally circulate later than this.
The apparent sporadic nature of the parasitaemia may be because
animals were sampled only once per day. A further experiment in which
several samples are collected each day might reveal a more accurate picture of
when T. gondii is present in blood following infection.
One of the aims of this chapter was to compare the onset, duration and
magnitude of the IgG antibody response in sheep and cattle experimentally
infected with T. gondii.
Although the sheep and cattle were initially infected with the same dose
3 5of oocysts, either 10' or 10', both innate and acquired immune mechanisms
may be involved in affecting parasite multiplication in vivo and hence the real
dose of infection within the sheep and cattle may differ. It is known that
antibody production is driven by the quantity of antigen in vivo and that as the
concentration of antigen decreases so production of antibody will also decrease.
(Roitt, 1991). Therefore a difference between the magnitude of the antibody
response between sheep and cattle may reflect differences in the actual quantity
of parasites in vivo. Thus if cattle are more efficient at controlling T. gondii
multiplication early on in vivo compared with sheep, then it might be predicted
that this may be reflected in the subsequent magnitude of the antibody
response. This did appear to be the case when comparing groups of sheep and
cattle infected with 10' T. gondii oocysts, where the former showed a nine-fold
increase in antibody titre whereas the cattle only had a three-fold increase. A
similar trend, although not so marked, was observed when 105 oocysts were
given. These data may provide indirect evidence that cattle were better able to
control the multiplication of T. gondii in vivo compared to the sheep.
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The study in cattle reported by Costa and collaborators (1977)
suggested that the higher the infective dose of T. gondii the larger the
subsequent antibody response. The data from this study would agree with this
3 • f
as cattle with 10 T. gondii oocysts developed a lower specific IgG response
than the cattle receiving 105 T. gondii oocysts. This relationship between
infective dose and antibody titre was not so obvious in the group of sheep.
The maintenance of antibody titres over time is thought to reflect
persistence of antigen within the host. Where antigen does not persist antibody
levels decline. This has been demonstrated quite elegantly in experiments
carried out in sheep infected with the S48 strain of T. gondii, which is an
incomplete strain of the parasite and is not thought to persist (Wilkins et al.,
1987). In these animals specific antibody levels declined 30 weeks after the
initial infection (Buxton et al., 1993b).
Cattle are thought to harbour fewer T. gondii cysts in their tissues than
sheep (Dubey, 1986b) and these cysts may not persist in cattle as they do in
sheep. Therefore measurement of antibody levels over time may reflect whether
T. gondii was persisting within the animals. In this study cattle and sheep were
monitored for up to 1 year following infection with 10" T. gondii oocysts. In
both cases specific antibody was detected over the time period suggesting that
T. gondii infection persisted within both sheep and cattle.
In general the cattle had higher IgG IFAT titres prior to infection than
the sheep. As so little is understood about T. gondii infection in cattle, it was
difficult to determine with confidence a cut off titre in the IFAT test which
would allow one to distinguish a naive from a previously exposed animal.
There has been no data published to the author's knowledge on
secondary T. gondii infection of cattle, however there are reports describing the
events following secondary infection of sheep. The majority of the reports
concur that on a secondary infection with T. gondii, regardless of the stage of
the parasite used, there is no boost to antibody levels and no pyrexia is
provoked (Blewett et al., 1982, 1983; McColgan et al., 1988; Buxton et al.,
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1991; Innes and Wastling, 1995). As the cattle in this study showed a
significant febrile response and increase in specific antibody titre, it is
concluded that they were undergoing primary infection.
6.5 Conclusions
The sheep developed an earlier temperature response which lasted
longer than the cattle and they also showed a greater magnitude of antibody
response compared to cattle. These findings taken together suggest that the
cattle were better able to control early multiplication of T. gondii better than
sheep.
However the innate and specific immune mechanisms responsible for
the enhanced ability of cattle to control the parasitaemia are unknown.
Cell mediated immune mechanisms are thought to be important in
resolving primary T. gondii infection (Frenkel, 1967; Krahenbuhl and
Remington, 1982; Suzuki et al., 1988; Suzuki and Remington, 1988; Nagasawa
et al., 1991; Gazzinelli et al., 1991). The following chapter examines aspects of




Cellular immune response of sheep and
cattle to Toxoplasma gondii infection
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Aims
To measure cell mediated immune responses in cattle and sheep during
a primary infection with T. gondii induced by the oral administration of
oocysts.
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7. Cellular immune responses of sheep and
cattle to Toxoplasma gondii infection
7.1 Introduction
As T. gondii is an intracellular parasite, cell-mediated immunity would
be expected to play a major role in host defence. By far the majority of data
related to immune mechanisms have originated from studies using
experimentally infected mice. While providing important information on the
mechanisms involved in the control of Toxoplasma infection, attention should
be paid when attempting to extrapolate data to other animal species due to the
wide variation in vulnerability to T. gondii infection between different animal
species.
Studies using T. gondii infected mice have demonstrated the importance
of IFNy in protective immunity (Subauste and Remington, 1991). This cytokine
is produced by both CD4+ and CD8+T cells with more recent data
demonstrating the role of natural killer (NK) cells in the early production of
IFNy (Gazzinelli et al., 1993). Adoptive transfer experiments between inbred
mouse strains have demonstrated the importance of CD8+ T cells in controlling
a primary infection (Suzuki and Remington, 1988). While it may be possible to
generate CD8+ effector cells without CD4+ help, optimal activation is achieved
when the two T cell subsets act in synergy. The CD4+ T cells (predominantly
the Thl subtype) are known to produce the cytokine IFNy which is thought to
be necessary in the induction of a CD8+ response. In one study in which CD4+
T cells were depleted from mice, inhibition of the CD8+ T cell response was
seen. The inhibition could be partially corrected by the addition of recombinant
IL-2, suggesting that the generation of cytotoxic CD8+ effector cells was
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enhanced by IL-2 production from CD4+T cells (Leist et al., 1989). Innes and
collaborators (1995a) reported that CD4+ T lymphoblasts preceded the
appearance of CD8+ T lymphoblasts in responding lymph to T. gondii infection
and the addition of exogenous IL-2 was a necessary requirement to activate
CD8+ T cells in vitro.
There are limited studies on the immune response to Toxoplasma
infection in other animal species. In sheep, the incomplete S48 strain (Wilkins
et al., 1987) of T. gondii which lacks the ability to produce tissue cysts (and
therefore to establish persistent infection) has been used in experimental
infections. Following subcutaneous inoculation of naive sheep with S48
tachyzoites, phenotypic analysis of lymphoblast cells in the efferent lymph
showed that the cells responding to infection were mainly T cells. Initially
those with a CD4+ phenotype were more numerous than CD8+ cells but at
around day 9 to 10 after infection, at the time of peak lymphoblast response, the
CD8+ cells became predominant. The disappearance of the parasite from the
lymph also occurred at this time (Innes and Wastling, 1995). IFNy was detected
in cell-free lymph supernatant from days 3 to 10 after primary infection but
appeared in lymph as early as 24 hours after secondary challenge (Innes et al.,
1995b). Both CD4+ and CD8+ T cell subsets have the potential to produce IFNy
after appropriate stimulation (Morris et al., 1982; Mosmann and Coffman,
1987). IFNy production, originated predominantly from the CD4+ T cell subset
was demonstrated after stimulation of immune spleen cells in vitro with a crude
tachyzoite antigen (Gazzinelli et al., 1991). Similar results were described by
Innes and collaborators (1995a, b) after examining the in vivo immune response
of sheep to subcutaneous (s.c.) inoculation of S48 strain T. gondii tachyzoites.
These observations suggest that a T cell response combined with IFNy
production plays a major role in immunity to T. gondii infection in sheep.
These in vivo observations are further supported by functional in vitro studies
which have shown that recombinant ovine IFNy will inhibit the growth of T.
gondii in ovine cells (Oura et al., 1993).
175
In an attempt to understand the role of cellular immune mechanisms in
the innate resistance of cattle to T. gondii infection, experiments were set up to
monitor antigen specific lymphocyte proliferation responses, the presence of
IFNy in blood plasma and in supernatants from activated cells, and an analysis
of the T cell subsets in peripheral blood of cattle and sheep during a primary
oral infection with T. gondii oocysts.
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7.2 Materials and methods
7.2.1 Animals
Ten adult sheep (ages ranging from 2 to 5 years) and ten calves (ages
ranging from 6 to 7 months) shown to be seronegative by IFAT to T. gondii at
the start of the experiment were used in this study.
Mature Swiss White mice of both sexes from Toxoplasma free colonies
were used to passage and maintain the S48 strain of T. gondii tachyzoites as
described in Chapter 3 (3.1.3).
Cats of both sexes, under six months of age and seronegative by IFAT
for antibodies to T. gondii, obtained from a Toxoplasma free colony in the
University of Newcastle (UK), were used in this study.
7.2.2 Toxoplasma gondii
Oocysts were prepared from the faeces of seronegative cats which had
been fed T. gondii tissue cysts as described in Chapter 3 (3.2.1.3).
A crude sonicated lysate of T. gondii tachyzoites prepared as described
in the Chapter 3 (3.3) was used as the specific antigen in the proliferation
assay.
7.2.3 Experimental design
Sheep and cattle were allocated into four groups as described in Table
7. 1. Doses of either 103 or 105 T. gondii oocysts were administrated by gavage.
These are the same experimental groups used in Chapter 5 of this thesis.
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Table 7. 1 Experimental design
Group Species Animal numbers M3 oocysts
1 sheep 8,1,8,2,8,3,8,4 103
2 cattle C21, C22, C23, C24 103
3 sheep S31,S32, S33, S34, S35, S36 10s
4 cattle C4I, C42, C43, C44, C45, C46 10s
SnN: sheep number N from group n, C„N: cattle number N from group n
7.2.4 Cellular immune response
Blood samples from sheep and cattle were collected from the jugular
vein into preservative-free heparinised evacuated tubes. Cell free peripheral
blood plasma was separated by centrifugation and PBM cells were separated by
centrifugation over Lymphoprep (Nycomed, Norway) (Chapter 3 3.4.2, 3.4.3).
7.2.4.1 Phenotypic analysis ofperipheral blood mononuclear cells
An indirect immunofluorescence test was used to stain the peripheral
lymphocytes from the sheep and cattle infected with 105 oocysts as described in
Chapter 3 (3.7.2). Three base line samples were collected prior to infection and
thereafter samples were collected every second day for three weeks.
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7.2.4.2 Cytokine analysis
Cell free peripheral blood plasma and supernatants from short-term
cultured PBM cells were tested for the presence of biologically active IFNy
using a bioassay described by Entrican and collaborators (1989, 1992) and an
enzyme immunoassay test (CSL Veterinary, Australia) as described by the
manufacturer. These methods are described in full in Chapter 3 (3.7.3).
7.2.4.3 Antigen inducedproliferation assay on peripheral blood
mononuclear cells
A proliferation assay on peripheral blood mononuclear cells was carried
out to monitor the response of cells to the crude lysate antigen of T. gondii
antigen as described by Innes and collaborators (1995a) (see Chapter 3, 3.7.1).
In brief, 4xl05 cells were cultured in each well of a 96 well round
bottomed plate along with a known dilution of T. gondii antigen. Concanavalin
A was used as positive control, to demonstrate that the cells were able to
respond in the culture conditions of the test and medium alone without antigen
as a negative control to examine the spontaneous proliferation of cells in the
absence of specific antigen. The cells were cultured for five days at 37°C in a
humidified 5% CO? incubator, they were pulsed for the final 18 hours with
18.5 kBq [~H]-thymidine per well prior to harvesting onto filters and cell
associated radioactivity was quantified in a (3 Scintillation counter.
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7.3 Results
7.3.1 Phenotypic analysis of peripheral blood mononuclear cells
An indirect immunofluorescence test was used to stain the PBM cells
from sheep and cattle undergoing primary oral infection with T. gondii, using
the appropriate monoclonal antibodies at a pre-determined optimal dilution.
Figure 7. 1 and Figure 7. 2 illustrate the mean percentage change from
base line values of CD2+, CD4+ and CD8+ T cells present in peripheral blood of
six sheep and six cattle, both before and after infection with 105 oocysts. Data
showing the percentage composition of peripheral blood mononuclear cells for
individual animals are shown in Appendix Chapter 7 (Table 1 to Table 6).
The three base line values for each T cell subset were calculated as the
mean percentage of each phenotype before infection. The percentage change of
sheep CD2+ T cells increased from pre-infection base line values by day five
after infection (Figure 7. la). The percentage of these cells increased steadily
during the experimental period, reaching maximum values on days 7 and 14,
and declined back to base line levels around day 16-19 post infection.
Study of the response of the two main peripheral T cell subsets from
sheep showed a significant increase in the percentage of CD4+ cells from day
five after infection and showed maximum values on day 14 (Figure 7.1a). The
percentage of cells stained with the monoclonal antibody recognising CD8+ T
cell subset declined briefly during the first 48 hours after infection then rose to
exceed pre-infection base line values from day five.
The results in Figure 7. lb show the mean results from of all the cattle
orally infected with 105 oocyst of T. gondii. The numbers of CD2+, CD4+ and
CD8+ T cells declined briefly during the first 48 hours of infection. During the
monitored period of 21 days of infection, only the percentage of CD4+ T cells
increased from pre-infection base line values from day five after infection
reaching the maximum value, after which they declined again to values below
base line on day nine.
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Figure 7.1 Mean (n=6) percentage change from base line values (± sem) of ovine and bovine
peripheral blood lymphocyte cells staining with monoclonal antibodies recognizing different
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Figure 7. 2 illustrates the mean change in percentage (relative to base
line values) of sheep and cattle peripheral blood T cells staining with
monoclonal antibodies recognizing CD2+, CD4+ and CD8+ subsets following a
primary oral infection with T. gondii.
The number of CD2+ T cells increased in sheep from day 5 of infection
to a maximal 50% higher than preinfection base line values. In contrast the
percentage of CD2+ T cells in cattle showed an initial decrease in the
percentage of cell from this subset during the first 48 hours and then values did
not change much from base line values (Figure 7.2a).
Analysis of CD4+ T cells showed a large increase in the number in the
sheep peripheral blood from day seven after infection. In the group of cattle
there was a brief increase in the number of CD4+ T cells, which then settled
down to base line values on day 9 after infection (Figure 7.2b).
Finally, the percentage of CD8+ T cells within the sheep PBM sample
increased, from base line values on day 5 post infection and did not return to
preinfection levels until day 16. On the contrary the % of cattle CD8+ T cells in
PBM did not change much over the observed time period (Figure 7.2c).
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Figure 7. 2 Mean (n=6) percentage change from base line values (± sem) of ovine and bovine
peripheral blood CD2+ (a), CD4+ (b) and CD8+ (c) lymphocyte subsets following a primary oral







Cell free peripheral blood plasma from sheep and cattle undergoing
primary oral Toxoplasma infection with two different doses of parasite were
firstly screened for the presence of IFN using an antiviral bioassay (see Chapter
3, 3.7.3.3). Samples which were positive by bioassay were then analysed
specifically for the presence of IFNy using an ELISA (Chapter 3, 3.7.3.4). Cell
free supernatants from short term culture of ovine and bovine PBM cells
primed in vivo and stimulated in vitro with T. gondii antigen were collected and
analysed for the presence of IFN by the methods described above. Data are
represented in Figure 7.3 to Figure 7.9, and Table 7.2 to Table 7.9.
7.3.2.1 Cellfree peripheral bloodplasma samples
7.3.2.1.1 Oocyst dose: 103 T. gondii oocysts
The results in Table 7. 2 show biologically active IFN detected in
peripheral plasma samples of sheep and cattle undergoing primary oral
infection. It can be seen that biologically active IFN was more frequently
detected in the group of cattle than the group of sheep. Three out of four sheep
were positive in the antiviral bioassay for detection of IFN, while IFN was
found in all the cattle. After primary infection with T. gondii, biologically
active IFN was detectable in ovine cell-free peripheral plasma from day 3 until
day 7 of infection. In the cattle group the highest frequencies of positive results
were recorded on day 3, 5 and 7 with some outlying positive samples on day 12
to 19 of infection.
184
Table 7. 2 Biologically active IFN detected in cell free peripheral blood plasma of sheep and cattle
orally infected with T. gondii oocysts measured by an antiviral bioassay
Oocyst dose: 103 T. gondii oocysts
Animal days of infection
-3 -1 2 3 5 7 10 12 14 17 19 21 26
S,1 - - - <r - - - -
S,2 - - - - - - -
S]3 - -
S,4 -
C21 - ■> <r ■> - ■5" -
C22 - ■D- ■> <r - ■> - -
C23 - ■fr ■> <r - - - ■fr
C24 - - ■> - ■5- -
■J1: biologically active IFN detected by an antiviral bioassay
no detection of biologically active IFN by an antiviral bioassay
Cell-free peripheral blood plasma samples from sheep and cattle in
which biologically active IFN was detected were analysed for the presence of
IFNy using an ELISA. The ELISA was calibrated using standards of
recombinant bovine and ovine IFNy prepared from doubling dilutions of a
stock of rIFNy and the values of %OD obtained were graphically represented
versus the corresponding known amounts of IFNy for each %OD and expressed
in U/ml for sheep (Figure 7. 3) and in pg/ml for cattle (Figure 7. 4).
One unit of IFN corresponds to the lowest concentration of recombinant
(r) IFNy which would inhibit the cytopathic effect of SFV on target cells by
greater than 50% (Entrican et al., 1989, 1992) and that approximately 50pg/ml
of bovine rIFNy correspond to lU/ml (personal communication by Dr. G.
Entrican). Summary of the values of ovine and bovine rIFNy standards are
displayed in Table 7. 3.
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Figure 7. 3 Ovine recombinant EFNy standards analysed by ELISA




Figure 7. 4 Bovine recombinant IFNy standards analysed by ELISA
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Table 7. 3 Ovine and bovine rlFNy standards using ELISA
bovine standards ovine standards
%OD pg/ml U/ml %OD U/ml
1.743 500 10 2.721 200
0.872 250 5 2.453 100
0.525 125 2.5 1.995 50
0.318 62.50 1.25 1.306 25
0.235 31.25 0.62 0.778 12.50
0.215 15.62 0.31 0.453 6.25
0.152 7.81 0.15 0.270 3.13
0.114 3.13 0.08 0.178 1.56
The amount of IFNy detected in cell-free peripheral blood plasma from
cattle and sheep were calculated from the standard curves represented in Figure
7. 3 and Figure 7. 4 (Mead et al., 1993). They are displayed in Table 7. 4 and
represented in Figure 7. 5 and Figure 7. 6.
It can be seen in Table 7. 4 that IFNy was detected in all the peripheral
blood plasma samples from infected sheep which had being previously positive
when analysed for the presence of biologically active IFN. Two of the animals
presented levels greater than 2 U/ml and one of the sheep had up 6 U/ml of
IFNy in peripheral blood plasma.
In all the Toxoplasma-infected cattle levels of IFNy above lU/ml were
found on day 5 of infection, on day 7 after infection in 2 of the cattle (C22 and
C23). 3.73 U/ml of IFNy were detected in plasma sample of one of the cattle
(C24) on day 14 after oral infection (Table 7. 4).
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Table 7. 4 IFNy detected in cell free peripheral blood plasma of sheep and cattle orally infected with
103 T. gondii oocysts measured by ELISA.
a)sheep
Oocyst dose: 103 T. gondii oocysts
Animal day of infection % OD sd sem U/ml
s,i 7 0.62 0.026 0.037 6.02
S]2 3 0.13 0.036 0.051 2.69
Sj3 3 0.09 0.003 0.04 2.51
5 0.18 0.029 0.041 2.95
b)cattle
Oocyst dose: 103 T. gondii oocysts
Animal day of infection % OD sd sem pg/ml U/ml
C21 3 0.123 0.023 0.033 33.73 0.67
5 0.189 0.009 0.013 52.03 1.04
7 0.093 0.002 0.003 25.47 0.51
12 0.151 0.001 0.001 41.57 0.83
17 0.107 0.001 0.001 29.46 0.59
C22 3 0.083 0.000 0.001 22.71 0.45
5 0.437 0.023 0.033 120.31 2.40
7 0.330 0.003 0.004 90.85 1.87
14 0.069 0.004 0.006 19.00 0.38
C23 3 0.118 0.004 0.006 32.35 0.65
5 0.624 0.016 0.022 171.79 3.44
7 2.148 0.030 0.043 591.37 11.82
19 0.059 0.006 0.009 16.24 0.32
C24 5 0.813 0.124 0.175 223.83 4.48
7 0.081 0.001 0.002 22.30 0.45
14 0.676 0.035 0.049 186.11 3.72
17 0.089 0.005 0.007 24.36 0.49
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Figure 7. 5 Amount of IFNy in plasma from sheep undergoing primary oral infection with 103 T.




Figure 7. 6 Amount of IFNy in plasma from cattle undergoing primary oral infection with 103 T.
gondii oocysts (See Table 7.4b for time of plasma sampling)
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7.3.2.1.2 Oocyst dose: 105 T. gondii oocysts
Table 7. 5 displays the results obtained from the antiviral bioassay
carried out on peripheral plasma samples of sheep and cattle undergoing
primary oral infection with 105 T. gondii oocysts. IFN. When the oocyst dose
was increased from 103 (Table 7. 2) to 105 (Table 7. 5), biologically active IFN
was not detected in the sheep samples, while IFN was detectable in all the
cattle between day 2 and 7 after infection.
Table 7. 5 Biologically active IFN detected in cell free peripheral blood plasma of sheep and cattle
orally infected with T. gondii measured by antiviral bioassay
Oocyst dose: 10s T. gondii oocysts
Animal days of infection





535 . . -
536
C41 ■fr ■fr ■fr
C42 ■fr ■ •fr ------
C43 ■fr ■ ■fr - -
C44 ■fr ■fr .fr ------ -
C45 ■fr ■fr ■fr ----- -
C46 ■fr ■fr -
■fr: biologically active IFN detected by an antiviral bioassay
no detection of biologically active IFN by an antiviral bioassay
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Cell-free peripheral blood plasma samples from cattle in which
biologically active IFN was detected were also analysed for the presence of
IFNyby ELISA. Recombinant bovine IFNy standards were used to determine
the amount of IFNy in cell-free peripheral blood plasma from cattle (Table 7.3
and Figure 7. 4). Data for individual animals are displayed in Table and Figure
7.7.
Table 7. 6 IFNy detected in cell free peripheral blood plasma of cattle orally infected with 10s T.
gondii oocysts measured by ELISA.
Oocyst dose: 10 T. gondii oocysts
Animal day of infection %OD sd sem pg/ml U/ml
C41 2 0.070 0.00 0.00 19.27 0.39
5 0.791 0.03 0.04 217.77 4.36
7 0.139 0.00 0.00 38.13 0.76
C42 2 0.076 0.00 0.00 20.92 0.42
7 0.303 0.09 0.12 83.42 1.67
C43 2 0.131 0.00 0.00 35.93 0.72
7 0.076 0.00 0.01 20.92 0.42
C44 2 1.438 0.12 0.17 395.90 7.92
5 0.239 0.01 0.01 65.80 1.32
7 0.091 0.00 0.00 24.92 0.5
C45 2 0.147 0.00 0.00 40.33 0.81
5 0.098 0.00 0.01 26.98 0.54
7 0.102 0.01 0.01 28.08 0.56
C46 2 0.860 0.03 0.04 236.63 4.73
5 0.177 0.02 0.03 48.59 0.97
7 0.104 0.01 0.01 28.63 0.57
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7.3.2.2 Cellfree supernatants from antigen inducedproliferation assays on
PBM cells
7.3.2.2.1 Oocyst dose: 103 T. gondii oocysts
Cell free supernatants from short term culture of ovine and bovine PBM
cells primed in vivo and stimulated in vitro with T. gondii antigen were
collected and analysed for the presence of biologically active IFN using an
antiviral bioassay. Data for individual animals are displayed on Table 7. 7.
Biologically active IFN was detected more frequently in supernatants
from bovine cells cultured and stimulated with Toxoplasma antigen than in
sheep cells under the same conditions. IFN was detected in all four sheep
infected with 103 Toxoplasma oocysts, between day 12 and 19 after infection.
In contrast, the presence of biologically active IFN in supernatant from
short term cultures of PBMC stimulated with Toxoplasma antigen, was shown
between days 7 and 26 after infection in all the cattle used in this study. IFN
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was detected in 3 out of 4 cattle (C2I, C22 and C24) from cell supernatants
cultured on day 3 after infection.
There was insufficient supernatant from short term cultures of antigen-
stimulated PBM cells from sheep and cattle infected with a low dose of T.
-3
gondii oocysts (10 ). Therefore, it was not possible to determine if the
biologically active IFN detected from the samples mentioned above was IFNy.
Table 7. 7 Biologically active IFN detected in cell free supernatants from short term culture of
PBMC primed in vivo after in vitro stimulation with T. gondii antigen
Oocyst dose: 10 T. gondii oocysts
animals days of infection





C21 - + . + + + +
C22 - ❖ . + +
C23 - - - ■> ■> ■> 4" ■> "fr ">
C24 . - +
•fr: biologically active IFN detected by an antiviral bioassay
no detection of biologically active IFN by an antiviral bioassay
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7.3.2.2.2 Oocyst dose: 105 T. gondii oocysts
Cell free supernatants from short term culture of PBM cells from sheep
and cattle stimulated in vitro with Toxoplasma antigen were collected and
analysed for the presence of IFN by ELISA. The amount of IFNy detected in
these samples was calculated using standards ovine and bovine rIFNy standards
(Table 7. 3, Figure 7. 3 and Figure 7. 4). Data for individual animals are
displayed on Table 7. 8, Table 7. 9 and represented in Figure 7. 8 and Figure
7. 9.
More than 2 U/ml of IFNy was detected in all the samples analysed
from infected sheep (Table 7. 8) which were collected on days 2, 5, 12 and 19
after oral infection. In the samples taken from the cattle group on the same
days, IFNy (>lU/ml) was detected from all the animals studied in the
experiment (Table 7. 9). Due to insufficient sample volume, it was not possible
to determine whether the IFNy was biologically active.
It is important to mention that similar amounts of IFNy were detected
from all the sheep samples analysed after infection with 105 T. gondii oocysts,
but within the cattle group infected with the same dose, there is variation
between individual animals regarding the amount of IFNy detected.
Supernatants samples from both ovine and bovine cells cultured in
medium alone were consistently negative for IFNy.
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Table 7. 8 IFNy detected in cell free supernatants from short term culture of PBMC from sheep
after in vitro stimulation with T. gondii antigen
Oocyst dose: 10' T. gondii oocysts
Animal day of infection %OD sd sem U/ml
s3i 2 0.073 0.01 0.00 2.45
5 0.065 0.00 0.00 2.45
12 0.073 0.00 0.00 2.45
19 0.089 0.00 0.00 2.51
S32 2 0.070 0.01 0.01 2.45
5 0.072 0.00 0.00 2.45
12 0.078 0.00 0.00 2.51
19 0.105 0.00 0.00 2.63
S33 2 0.082 0.00 0.00 2.51
5 0.066 0.00 0.00 2.45
12 0.069 0.00 0.00 2.45
19 0.151 0.12 0.08 2.81
S34 2 0.063 0.00 0.00 2.45
5 0.074 0.00 0.00 2.45
12 0.074 0.00 0.00 2.45
19 0.065 0.00 0.00 2.45
S35 2 0.075 0.00 0.00 2.45
5 0.069 0.00 0.00 2.45
12 0.074 0.00 0.00 2.45
19 0.150 0.11 0.08 2.81
S36 2 0.085 0.01 0.00 2.51
5 0.092 0.01 0.01 2.57
12 0.072 0.00 0.00 2.45
19 0.084 0.00 0.00 2.51
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Table 7. 9 IFNy detected in cell free supernatants from short term culture of PBMC from cattle
after in vitro stimulation with T. gondii antigen
Oocyst dose: 10' T. gondii oocysts
Animal day of infection %OD sd sem pg/ml U/ml
C41 2 0.794 0.09 0.06 218.60 4.37
5 0.609 0.02 0.01 167.53 3.35
12 0.473 0.02 0.02 130.08 2.60
19 0.245 0.01 0.01 67.45 1.35
C42 2 0.070 0.00 0.00 19.13 0.38
5 0.192 0.01 0.01 52.86 1.06
12 0.082 0.00 0.00 22.44 0.45
19 0.261 0.00 0.00 71.86 1.44
C43 2 0.105 0.01 0.00 28.91 0.58
5 0.213 0.01 0.00 58.50 1.17
12 0.251 0.02 0.01 68.97 1.38
19 0.444 0.02 0.01 122.10 2.44
C44 2 0.247 0.01 0.01 68.00 1.36
5 2.311 0.11 0.08 636.10 12.72
12 0.568 0.09 0.06 156.38 3.13
19 0.176 0.01 0.00 48.32 0.97
C45 2 0.135 0.01 0.01 37.03 0.74
5 0.150 0.00 0.00 41.30 0.83
12 0.383 0.01 0.00 105.44 2.11
19 0.090 0.00 0.00 24.78 0.50
C46 2 0.083 0.00 0.00 22.71 0.45
5 0.235 0.01 0.01 64.56 1.29
12 0.465 0.03 0.02 128.02 2.56
19 0.349 0.02 0.02 95.95 1.92
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Figure 7. 8 IFNy in cell free supernatants from short term culture of ovine PBMC after in vitro
stimulation with T. gondii antigen
%OD
Figure 7. 9 IFNy detected in cell free supernatants from short term culture of bovine PBMC after in
vitro stimulation with T. gondii antigen
0.0 0.5 1.0 1.5 2.0 2.5
%OD
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7.3.3 Antigen-induced proliferation assay on peripheral blood
mononuclear cells
Peripheral blood mononuclear cells were tested for their ability to
respond to T. gondii antigen to determine at what time after infection antigen-
specific cells could be detected in peripheral blood.
The results are expressed as Logio stimulation indices and are illustrated
in Figure 7.10 to Figure 7.13. SI were determined by dividing the arithmetic
mean of counts per minute (cpm) from the Toxoplasma antigen stimulated
cultures, pulsed with 3 [H]-thymidine, by the arithmetic mean of cpm of the
background medium control cultures. The data correspond to individual
35animals undergoing primary oral infection with either 10 or 10 oocysts of T.
gondii. The results are expressed as LogioSI to enable comparison between
animals. Actual cpm values for proliferative responses to medium control, Con
A control and T. gondii antigen are presented in Appendix Chapter 7 Table 7 to
Table 26.
In this experiment the test is considered positive when the SI has a
value above 2.5-3 according to Kristensen and coworkers (1982). This is
represented in the graphs by a continuous line at Logio3= 0.47.
Figure 7. 10 illustrates the results obtained from sheep infected with 10
oocysts. Variable responses were recorded in the sheep. Two of the animals
showed positive proliferation to T. gondii antigen on one occasion prior to
infection. Two out of the four sheep showed positive proliferation activity to T.
gondii antigen at 10, 14 and 19 days post infection.
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Figure 7. 11 illustrates the results obtained from the four cattle infected
with 10 oocysts. In this case, proliferative responses were more frequently
detected with higher SI values compared to the group of sheep receiving a
similar dose of oocysts.
Two of the animals (C22 and Czi) presented SI values above 3 on one
occasion prior to infection. All the cattle showed positive SI values (greater
than 3) following infection with oocysts, although there was considerable
variation in the magnitude of the response between the four animals. The
highest SI responses were detected between days 12 and 19 post infection.
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Figure 7.11 Proliferation of PBMC from cattle following stimulation with 12.5jig/ml of T. gondii
antigen.
Log10SI versus Days of infection
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Infective dose: 10 T. gondii oocysts of M3 isolate. Cut off point: Log103= 0.47.
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Figure 7. 12 and Figure 7. 13 show the proliferation of PBM cells from
sheep and cattle orally infected with a high dose of infective oocysts (105) of
T. gondii.
In this case, when the infective dose was increased, greater proliferative
responses were recorded and more frequently from the sheep group when
compared with the same species receiving the lower infective dose (Figure 7.
12 and Figure 7. 13). Positive proliferation of cells to T. gondii antigen was
observed in 5 out of 6 sheep by day seven after infection. In the sixth sheep,
proliferation to T. gondii antigen occurred on day 12-14 after infection.
However, occasionally positive proliferative responses to the specific antigen
occurred in some of the animals prior to infection.
Figure 7. 13 illustrates the proliferative responses of PBM cells to
T. gondii antigen in cattle given the high dose of T. gondii oocysts (105). There
was a lot of variation between responses of individual animals. In the majority
of cases proliferative responses to T. gondii antigen occurred around day 7-9
after infection but in common with the group of sheep there were occasional
responses prior to infection. Maximum SI values were registered between days
12 and 14 of the monitored period.
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Figure 7. 12 Proliferation of PBMC from sheep to stimulation with 12.5|ig/ml of T. gondii antigen.
LogioSI versus Days of infection
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Infective dose: 105 T. gondii oocysts of M3 isolate. Cut off point: Log103= 0.47.
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Figure 7.13 Proliferation of PBMC from cattle to stimulation with 12.5 (J.g/ml of T. gondii antigen.
Log10SI versus Days of infection
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7A Discussion
It is well known that sheep and cattle differ markedly in their
vulnerability to peroral T. gondii infection acquired for the first time during
pregnancy. Studies using experimentally infected mice have shown that cell
mediated immunity is important in the host defence to T. gondii infection.
These findings have been supported by the fact that Toxoplasma encephalitis
has been observed only in immunocompromised patients with low CD4+ and
CD8+ T cell counts and decreased serum levels of IFNy (Gazzinelli et al.,
1993).
In order to increase the understanding of why cattle may be more
resistant than sheep to T. gondii infection, aspects of the cell mediated immune
responses were examined.
Much of the work on host immune responses to T. gondii has been
carried out on murine models, indicating that both CD4+ and CD8+ T cells are
relevant in the development of protective immunity (Suzuki and Remington,
1988; Gazzinelli et al., 1991) and moreover that the CD8+ T cell subset is the
major effector population in controlling the infection (Suzuki and Remington,
1988; Parker et al., 1991; Khan et al., 1994). Innes and co-workers,(1995a)
demonstrated that the majority of lymphoblast cells in efferent lymph from
sheep responding to a primary infection, were T cells. They also reported an
increase in the CD8+:CD4+ T cell ratio in lymph during the peak lymphoblast
response which coincides with disappearance of the parasite from the efferent
lymph. The data presented in this chapter also showed an increase in the
percentage of CD8+ cells compared to CD4+cells in the peripheral blood of
sheep following oral infection with T. gondii. However the timing of
appearance of the CD8+ increase reported by Innes and co-workers (1995a) was
later than in this study where the percentage of CD8+ T cells increased between
days 2 and 5 after infection. This difference may be due to the fact that the
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animals used in this study were infected with oocysts, unlike the sheep used by
Innes and co-workers (1995a) which received a subcutaneous inoculation of
tachyzoites. An increase in the proportion of CD8+ T cells compared to CD4+ T
cells in peripheral blood was also reported in human cases of acute
toxoplasmosis (Luft et al., 1984; Sklenar et al., 1986). Blackwell and co¬
workers (1993) showed that mice responding to acute Toxoplasma infection
had an increase in the number of CD8+ T cells and an increase in the
CD8+:CD4+ T cell ratio when they examined spleen cells. They speculated that
the increase in the CD8+:CD4+T cell ratio could be an indication of an immune
response in the periphery triggering the parasite to encyst, thus resulting in a
larger number of T. gondii cysts in the tissues of those animals. Consequently,
as there was no obvious increase in the percentage of CD8+ T cells in the cattle
it may be interesting to speculate whether this response may be involved in
determining tissue cyst development in cattle. However, it is not possible to
verify these findings as there are no other studies to my knowledge examining
cell mediated immunity to Toxoplasma infection in cattle.
The cytokine IFNy is known to play a decisive role in the outcome of a
T. gondii infection (Subauste and Remington, 1991). The importance of IFNy
in protection against T. gondii infection has been demonstrated in murine
infection models. Treatment of mice with recombinant murine IFNy protected
against virulent Toxoplasma challenge (McCabe et al., 1984) and depletion of
IFNy in mice by specific monoclonal antibodies abolished resistance to a
normally avirulent strain of T. gondii (Suzuki et al., 1989). Further studies in
vitro have shown that IFNy plays a crucial role in activation of particular cell
types, such as macrophages, to inhibit multiplication of the parasite. Thus,
treatment of murine peritoneal or alveolar macrophages in vitro with
recombinant murine IFNy inhibited intracellular multiplication of T. gondii
(Black et al., 1987). Human recombinant IFNy also inhibited T. gondii
intracellular replication in both macrophages (Nathan et al., 1983) and
fibroblasts (Pfefferkon and Guyre, 1984). Similar results were reported by Oura
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and collaborators (1993) where ovine recombinant IFNy inhibited T. gondii
replication within both ovine fibroblasts and macrophages in vitro. However, it
was suggested that there was some form of species variation in the capacity of
IFNy to activate particular cell types to inhibit multiplication of the parasite as
murine IFNy failed to inhibit T. gondii multiplication within murine fibroblasts
in vitro (Schwartzman et al., 1990). Gamma interferon is also involved in the
maturation of CD8+ cells into effector cytotoxic cells (Zanovello et al., 1988).
The data from this study showed that IFN y was detected more frequently in
peripheral blood plasma from the cattle compared to the sheep. Although the
titres of IFN detected in the cattle were low. The most probable reason for this
is that the samples were collected from peripheral blood and therefore any IFN
produced as a result of T. gondii infection would be present in very low levels
in the periphery. In this study IFN was not detected in sheep peripheral blood
plasma. However, a previous study examining the local immune response
following T. gondii infection in sheep showed high titres of IFNy in efferent
lymph samples from a node draining the site of infection (Innes et al., 1995b).
A recent study conducted at Moredun Research Institute showed that
peripheral blood plasma from cattle infected with the closely related parasite
Neospora caninum did not contain detectable levels of IFNy but when PBM
cells were stimulated with N. caninum antigen in vitro the cells produced high
titre of IFNy (Innes et al.-personal communication). These studies would
suggest that measurement of IFN levels directly from blood plasma is not a
particularly sensitive or specific method to monitor CMI in large animal
species.
When PBM cells from the sheep and cattle were stimulated with
T. gondii antigen in vitro, IFNy was detected in both groups. It was interesting
to observe that in the experiment examining the responses of sheep and cattle
given 103 T. gondii oocysts biologically active IFN was detected more
frequently and for a longer period of time in the PBM cells of cattle stimulated
with antigen in vitro compared to the sheep. Unfortunately there was an
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insufficient volume of each sample to do further work in this area. Future
studies should aim to collect larger volumes of antigen stimulated cell culture
supernatants to allow a more detailed study of the cytokines which may be
relevant to the understanding of ovine and bovine immunity to T. gondii.
Proliferation of PBM cells to T. gondii antigen following in vitro
stimulation was detected in both cattle and sheep during a primary infection
with T. gondii. In general a low proliferative response was detected in the
group of sheep inoculated with 103 oocysts. Whereas the cattle given the same
dose of oocysts showed a more pronounced proliferation although there was a
large variation between animals within the group. When the dose of oocysts
was increased to 105 in the second experiment a stronger and more frequent
antigen induced cell proliferation was detected in both sheep and cattle.
Generally the sheep began to respond on day 7-9 after infection. This timing of
detection of this antigen induced cell proliferation is similar to that described
by Innes and collaborators (1995a) when examining the proliferation of efferent
lymph cells to T. gondii antigen in vitro, where they demonstrated cell
proliferative responses from day 6 following a primary infection. This was also
the case when mesenteric lymph node cells from orally infected mice were
tested for their ability to respond to T. gondii antigen in vitro (Chardes et al.,
1993).
Cell proliferation in response to T. gondii antigen was detected earlier
after infection in cattle than in sheep. However, proliferative activity was
observed in some of the animals prior to infection. The reasons for this
seemingly non-specific proliferative activity are not clear. The cattle and sheep
were seronegative for T. gondii before infection and therefore it was assumed
that these animals were undergoing a primary infection with the parasite. The
proliferative activity before infection may indicate some form of cross reactive
response to a component of T. gondii antigen preparation. Recent experiments
examining cell proliferative responses in animals infected with N. caninum
indicated that there was considerable cross reactivity using crude lysate antigen
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preparations of N. caninum and T. gondii (Khan et ai, 1997). This cross
reactive response has also been observed in cattle infected with N. caninum,
where cells proliferated to both N. caninum and T. gondii lysate antigen,
although the cattle were seronegative to T. gondii throughout the experiment
(Innes et a/.-personal communication). The cattle in this experiment were
seronegative to N. caninum before infection but it is not known whether the
animals were seronegative for Sarcocystis spp. or whether there are cross
reactive antigens between Sarcocystis spp., T. gondii and N. caninum. This may
explain some of the seemingly non-specific proliferative activity observed
particularly in the cattle, before infection. As very little is known about cell
mediated immunity to Sarcocystis spp. or the antigens recognized by infected
hosts this may be an important area of investigation (Fayer and Dubey, 1984;
Gasbarre et al., 1984; Dubey et al., 1989).
Seemingly, non-specific proliferative responses of human lymphocytes
from seronegative patients to water soluble T. gondii antigen have also been
reported (Hughes et al., 1984). This non-specific proliferation was significantly
reduced when they used secretory antigens as opposed to water soluble
antigens, indicating that the specificity of the antigen used in the proliferation
assay is critical in determining the specificity of the proliferative response
(Hughes et al., 1984). Also it is known that resting lymphocytes, as a
homogeneous population, have a low uniform RNA- and DNA-content with a
low incorporation of 3H-thymidine. However, freshly collected lymphocytes
may have a very high thymidine uptake, depending on their cell cycle at the
time of collection. This activity is sometimes maintained in the in vitro culture
resulting in high background proliferation (Kristensen et al., 1982).
A phenotypic analysis of the proliferating cells before and after
infection may also help to determine the nature of this non-specific
proliferation. This would also have been helpful to determine which cells were
responsible for the IFNy production. Stimulation of immune spleen cells in
vitro with a crude tachyzoite antigen induced IFNy production, predominantly
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from the CD4+T cell subset (Gazzinelli et al., 1991). Phenotypic analysis of
short term cultures of ovine cells also showed that CD4+ T cells were
responsible for much of the IFNy production (Innes and Wastling, 1995).
It has been suggested that CD4+ T cells are an important component of
the immune response during the early stages of infection (Araujo, 1991). While
CD8+ cells are reported to be the major effector T lymphocyte, their induction
and optimal activity are dependent upon CD4+ helper function (Denkers et al.,
1993) presumably through the production of Thl cytokines such as IL-2 and
IFN y. The cattle in this study showed an early increase in CD4+ T cells and
showed earlier production of IFN compared to the sheep. It is likely that the
outcome of a T. gondii infection is determined at a very early stage in the
encounter between parasite and host. The early induction of IFNy seems to be
critical to host survival and also will direct the adaptive immune response
towards a Thl/CD8+ T cell pathway. Recently, very interesting work has shown
that T. gondii has the ability to directly activate macrophages to produce
cytokines such as IL-12 which will stimulate NK cells to produce IFNy.
Therefore prior to the induction of the adaptive immune response the innate
mechanisms are already inhibiting parasite multiplication and providing the
correct cytokine environment for the induction of an effective immune
response (Gazzinelli et al., 1993).
If cattle are more efficient than sheep as regards the early induction of
IFNy this may help to explain their superior resistance. Comparing the ability
of T. gondii antigens to directly stimulate cattle and sheep macrophages and
examining the resultant cytokines produced may help us to understand this
early and perhaps critical immune response.
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7.5 Conclusions
Most of the work examining host immune responses to Toxoplasma
infection has emphasised the strong and persistent CMI response that the
parasite elicits, which protects the host against rapid parasite growth and
consequent pathology.
In this comparative study cells from both cattle and sheep showed
proliferative activity to a crude lysate of T. gondii in vitro, although in general
the cells from cattle showed a stronger response and were detected more
frequently than cells from sheep. IFNy was also detected more frequently in the
cattle samples compared to the sheep.
In summary the cattle seem to develop a more pronounced cell
mediated immune response than the sheep following oral infection with either
3 510 or 10 T. gondii oocysts.
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Chapter 8
General discussion and concluding remarks
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8. General discussion and concluding remarks
The main aims of the present study were to compare the immune responses
and pathogenesis of sheep and cattle following a primary oral infection with
Toxoplasma gondii. The rationale behind the study was to further our understanding
of why these two animal species are different in their vulnerability to Toxoplasma
infection.
A summary of the main findings of this study is described below:
When sheep and cattle are infected with the same dose of T. gondii, the sheep
show a more severe temperature response which begins earlier and last longer than
that observed in cattle. Parasitaemia is more frequently detected in sheep than in
cattle using similar sampling procedures. Also T. gondii was detected in the tissues
of sheep whereas it was not detected in cattle tissues at post mortem.
These data would suggest that the cattle were better able to control the
resultant infection following oral inoculation of T. gondii oocysts compared to the
sheep.
To further our understanding of the mechanisms which may be important in
resistant to T. gondii, several aspects of the host immune response were measured in
sheep and cattle.
There was a greater increase in specific antibody titre in sheep compared to
cattle following infection. The magnitude of the antibody response appeared to
correlate with the magnitude of the systemic T. gondii infection. In sheep given a
titrated dose of oocysts the group given the highest dose (105) showed the greatest
increase in antibody titre. Therefore as the sheep showed a greater magnitude of
specific antibody response than the cattle given the same dose of oocysts, one could
speculate that this may reflect the fact that the cattle were better able to control the
parasitaemia than the sheep.
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When examining cell mediated immunity there was a consistent, early
increase in the percentage of CD4+ T cells (from base line values) in the group of
cattle following T. gondii infection. Also the cytokine IFNy was more frequently
detected in samples of cell free plasma or from cultured cell supernatants in the cattle
compared to the sheep. CD4+T cells have been shown in previous studies to be a
major source of the cytokine IFNy (Gazzinelli et al., 1991). In general, proliferation
of cells to a crude lysate antigen of T. gondii was more frequently detected and of a
higher magnitude in the cattle compared to the sheep.
Therefore the results from the assays conducted in this experiment would
suggest that the cell mediated immune responses of cattle were more pronounced
than those of the sheep.
8.1 Presence of T. gondii within tissues
The study described in this thesis showed that the presence of parasites in
tissues was much more frequently detected in sheep compared to cattle following
infection of both groups of animals with an equal dose of oocysts. T. gondii was
more frequently detected in brain and cardiac muscle. The reason why it was easier to
detect T. gondii in sheep tissues compared to cattle is not known. The sheep and
3 5cattle were initially given the same oocyst dose (10" or 10 ), however, host immune
mechanisms are likely to have a profound effect on parasite multiplication in vivo.
Therefore, one can assume that if cattle are more efficient at controlling T. gondii
multiplication early in the infection due to an effective immune response, then less
parasite would disseminate to the tissues, and consequently T. gondii is less
frequently detected in cattle than in sheep. However, it is important to consider the
size of the sample examined and to note that a negative result from any sample does
not necessarily mean that the whole tissue is free of the presence of the parasite. The
problem of sample error when working with large animal species can only be avoided
by examining the whole animal, which is clearly impractical. Therefore when
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attempting T. gondii detection from large animal species, the size of the sample
examined along with the specificity and sensitivity of the technique used are
important factors to consider and lack of detection may be due to a combination of
these two factors and not necessarily to the absence of parasite in the tissues.
8.2 Comparison of techniques to detect T. gondii
The detection of T. gondii in tissue sections by histology may prove difficult
due to the morphological similarities between T. gondii and other closely related
parasites such as N. caninum and Sarcocystis spp. and the low density of parasites
within the tissues (Uggla and Buxton, 1990; Cole et al., 1993). Thus, a more
sensitive and specific test is required to reveal the presence of T. gondii in large
animals.
Isolation of T. gondii is usually carried out by inoculation of samples into
laboratory animals. Cats constitute the ideal model for isolation of Toxoplasma due
to both high specificity and the possibility of analysing a large sample size (Dubey
and Thulliez, 1993). However the drawback of this method is the low availability of
seronegative cats required for the isolation of T. gondii. Mice are the most commonly
used animal when attempting T. gondii isolation as they are very sensitive to
infection. However, although the isolation of parasites by inoculation of samples into
mice is conclusive and specific (Dubey and Frenkel, 1973; Lindberg and Frenkel,
1977; Derouin et al., 1987), it is not possible to inoculate large tissue samples into
mice.
The PCR test has been used to detect T. gondii DNA from several different
samples taken from various animal species (Turner and Savva, 1991; Wastling et al.,
1993; Buxton et al., 1994; Steuber et al., 1995; Stiles et al., 1996). Considering the
high conservation across strains of T. gondii of the B1 multicopy gene (Burg et al.,
1989) and the very close agreement between the PCR technique and mouse
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inoculation for detection of parasites (Wastling et al., 1993), PCR is a useful
alternative for demonstrating the presence of parasite. However, although the PCR is
highly sensitive, it does not distinguish whether the parasite material is dead or alive.
Inoculation into mice reveals the presence of viable T. gondii in the tissues.
8.3 Temperature response
A common feature of T. gondii infection is a brief fever response. This has
been reported in sheep and cattle following T. gondii infection (Buxton et al., 1994;
McColgan et al., 1988; Buxton et al., 1991; Costa et al., 1977;Munday, 1978;
Dubey, 1983). This study showed that the temperature response occurs earlier in
sheep and lasted longer compared to the temperature response in cattle. It is known
that the cytokine IL-1 is an endogenous pyrogen and that the prostaglandin E2 (PGEo)
is involved in suppression of a variety of relevant immune factors (lymphocyte
proliferation, cytotoxic T lymphocytes, NK cells and cell to cell interaction).
Moreover, induction of both of these immune components is associated with the
quantity of antigen in vivo which comes in contact with macrophages (Austyn and
Wood, 1993). If one assumes that the temperature response induced in animals
following infection with T. gondii is dependent on IL-1 with the involvement of
prostaglandin E2, then if there are a larger number of parasites and hence antigenic
material in the sheep, this may directly provoke the macrophages with associated
induction of IL-1 and PGE2. If there is less antigen in the cattle then presumably there
will be less IL-1 and PGE2 activity which is reflected in a less severe temperature
response.
In summary, if cattle are more efficient in controlling early T. gondii
multiplication compared to sheep, less Toxoplasma antigen would circulate in the
host, and subsequently a less severe temperature response would be recorded, which
fits with the observed findings in this study.
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8.4 Humoral immune response
Both sheep and cattle showed specific T. gondii antibody responses following
infection. The sheep showed a higher increase in specific antibody titre compared to
the cattle. It is known that in general terms antibody production is driven by the
quantity of antigen in vivo and that as the antigen decreases so production of antibody
decreases by a simple feedback mechanism (Roitt, 1991). The data from this
comparative study reveals further supporting evidence that the cattle were better able
to control T. gondii establishment and multiplication than the sheep. This is reflected
in the relative magnitude of the antibody responses.
The anti-T. gondii function of this antibody response was not addressed in
this thesis but reports in the literature have suggested various roles for antibody in
immunity to T. gondii. Specific antibodies can destroy tachyzoites in the presence of
complement as was demonstrated when tachyzoites incubated with immune serum
revealed distortion of the Toxoplasma cytoplasm resulting in poor staining compared
with the deep blue stained cytoplasm of Toxoplasma incubated with nonimmune
serum. This is the basis of the Sabin and Feldman dye test for diagnosis of T. gondii
which is still held in many test centers as the "gold standard" (Sabin and Feldman,
1948). Tachyzoites opsonized by antibodies or complement are not able to evade the
normal killing mechanisms following uptake by macrophages (Joiner et al., 1990).
This was demonstrated using viable antibody-coated T. gondii tachyzoites incubated
with Chinese hamster ovary cells (CHO) transfected with macrophage-lymphocyte Fc
receptors. The uptake of the antibody-coated tachyzoites led to the formation of
vacuoles capable of both fusion and acidification. It has also been suggested that
Toxoplasma specific antibodies may inhibit the invasion of cells by blocking the
activity of secretory-excretory elements responsible of promoting host cell
penetration, like rhoptries or micronemes (Schwartzman, 1986). However, in a
primary T. gondii infection the kinetics of induction of specific antibody response is
relatively slow, specific antibodies first being detected on day 7-8 after infection
(Innes and Wastling, 1995). Therefore while antibody may play an important role in
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secondary infection, in primary infection its role may take second place to cell
mediated or innate immune mechanisms which are induced at an earlier stage in
infection.
8.5 Cell mediated immune response
Since T. gondii is an obligate intracellular parasite, cell mediated immune
mechanisms are thought to be important in resolving primary infection. From the
extensive work carried out on the immunity elicited by T. gondii in mouse models, T
cells and IFNy are known to be key factors in determining the outcome of infection
(Gazzinelli et al., 1991; Subauste and Remington, 1991). The importance of T cells
in protective immunity has been revealed through adoptive transfer experiments
using murine models (Suzuki and Remington, 1988; Parker et al., 1991). This is
corroborated by the recrudescence of latent T. gondii infections in patients with AIDS
where CD4+ and CD8+ T cell counts fall below certain levels (Luft et al., 1984;
Navia et al., 1986).
In this study, cattle showed an early and brief increase in the percentage of
CD4+T cells in peripheral blood and showed stronger and more frequent proliferative
activity in PBM cells cultured with specific antigen in vitro and IFNy was more
frequently detected in either blood plasma or in activated PBM cells when compared
to sheep under the same conditions. Phenotypic analysis of PBMC in sheep
undergoing a primary infection showed an increase in the CD8+: CD4+ T cell ratio,
which is in agreement with a study reported by Innes et al., (1995a) following
experimental inoculation of sheep. They described a similar phenomenon in ovine
efferent lymph cells responding to a primary T. gondii infection. The cattle showed
an early and brief increase in the percentage of CD4+ T cells which was not seen in
the sheep. CD4+ T lymphocytes have been shown to have a major role in the
development of resistance to the parasite (Suzuki and Remington, 1988; Araujo,
1991). Araujo demonstrated the participation of CD4+ T cells in the development of
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resistance to T. gondii and in the mechanisms controlling the formation of T. gondii
cysts in the brains of mice. This activity was revealed when the number of T. gondii
cysts in the brains of mice treated with a monoclonal antibody against CD4+ was
significantly higher than in mice with intact CD4+ populations (Araujo, 1991).
Moreover, although it has been suggested that CD8+ T cells are the major effector
cells in T. gondii infection, their induction and optimal activity is dependent upon
CD4+ helper function (Denkers et al., 1993; Innes et al., 1995a).
IFNy is known to be important in protective immunity to T. gondii and has
been suggested as the major mediator of host resistance (Suzuki et al., 1988). This
cytokine is known to be able to activate several cell types, in particular macrophages
to kill multiplying parasites within the cells (McCabe et al., 1984; Murray et al.,
1985; Black et al., 1987). EFNy has also been reported to promote the maturation of
CD8+ T cells into effector cytotoxic cells (Zanovello et al., 1988). CD4+ and CD8+ T
cells are known to produce IFNy in response to stimulation with T. gondii (Gazzinelli
et al., 1993), although in vitro at least, CD4+ T cells seem to be the major producers
of IFNy. Interestingly, recent studies have demonstrated that NK cells can produce
IFNy very early in T. gondii infection prior to the induction of specific cell mediated
immune responses (Hauser et al., 1982, 1983; Sher et al., 1993). Previous studies in
sheep examining cell free efferent lymph plasma have shown the presence of IFNy in
animals undergoing primary and secondary infection with T. gondii (Innes et al.,
1995b). The presence of IFNy has been also observed in supernatants of primed
mesenteric lymph node cells in mice following an oral T. gondii infection (Chardes et
al., 1993). However, both of these studies were examining local immune responses
and not responses in the periphery. This study showed that in general IFN was more
frequently detected in cattle than in sheep, however the quantity of IFN detected was
comparatively low compared to that reported by Innes and collaborators (1995b). A
possible explanation for this may be that cytokines are likely to be found at a
comparatively higher concentration in local immune responses than in the periphery.
Therefore a study of the cytokine response following T. gondii infection is probably
best achieved by examining a local immune response and in the case of orally
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infected animals it would be best to examine responses in the gut. However,
measuring the kinetics of cytokine responses locally in the gut of large animal species
such as cattle and sheep would pose considerable difficulties.
The results from this thesis have largely described and compared the immune
responses of cattle and sheep following a primary oral infection with T. gondii.
Studies on the anti-T. gondii mechanisms of various components of the immune
response would be the next step to help determine why cattle are better able to
control the infection than sheep.
8.6 Concluding remarks and future studies
The results arising from the present study indicate that resistance to oral
Toxoplasma infection is likely to mediated by a number of immune mechanisms
acting together. It is difficult to draw any precise conclusion as to why cattle may be
less vulnerable to T. gondii infection than sheep. In general the cattle appear to be
better able to control the parasitaemia resulting in fewer parasites being detected in
their tissues compared with sheep. Interestingly the cytokine IFNy was more
frequently detected either from plasma or activated cell supernatants in the infected
cattle compared to the sheep. This cytokine is known to play an important role in
protection against T. gondii and has been implicated as a factor involved in the
differentiation of tachyzoites to bradyzoites (tissue cyst stage). Therefore if IFNy is a
critical factor in determining the outcome of a T. gondii infection, future studies
should focus on the mechanisms of induction of IFNy within species of differing
vulnerability to T. gondii.
In oral Toxoplasma infection, the first line of host defence is in the intestinal
mucosa surface, which consists of epithelial cells, intraepithelial lymphocytes
(mainly CD8+ phenotype), mucus and secretory immunoglobulins (IgA) (Chardes et
al., 1993). Increasing evidence suggests that intraepithelial lymphocytes play a major
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role at the mucosal surfaces as a first line of defence against enteric invasion
(Chardes et al., 1994) The mucosal effector mechanism has been characterized as
cytotoxic T cell activity directed against T. gonr/h'-infected-epithelial cells, which are
then eliminated from the epithelium. Defined mucosal immunity can be elicited with
the presence of T. gondii immunogens, which are potent inducers of local immune
response via IgA production, T cell stimulation and cytokine secretion. Studies on the
early mucosal immune response elicited following oral Toxoplasma infecting in
cattle might elucidate the cause of the efficiency of cattle in controlling parasite
multiplication.
Several studies have clearly demonstrated the unusual capacity of T. gondii to
nonspecifically activate macrophages as well as natural killer cells leading to the
early production of cytokines as IFNy and TNF-a during initial stages of infection
before specific T cell induction (Hauser et al., 1982, 1983; Gazzinelli et al., 1993). It
is believed that an early stimulation of both of these cell populations by the parasite
is crucial in establishing an early nonspecific resistance against the rapidly dividing
tachyzoites before development of an adaptive T cell mediated immune response
(Gazzinelli et al., 1993). The early production of IFNy by NK cells has also been
implicated in the biasing of the CD4+ T cell response towards the Thl phenotype,
which produces the inflammatory cytokines, IL-2 and IFNy known to be important in
protective immunity to T. gondii.
In conclusion, the information arising from the present study and from the
relevant literature on T. gondii infection, suggest that cattle are better able to control
T. gondii multiplication, and subsequently reducing the number of parasites
disseminated to the tissues probably via a combination of effective immune
mechanisms.
The study of the early induction of IFNy by innate mechanisms may provide
the answer as to why cattle are more resistant than sheep or other more vulnerable
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Appendix Chapter 4 Table 1 Animals orally infected with a titrated dose of sporulated T. gondii oocysts
Group M3 oocyst dose Animal number Species Breed Sex Age













Appendix Chapter 4 Table 2 Rectal temperatures before and after oral infection of sheep given 105
T. gondii oocysts of the M3 isolate.
days of infection SI S2 S3 S4 mean sd* sem*
-2 39.78 39.55 40.10 40.23 39.92 0.31 0.15
-1 39.75 39.88 40.19 39.94 39.94 0.18 0.07
0 39.68 39.63 40.13 40.25 39.92 0.31 0.13
1 40.05 40.14 40.01 40.25 40.11 0.11 0.05
2 38.89 40.18 40.05 40.60 39.93 0.73 0.15
3 41.83 41.69 39.80 40.49 40.95 0.98 0.40
4 42.51 42.48 42.09 42.26 42.32 0.20 0.08
5 42.25 42.45 42.53 42.61 42.46 0.15 0.04
6 41.65 42.05 42.2 42.24 42.04 0.27 0.05
7 41.15 41.53 41.19 41.60 41.37 0.23 0.09
8 41.31 41.20 41.35 41.97 41.46 0.35 0.17
9 39.99 41.69 40.03 40.78 40.62 0.80 0.34
10 39.61 40.36 39.52 40.07 39.89 0.40 0.18
11 39.59 41.46 39.76 40.04 40.21 0.85 0.38
12 39.49 39.85 39.65 40.16 39.79 0.29 0.11
13 39.85 39.78 39.84 39.93 39.85 0.06 0.03
14 39.66 40.15 39.88 39.89 39.90 0.20 0.07
*sd: standard deviation, sem: standard error of the mean
XXXIV
Appendix Chapter 4 Table 3 Rectal temperatures after oral infection of sheep given 104 T. gondii oocysts of
the M3 isolate
days of infection S5 S6 S7 S8 mean sd* sem*
-2 39.48 40.37 38.94 39.58 39.59 0.59 0.29
-1 39.70 39.71 39.58 39.73 39.68 0.07 0.03
0 39.77 39.65 39.51 39.33 39.57 0.19 0.07
1 39.39 39.72 39.43 39.85 39.60 0.22 0.09
2 39.93 39.85 39.83 39.83 39.86 0.05 0.01
3 39.85 39.81 39.53 39.69 39.72 0.14 0.06
4 41.66 41.68 40.03 41.94 41.33 0.87 0.42
5 42.40 42.20 42.51 42.47 42.40 0.14 0.07
6 41.97 42.21 42.41 42.17 42.19 0.18 0.06
7 41.69 41.84 41.71 41.68 41.73 0.07 0.03
8 40.66 41.33 41.57 40.37 40.98 0.56 0.26
9 40.94 41.21 41.63 41.20 41.25 0.29 0.10
10 39.94 40.55 40.37 39.95 40.20 0.31 0.13
11 39.38 39.60 40.12 39.57 39.67 0.32 0.13
12 39.63 39.17 39.71 39.68 39.55 0.25 0.12
13 39.83 39.53 39.77 39.57 39.68 0.15 0.05
14 39.42 39.57 39.65 39.445 39.52 0.11 0.04
*sd: standard deviation, sem: standard error of the mean
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Appendix Chapter 4 Table 4 Rectal temperatures after oral infection of sheep given 103 T. gondii oocysts of
the M3 isolate
days of infection S9 S10 Sll S12 mean sd* sem*
-2 39.65 39.46 39.93 39.83 39.72 0.21 0.10
-1 39.12 40.13 39.92 39.26 36.61 0.49 0.19
0 39.69 39.77 39.72 39.91 39.77 0.10 0.04
1 39.87 39.87 39.89 40.35 40.00 0.24 0.11
2 39.59 39.88 40.06 40.09 39.91 0.23 0.05
3 39.66 39.58 39.56 39.34 39.54 0.14 0.06
4 39.49 39.95 40.25 39.81 39.88 0.32 0.10
5 41.44 41.38 41.42 42.04 41.57 0.31 0.15
6 42.12 42.29 41.94 42.17 42.13 0.15 0.07
7 41.94 41.99 42.08 41.69 41.93 0.17 0.08
8 41.01 41.25 41.44 41.33 41.26 0.18 0.04
9 41.03 41.75 41.37 40.99 41.29 0.35 0.16
10 39.95 42.25 40.52 40.73 40.86 0.98 0.39
11 39.48 41.96 39.02 39.21 39.92 1.37 0.67
12 39.81 39.11 39.37 39.85 39.54 0.36 0.15
13 39.51 39.30 39.64 39.77 39.56 0.20 0.10
14 39.32 39.47 39.41 39.45 39.41 0.07 0.01
*sd: standard deviation, sem: standard error of the mean
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Appendix Chapter 4 Table 5 Reciprocal IFAT titres of IgG antibody in sheep infected with 105 T. gondii
oocysts of the M3 isolate
days of infection SI S2 S3 S4 mean sd* sem*
-2 0 32 16 32 16 2.38 1.19
0 0 0 16 16 4 2.31 1.15
2 0 0 0 0 0 0 0
4 32 32 32 32 32 0 0
6 32 32 16 32 32 0.50 0.25
8 64 32 1/32 32 32 0.50 0.25
10 128 64 64 64 64 0.50 0.25
12 1024 1024 1024 1024 1024 0 0
14 1024 1024 1024 1024 1024 0 0
Appendix Chapter 4 Table 6 Reciprocal IFAT titres of IgG antibody in sheep infected with 10J T. gondii
oocysts of M3 isolate
days of infection S5 S6 S7 S8 mean sd* sem*
-2 16 16 16 16 16 0 0
0 16 16 16 16 16 0 0
2 32 32 32 16 32 0.50 0.25
4 32 32 32 32 32 0 0
6 32 64 32 32 32 0.50 0.25
8 32 64 32 32 32 0.50 0.25
10 64 64 32 64 64 0.50 0.25
12 1024 1024 1024 1024 1024 0 0
14 256 1024 1024 1024 1024 1 0.5
*sd: standard deviation, sem: standard error of the mean
XXXVII
Appendix Chapter 4 Table 7 Reciprocal IFAT titres of IgG antibody in sheep infected with 103 T. gondii
oocysts of M3 isolate
days of infection S9 S10 Sll S12 mean sd* sem*
-2 16 16 16 16 16 0 0
0 16 16 16 16 16 0 0
2 32 16 32 32 32 0.50 0.25
4 32 16 32 32 32 0.50 0.25
6 32 16 32 32 32 0.50 0.25
8 16 64 256 64 64 1.63 0.82
10 16 16 32 32 32 0.58 0.29
12 256 1024 256 512 512 0.96 0.48
14 512 1024 256 512 512 0.82 0.41
Appendix Chapter 4 Table 8 % OD detected by IgG-ELISA in serum from sheep infected with 10s
T. gondii oocysts of M3 isolate
days of infection SI S2 S3 S4 mean sd* sem*
-2 10 10 10 10 10 0 0
0 10 10 10 10 10 0 0
2 10 10 10 10 10 0 0
4 10 10 10 10 10 0 0
6 10 10 10 10 10 0 0
8 10 10 10 10 10 0 0
10 21 10 10 10 12.75 5.50 0.69
12 33 18 16 30 24.25 8.50 3.18
14 38 38 21 37 33.50 8.35 3.91
19 50 89 52 81 68 19.92 8.09
*sd: standard deviation, sem: standard error of the mean
XXXVIII
Appendix Chapter 4 Table 9 % OD detected by IgG-ELISA in serum from sheep infected with 104
T. gondii oocysts ofM3 isolate
days of infection S5 S6 S7 S8 mean sd* sem*
-2 10 16 10 16 13 3.46 1.44
0 10 10 10 19 12.25 4.50 2.13
2 10 15 10 18 13.25 3.95 1.63
4 10 17 10 17 13.50 4.04 1.68
6 10 17 10 15 13.00 3.56 1.49
8 10 10 10 15 11.25 2.50 1.18
10 10 19 10 21 15 5.83 2.43
12 20 23 21 40 26 9.42 4.29
14 30 33 38 48 37.25 7.89 3.18
19 44 52 76 86 64.5 19.76 7.34
Appendix Chapter 4 Table 10 % OD detected by IgG-ELISA in serum from sheep infected with 103
T. gondii oocysts of M3 isolate
days of infection S9 S10 Sll S12 mean sd* sem*
-2 10 10 17 10 11.75 3.50 1.66
0 10 10 19 10 12.25 4.50 2.13
2 10 10 20 10 12.50 5 2.37
4 10 10 18 10 12 4 1.89
6 10 10 17 10 11.75 3.50 1.66
8 10 10 18 10 12 4 1.89
10 10 10 10 19 12.25 4.50 2.13
12 10 10 28 19 16.75 8.62 3.72
14 10 21 42 32 26.25 13.82 4.50
19 36 78 52 61 56.75 17.54 5.66




Appendix Chapter 6 Table 1 Rectal temperatures before and after primary oral infection of sheep given 103
T. gondii oocysts of the M3 isolate
days of infection Sjl S,2 S,3 Si4 mean sd* se*
-3 38.7 39.85 39.53 39.9 39.50 0.55 0.28
-2 39.87 39.54 40.25 40.27 39.98 0.35 0.17
-1 40.13 39.6 39.69 40.31 39.93 0.34 0.17
0 40.01 39.63 39.62 40.09 39.84 0.25 0.12
1 39.59 39.85 40.05 39.88 39.84 0.19 0.09
2 39.77 39.27 39.62 39.55 39.55 0.21 0.10
3 39.78 39.46 39.94 39.61 39.70 0.21 0.10
4 40.83 40.54 40.85 41.1 40.83 0.23 0.11
5 41.53 41.5 41.65 41.45 41.53 0.08 0.04
6 41.6 41.65 41.44 41.68 41.59 0.11 0.05
7 41.05 41.01 41.45 41.37 41.22 0.22 0.11
8 40.89 40.78 41.33 40.88 40.97 0.25 0.12
9 39.96 39.44 40.77 40.01 40.05 0.55 0.27
10 39.65 39.25 39.45 39.25 39.40 0.19 0.10
11 39.44 39.17 39.45 39.3 39.34 0.13 0.07
12 39.72 39.44 39.59 39.67 39.61 0.12 0.06
13 39.21 39.2 39.49 39.26 39.29 0.14 0.07
14 39.48 39.09 39.57 39.49 39.41 0.22 0.11
*sd: standard deviation, sem: standard error of the mean
XLI
Appendix Chapter 6 Table 2 Rectal temperatures before and after primary oral infection of cattle given
103 T. gondii oocysts of the M3 isolate
days of infection C21 C22 C23 C24 mean sd* se*
-3 38.81 38.8 38.27 38.37 38.56 0.28 0.14
-2 38.68 38.91 38.69 39.04 38.83 0.18 0.09
-1 38.78 38.99 38.75 38.92 38.86 0.11 0.06
0 38.61 40.54 39.03 38.98 39.29 0.85 0.43
1 39.07 39.28 38.64 38.85 38.96 0.28 0.14
2 38.93 38.86 39.06 38.21 38.77 0.38 0.19
3 38.07 39.01 38.65 38.69 38.61 0.39 0.20
4 39.01 38.77 38.77 39.02 38.89 0.14 0.07
5 38.81 40.37 39.77 40.33 39.82 0.73 0.36
6 40.93 40.25 40.88 40.15 40.55 0.41 0.20
7 40.92 39.77 40.77 40.01 40.37 0.56 0.28
8 40.25 39.09 39.99 39.77 39.78 0.50 0.25
9 39.23 38.57 39.16 38.98 38.99 0.30 0.15
10 38.61 38.72 38.77 39.06 38.79 0.19 0.10
11 38.47 38.69 38.69 38.55 38.60 0.11 0.05
12 38.44 38.85 38.79 38.89 38.74 0.21 0.10
13 38.67 38.8 38.61 38.65 38.68 0.08 0.04
14 38.74 38.61 38.68 38.93 38.74 0.14 0.07
*sd: standard deviation, sem: standard error of the mean
XLII
Appendix Chapter 6 Table 3 Rectal temperatures before and after primary oral infection of sheep given 10s
T. gondii oocysts of the M3 isolate
days of infection s3i S32 S33 S34 S35 S36 mean sd* sem*
-3 39.93 40.25 39.61 38.97 39.93 39.36 39.68 0.46 0.19
-2 39.45 39.57 39.63 39.6 39.49 39.34 39.51 0.11 0.05
-1 39.71 39.4 39.69 39.71 39.65 39.55 39.62 0.12 0.05
0 40.32 39.36 39.41 39.01 39.62 39.33 39.51 0.44 0.18
1 39.46 39.27 39.25 38.98 39.45 38.79 39.20 0.27 0.11
2 40.02 39.49 39.73 38.96 39.97 39.95 39.69 0.41 0.17
3 40.91 41.05 40.94 39.32 41.04 41.1 40.73 0.69 0.29
4 41.45 41.64 41.93 41.2 41.57 41.78 41.60 0.26 0.11
5 41.7 41.12 41.55 41.37 41.59 41.19 41.42 0.23 0.10
6 40.89 41.04 41.33 41.47 41.49 41.15 41.23 0.24 0.10
7 40.98 41.08 41.05 40.93 41.37 40.45 40.98 0.30 0.13
8 40.89 40.13 41.34 39.63 41.12 40.05 40.53 0.68 0.28
9 39.41 38.52 40.68 38.97 40.34 38.53 39.41 0.92 0.38
10 39.56 39.17 39.69 38.84 38.68 39.49 39.24 0.41 0.17
11 39.49 39.01 39.18 39.21 39.09 39.19 39.20 0.16 0.07
12 38.85 39.08 39.09 38.57 38.97 39.2 38.96 0.23 0.09
13 39.37 39.17 39.17 39.21 39.25 39.16 39.22 0.08 0.03
14 39.51 39.13 39.36 39.13 39.32 39.11 39.26 0.16 0.07
*sd: standard deviation, sem: standard error of the mean
XLIII
Appendix Chapter 6 Table 4 Rectal temperatures before and after primary oral infection of cattle given 10s
T. gondii oocysts of the M3 isolate
days of infection C41 C42 C43 C44 C45 C46 mean sd sem
-3 38.08 37.63 37.66 38.26 38.2 38.48 38.05 0.34 0.14
-2 38.53 38.89 38.65 38.73 38.69 38.34 38.64 0.19 0.08
-1 37.99 38.26 39.01 38.56 38.79 38.38 38.50 0.37 0.15
0 38.33 38.21 38.18 38.85 38.47 38.17 38.37 0.26 0.11
1 38.81 38.34 38.42 38.65 38.44 38.53 38.53 0.17 0.07
2 38.44 38.64 38.7 38.77 38.73 38.23 38.59 0.21 0.09
3 39.47 40.61 39.01 40.13 38.78 38.89 39.48 0.74 0.31
4 39.91 40.3 40.36 39.49 40.84 39.28 40.03 0.58 0.24
5 40.32 40.89 40.87 38.37 39.8 40.72 40.16 0.97 0.40
6 39.69 40.29 40.09 38.48 39.81 40.29 39.78 0.68 0.28
7 38.65 39.54 39.19 37.99 39 39.9 39.05 0.67 0.28
8 38.48 39.22 38.13 37.92 37.94 38.65 38.39 0.50 0.21
9 37.18 38.23 38.2 37.94 37.09 37.76 37.73 0.50 0.21
10 37.65 38.23 37.82 37.89 37.61 37.87 37.85 0.22 0.09
11 37.42 38.39 38.53 38.38 38.5 38.53 38.29 0.43 0.18
12 38.97 38.26 37.41 38.43 38.13 38.28 38.25 0.50 0.21
13 37.5 38.3 38.37 37.9 38.17 38.31 38.09 0.34 0.14
14 38.11 38.24 38.4 38.22 37.47 38.18 38.10 0.32 0.14
*sd: standard deviation, sem: standard error of the mean
XLIV
Appendix Chapter 6 Table 5 Reciprocal IFAT titres of IgG antibody in sheep infected with 103 T. gondii
oocysts of M3 isolate
days of infection s,i S,2 S,3 S,4 mean sd* se*
-3 16 16 16 16 16 0.00 0.00
-2 16 16 16 16 16 0.00 0.00
-1 16 16 16 16 16 0.00 0.00
0 16 16 16 16 16 0.00 0.00
3 16 16 16 5 16 0.50 0.25
5 32 32 16 64 32 0.82 0.41
7 16 16 16 64 32 1.00 0.50
10 128 16 64 256 64 1.71 0.85
12 1024 1024 1024 2048 1024 0.50 0.25
14 8192 2048 1024 2048 2048 1.26 0.63
17 8192 2048 1024 8192 4096 1.50 0.75
19 16384 4096 1024 16384 8192 1.91 0.96
21 8192 4096 2048 16384 8192 1.29 0.65
28 16384 4096 8192 8192 8192 0.82 0.41
182 512 256 512 0.71 0.50
210 512 512 512 0.00 0.00
238 256 256 256 0.00 0.00
266 256 256 256 0.00 0.00
301 256 256 256 0.00 0.00
329 256 256 256 0.00 0.00
371 1024 256 512 1.41 1.00
*sd: standard deviation, sem: standard error of the mean
Sheep Sj3 and S]4 were killed at 6 weeks after infection and postmortem examination was carried out
XLV
Appendix Chapter 6 Table 6 Reciprocal IFAT titres of IgG antibody in cattle infected with 103 T. gondii
oocysts of M3 isolate
days of infection c2i C22 C23 C24 mean sd* se*
-3 256 256 64 128 128 0.48 0.48
-2 256 256 64 128 128 0.48 0.48
-1 256 256 64 128 128 0.96 0.48
0 256 256 64 128 128 0.96 0.48
3 256 256 128 128 256 0.58 0.29
5 256 256 128 128 256 0.58 0.29
7 256 256 128 512 256 0.82 0.41
10 256 256 256 512 256 0.50 0.25
12 1024 256 8256 1024 9512 1.15 0.58
14 512 512 1024 1024 1024 0.58 0.29
17 512 1024 1024 1024 1024 0.50 0.25
19 512 1024 1024 1024 1024 0.50 0.25
21 1024 1024 1024 1024 1024 0.00 0.00
28 1024 1024 1024 1024 1024 0.00 0.00
182 4096 2048 4096 0.71 0.50
210 4096 4096 4096 0.00 0.00
238 4096 4096 4096 0.00 0.00
266 2048 4096 4096 0.71 0.50
301 2048 1024 2048 0.71 0.50
329 2048 8192 4096 1.41 1.00
371 2048 2048 2048 0.00 0.00
*sd: standard deviation, sem: standard error of the mean
Cattle C21 and C23 were killed at 6 weeks after infection and postmortem examination was carried out
XLVI
Appendix Chapter 6 Table 7 Reciprocal IFAT titres of IgG antibody in sheep infected with 10s T. gondii
oocysts of M3 isolate
Days of infection s3i S32 S33 S34 S35 S36 mean sem* sd*
-3 32 64 128 64 128 128 64 0.33 0.82
-2 32 64 128 64 128 128 64 0.33 0.82
-1 32 64 128 64 128 128 64 0.33 0.82
0 32 128 128 64 256 128 128 0.42 1.03
3 32 128 128 128 256 128 128 0.40 0.98
5 32 128 128 128 512 128 128 0.52 1.26
7 64 128 128 128 512 256 128 0.42 1.03
10 512 256 512 512 2048 1024 512 0.42 1.03
12 1024 512 1024 1024 2048 4096 1024 0.42 1.03
14 2048 2048 2048 8192 8192 4096 4096 0.40 0.98
21 4096 8192 2048 8192 8192 8192 8192 0.34 0.84
28 8192 4096 16384 8192 16384 8192 8192 0.31 0.75
36 8192 4096 16384 16384 16384 16384 16384 0.34 0.84
43 8192 8192 16384 16384 32768 16384 16384 0.31 0.75
73 16384 8192 16384 16384 0.33 0.58
103 8192 4096 4096 4096 0.33 0.58
133 8192 2048 4096 4096 0.58 1.00
166 8192 8192 4096 8192 0.33 0.58
*sd: standard deviation, sem: standard error of the mean
Sheep S31, S32 and S34 were killed at 6 weeks after infection and postmortem examination was carried out
XLVII
Appendix Chapter 6 Table 8 Reciprocal IFAT titres of IgG antibody in cattle infected with 10s T. gondii
oocysts of M3 isolate
Days of infection C41 C42 C23 C44 C45 C46 mean sd* sem*
-3 128 128 128 128 128 128 128 0.00 0.00
-2 128 128 128 128 128 128 128 0.00 0.00
-1 128 128 128 128 128 128 128 0.00 0.00
0 128 128 128 128 128 128 128 0.00 0.00
3 128 256 128 128 128 128 128 0.41 0.17
5 128 256 256 128 128 128 128 0.52 0.21
7 128 256 256 128 128 512 256 0.82 0.33
10 1024 256 8192 256 256 512 512 1.97 0.80
12 1024 1024 16384 256 256 1024 1024 2.19 0.89
14 1024 2048 16384 256 512 1024 1024 2.07 0.84
21 2048 4096 16384 512 512 2048 2048 1.90 0.77
28 8192 16384 16384 8192 8192 16384 16384 0.55 0.22
36 16384 16384 16384 8192 8192 16384 16384 0.52 0.21
43 8192 16384 32768 8192 8192 16384 16384 0.82 0.33
73 4096 8192 16384 8192 1.00 0.58
103 1024 2048 8192 2048 1.53 0.88
133 1024 2048 8192 2048 1.53 0.88
166 4096 2048 4096 4096 0.58 0.33
*sd: standard deviation, sem: standard error of the mean




Tables 1 to 6 display the percentage of PBMC staining with monoclonal
antibodies recognizing CD2+, CD4+ and CD8+ T cell subsets following a primary oral
infection of sheep and cattle with 10 I gondii sporulated oocysts, where sd is
standard deviation, sem is standard error of the mean and nd: not done because of
lack of sample
L
Appendix Chapter 7 Table 1 Percentage of PBMC staining with monoclonal antibodies recognizing CD2+
subsets following a primary oral infection of sheep with 10J T. gondii oocysts
CD2+
Days of infection s3i S32 S33 S34 S35 S36 mean sd* sem*
-3 0.36 15.93 13.34 8.62 12.85 15.34 11.07 5.85 2.39
-1 18.08 14.3 26.33 12.63 20.61 33.53 20.91 7.86 3.21
0 50.25 9.5 13.92 26.32 15.93 67.29 30.53 23.19 9.47
2 -16.34 7.96 20.77 24.83 34.28 14.87 19.84 9.08 3.71
5 46.27 33.56 19.61 52.52 53.25 54.36 43.26 13.94 5.69
7 65.5 90.83 54.87 63.04 62.65 70.21 67.85 12.31 5.03
9 48.88 45.12 61.92 29.92 50.4 65.05 50.22 12.62 5.15
12 26.37 34.58 64.56 28.22 44.35 42.93 40.17 14.03 5.73
14 75.89 61.11 76.56 78.17 n d 64.3 71.21 7.89 3.53
16 41.19 13.79 50.54 12.23 19.42 28.13 27.55 15.52 6.34
19 9.78 10.17 nd 5.83 9.08 11.74 9.32 2.18 0.98
21 33.49 18.33 30.64 39.93 38.78 44.3 34.24 9.17 3.75
*sd: standard deviation, sem: standard error of the mean
LI
Appendix Chapter 7 Table 2 Percentage of PBMC staining with monoclonal antibodies recognizing CD4
subsets following a primary oral infection of sheep with 10s T. gondii oocysts
CD4+
Days of infection s3i S32 S33 S34 S35 S36 mean sd* sem*
-3 9.97 8.95 8.38 3.15 7.67 10.47 8.10 2.63 1.07
-1 17.63 14.21 25.63 12.15 25.49 35.1 21.70 8.64 3.53
0 5.86 8.78 13.59 24.74 9.97 21.96 14.15 7.60 3.10
2 10.99 8.34 20.77 16.68 25.57 0.19 13.76 9.15 3.73
5 22.53 13.31 24.4 26.16 24.33 29.66 23.40 5.50 2.25
7 37.39 23.56 44.78 22.37 44.66 35.88 34.77 9.85 4.02
9 49.18 48.76 57.87 32.74 50.18 65.79 50.75 11.03 4.50
12 24.31 37.78 64.2 33.88 48.19 40.51 41.48 13.63 5.56
14 77.09 40.33 69.75 64.5 nd 59.45 62.22 13.87 6.20
16 41.41 14.75 47.06 12.22 24.48 26.87 27.80 14.01 5.72
19 11.59 11.58 nd 9.14 12.95 14.69 11.99 2.04 0.91
21 27.1 16.57 31.22 22.04 30.05 36.03 27.17 6.96 2.84
*sd: standard deviation, sem: standard error of the mean
LII
Appendix Chapter 7 Table 3 Percentage of PBMC staining with monoclonal antibodies recognizing CD8+
subset following a primary oral infection of sheep with 10= T. gondii oocysts
CD8+
Days of infection s3i S32 S33 S34 S35 S36 mean sd* sem*
-3 8.25 4.69 5.63 2.33 52 5.83 13.12 19.14 7.81
-1 6.19 52.72 7.99 3.81 12.95 8.9 15.43 18.52 7.56
0 45.81 4.11 6.59 15.78 13.67 52.1 23.01 20.65 8.43
2 2.24 10.66 18.71 5.29 9.94 2.06 8.15 6.34 2.59
5 48.55 6.21 12.73 56.02 42 51.24 36.13 21.24 8.67
7 65.32 62.12 48.2 71.29 54.83 70.38 62.02 9.05 3.69
9 16.28 57.59 56.75 44.11 44.23 44.49 43.91 14.94 6.10
12 19.37 9.97 19.7 14.36 15.06 15.21 15.61 3.60 1.47
14 68.93 56.37 44.42 70.13 nd 43.51 56.67 12.79 5.72
16 28.59 8.01 23.63 11.12 14.24 14.19 16.63 7.85 3.21
19 12.93 5.09 nd 6.98 4.7 4.1 6.76 3.61 1.62
21 27.22 17.66 24.6 55.84 42.6 39.24 34.53 13.99 5.71
*sd: standard deviation, sem: standard error of the mean
LIII
Appendix Chapter 7 Table 4 Percentage of PBMC staining with monoclonal antibodies recognizing CD2+
subset following a primary oral infection of cattle with 10' T. gondii oocysts
CD2+
Days of infection C41 C42 C43 C44 C45 C46 mean sd* sem*
-3 67.57 76.15 78.21 71.63 66.21 58.02 69.63 7.36 3.00
-1 61.4 53.68 62.27 59.71 nd 44.95 56.402 7.23 3.23
0 70.9 65.8 75.01 65.42 85.57 71.29 72.33 7.43 3.03
2 26.32 20.75 24.07 23.18 16.83 21.35 22.08 3.26 1.33
5 41.74 69.01 77.08 79.68 94.39 93.21 75.85 19.35 7.90
7 41.07 38.38 91.17 61.83 54.43 51.97 56.47 19.09 7.79
9 77.73 62.33 72.04 77.17 66.37 61.1 69.45 7.28 2.97
12 66.06 70.96 70.15 72.68 68.9 62.72 68.57 3.63 1.48
14 70.66 44.17 71.3 54 75.7 63.8 63.27 12.04 4.91
16 55.07 33.4 43.13 59.86 48.56 45.18 47.53 9.32 3.81
19 33.64 22.13 31.63 49.83 30.13 26.81 32.36 9.46 3.86
21 81.79 57.56 62.03 63.05 54.79 58 62.87 9.76 3.98
*sd: standard deviation, sem: standard error of the mean
LIV
Appendix Chapter 7 Table 5 Percentage of PBMC staining with monoclonal antibodies recognizing CD4+
subset following a primary oral infection of cattle with 10' T. gondii oocysts
CD4+
Days of infection C41 C42 C43 C44 C45 C46 mean sd* sem*
-3 67.57 35.16 29.18 17.06 20.33 22.67 31.99 18.60 7.59
-1 61.4 32.18 29.57 28.06 nd 21.13 34.46 15.60 6.98
0 70.9 45.44 37.26 32.96 56.12 48 48.44 13.69 5.59
2 26.32 18.56 13.71 11.11 13.21 11.26 15.69 5.86 2.39
5 48.72 50.26 62.22 63.07 89.17 74.37 64.63 15.26 6.23
7 41.07 75.82 86.83 42.19 58.1 56.14 60.02 18.24 7.45
9 77.73 38.32 30.1 33.7 33.53 25.69 39.84 19.03 7.77
12 66.06 34.81 27.55 24.38 26.79 23.5 33.84 16.28 6.65
14 70.66 39.2 34.65 27.55 34.64 30.3 39.5 15.78 6.44
16 55.07 17.74 18.51 25.62 22.97 22.52 27.07 14.03 5.73
19 33.64 8.21 9.16 7.87 11.3 10.7 13.48 9.97 4.07
21 81.79 44.1 43.2 35.51 41.91 37.68 47.36 17.19 7.02
LV
Appendix Chapter 7 Table 6 Percentage of PBMC staining with monoclonal antibodies recognizing CD8+
subset following a primary oral infection of cattle with 10s T. gondii oocysts
CD8+
Days of infection C41 C4 C43 C44 C45 C46 mean sd* sem*
-3 10.59 17.58 8.41 27.12 3.06 10.61 12.89 8.39 3.42
-1 40.24 12.73 20.64 20.07 nd 13.07 21.35 11.20 5.01
0 24.7 23.4 30.32 25.04 40.57 41.56 30.93 8.20 3.35
2 5.17 12.33 16.43 18.41 18.04 10.52 13.48 5.16 2.11
5 15.25 12.34 17.06 6.23 14.1 10.85 12.63 3.82 1.56
7 9.79 8.43 16.89 20.1 19.56 18.34 15.51 5.10 2.08
9 29.1 16.92 26.33 28.15 16.8 24.79 23.68 5.49 2.24
12 17.47 8.33 16.75 19.14 16.7 12.87 15.21 3.95 1.61
14 16.01 15.71 20.7 22.2 17.06 20.24 18.65 2.74 1.12
16 16.1 15.71 16.55 21.03 17.89 22.47 18.29 2.81 1.15
19 7.55 7.15 7.62 24.74 12.2 9.16 11.40 6.79 2.77
21 30.29 20.31 22.21 28.15 29.15 26.27 26.06 3.99 1.63
*sd: standard deviation, sem: standard error of the mean
LVI
Tables 7 to 26 display the proliferative response of peripheral blood
mononuclear cells during primary oral infection of sheep and cattle with either 103 or
105 T. gondii sporulated oocysts.
Mean count per minute (cpm) (n=4) responses of PBMC to in vitro
stimulation with Con A (positive control) or T. gondii antigen from sheep (S11, Si2,
S]3, Si4, S3I, S32, S33, S34, S35 and S36) and cattle (C2I, C22, C23, C24, C4I, C42,
C43, C44, C45 and C46) on days before and after primary oral infection with either
103 or 105 oocyst of a complete strain (M3) of T. gondii.
SI= Stimulation index
Medium= Medium as negative control
LVII






















































































































































Daysofinfectioncpmx10'±se -2 -1 3 5 7 10 12 14 17 19 21 29I.45±0.62 0.51±0.04 0.78±23 0.78±.045 II.38±1 22 0.59±05 0.37±0.05





21.93±14.74 38.18±2.5 43.80±3.37 18.80±8.42 19.50±8.8 29.12±6.85 31.01±1.63 21.08±4.09 11.96±0.1 6.43±1 52 77.87±2.76 8.92±1 41
15.12
0.26
74.866x10 56.15 24.10 1.71 49.35 83.81 42.16 56.95 16.92 259 30.75
0.001 0.28 0.53 0.025




0.53±0.23 5.58±1.5 1.20±0.58 2±0.52 10.52±0.11 2.07±0 35 0.45±.024 0.65±08 0.21±0.04 1.23±0.87 0.3±.03 0.4±0.1
0.36 11 1.54 2.56 0.92 3.5 1.22 1.3 1 3.24 1 1.4
0.027 0.043 0.52 0.26 0.08 0.025 0.06 0.15 0.99 0.41 0.9 0.33
6.25(i,g/ml
cpmxl(r±seSIPvalue
cpmx103±seSIPvalue 0.77±0.31 2.55±0.35 0.8±.09 2.52±1 26 5.49± .65 1.07± .23 0.53±0.0 8 0.57±0.08 0.23±.024 0.32±06 0.36±05 0.34±0.010.53 5 1 3.23 0.48 1.81 1.43 1.14 1.09 0.84 1.2 1.17
0.12 0.01 0.84 0.4 0.43 0.13 0.03 0.39 0.35 0.4 0.3 0.013
AppendixChapter7Tabl9Prolif rativeresponsofsh pBMCdu i grimarylinfecti nw h10.go iio cysts
S,3




















































































































































AppendixChapter7Tabl10Proliferativer sponsofsh pBMCdu i gp imaryalinfect onw h03 .gondiio cysts
M



























































































































































































































































































































































































































































AppendixChapter7Tabl13Proliferativer sponsfcat lBMCdu i gprimaryo alinfectionw h03 .gondiicysts
C23





























































































































































Daysofinfectioncpmxl03±seml seSIPvalupmxl03±semcpmxl03+sem -2 -1 3 5 7 10 12 14 17 19 21 2926.54±3 41 8.93±1 79 38.07+10.68 2.76+0.7 2.71±0.73 5.71±1 29 9.60±4.82 13.18±2.73 1.36±0.5 0.13±0.02 2.69±0.48 1.22±0.2738.49±2 58 23.86±1.59 57.98±2 45 44.96±5 28 34.20±1.19 27.77±1.96 86.65±1.77 51.29±3.81 19.48±0 17.09±0 46 60.87±5 48 85.57± 381.450.019 2.67x10"4 1.520 08 16.2841x10~4 12.62 131.510 4.8615x0 9.020 3.8921x10"4 14.320 0 22.6318x0" 70.146x1047.11±3.661.770.011 15.88±2 361.77 105.7±2.828.02
0.06
63.55±2.401.670 06 39.76±3 5214.408x0"^ 17.82±3 046.570.016 41.81±3 237.15x04 57.13±11 55.90.025
10"
18.05±0 7113.272x10"4 10.89± 9583.765x10"4 40.82±4 2415.1729x10"4 24.88±3.3020 40. 05
~-4
41.34±3 881.550 0 17.93±2 7120.045 52.56±0 91.380. 42 30.30±5 2810.970. 14 18.35±4 716.70.045 37.99±1.946.655x10 52.68±6 03.4854xl0"4 104±4.337.892xl0"4 15.11±1 411.1123x 0" 6.77±1.3851.530.01 40.46±8 12150.02 20.63±2 14178x0"4
,-4








DaysofinfectioncpmxlO3±sempmxl03±semSIPvalu -2 -1 0 2 5 7 9 12 14 16 19 210.22±0 0.07+1 0.3±0.13 0.18±0.01 0.07±3 0.07± .01 0.16±.1 0.03±.002 0.08± .01 0.05±.006 0.36±03 0.23±08.22±0 44 3.26±0.26 6.16±0 31
23.890.0091 112.890.0002 25.77 18.80
5.31±1. 7.69±0 42 7.80±0 27 3.46±0.052 6.86±0.75 7.09± .2 12.48±0. 8.11±0.22 13.96±1.5272.730.0014 166.080.00 2 9.14 27.1588.460.0014 97.360 76.900.0002 263.210
0.0008 0.0001
12.5pg/ml
cpmxlO'±semSIPvalue 0.48±0.1 0.11±0.0 4 0.28±0.031 0.135±0.023 0.074±05 5.05±0 54 1.02±0.19 0.012± .002 9.79±0. 7 2.79±0.47 1.96±0.29 4.94±0 4262.15 1.61 0.91 0.73 0.96 69.41 6.29 0.38 5.51






0.73±.2 0.19±0.02 0.26±05 0.12±.015 0.077± .013 4.92±0.19 0.265±.07 0.094±29 6.97±0.9 3.45±1.4 9.80±0. 7 4.24±0.21
3.31 1.59 0.88 0.69 1.00 69.78 2.75 18.71
0.037 0.019 0.028 0.81 0.12
67.690.0001 1.630.025 3.060.044 86.230.00 2
0.046 0.001 0.0001









DaysofinfectioncpmxlO"'±sempmxlO3SIPvalue -2 -1 0 2 5 7 9 12 14 16 19 210.24±03 0.22±06 0.23±04 0.24±0.015 0.18±0.014 0.10±0.0 9 0.079± .016 0.077±0.012 0.21±0.051 0.26±0.035 0.18±0.019 0.27±.0669.67±0.55 13.40±0.31 14.14± 10.16±0.4 6.50±0.2 8.26±0.61 5.96±2. 13.00±.35 10.85±0.4 4.32±0.41 9.95±0.68
39.17 63.37 58.21 35.22 75.69
12.47±0.3357.24
77.48 59.99 41.55 23.24 35.69
0.0002 0.0004 0
41.020.0001
0 0.0005 0 0.054 0.0013 0.0001 0.001 0.0004
cpmxlO"±semSIPvalue 1.56±0.53 1.53±0. 1.31±0. 7 0.3±0.02 0.31±0.039 0.97±0.11 1.24±0.48 0.21±0. 1.24±0.51 3.5±0.24 0.69±0 1.67±0.206.33 6.86 5.69 1.20 1.66 8.88 15.60 2.71 5.72 13.41 3.70 5.98
0.044 0.01 0.022 0.072 0.025 0.002 0.047 0.13 0.09 0.0005 0.0062 0.0033
cpmxlO"±semSIPvalue 1.1±0.28 0.52±0.18 1.31±0. 7 0.32±.024 0.29±0.041 0.64±0.11 0.31±0.03 0.33±0.13 0.33±0.12 2.55±0.23 0.73±0.13 1.49±0.234.44 2.33 5.69 1.29 1.56 5.82 3.89 4.31 1.53 9.76 3.93 5.35
0.029 0.1 0.0039 0.028 0.045 0.0096 0.0031 0.074 0.21 0.0011 0.013 0.0069









DaysofinfectioncpmxlO3±semcpmxlO3 seSIPvalue -2 -1 0 2 5 7 9 12 14 16 19 210.55±0.26 0.17±0.03 0.15±0.02 0.35±0.21 0.23±0.0 7 0.16±0.04 0.11±0.006 0.092±07 0.077± .016 0.079±. 08 0.21±0.02 0.31±0.049.30±1.4316.8 6.10±0.7235.26 11.52±0.4376 95 10.33±1.1729 4 8.23±0 4835.47 12.63±0.3074.79 7.44±065.85 7.44±0.3680.3 16.15±0.62208.31 8.18±0.76103.14 8.06± .5237 9 10.98±o.4634.87
0.0044 0.0019 0.0001 0.0017 0.0002 0 0.0002 0.0001 0.0001 0.0009 0.0003 0.0001
cpmxlO3±semSIPvaluecpmxlO3valu 1.83±0.70 0.18±0.03 0.24±06 0.31±0.08 0.52±0.08 0.08±33.320.083 1.060 39 1.610 12 0.8967 2.270.01 1.86±0.471.050.018 0.23±052 4.050 0.8766 7.33±1.6394.550.022 1.50±0.528.910.036 5.76±0.7827.110.0 2 5.92±0. 318.80.0 013.08± .19 0.18±0.04 0.38±0.05 0.72±0.41 0.62±0.14 0.86±09 0.15±0.008 0.07±.025 2.75±0.91 1.06± .32 3.84±0.32 5.57±0.3
5.57 1.07 2.55 2.07 2.68 5.10 1.39 0.83 35.59 13.44 18.06 17.68
0.0004 0.40 0.0087 0.21 0.033 0.0021 0.0063 0.71 0.03 0.026 0.0008 0.0002
AppendixChapter7Tabl18Proliferativer sponsofsh pBMCdu i gp imaryalinfectionw h05 .gondiicysts
S34






























































































































































0 2 5 7 9
12 14 16 19 21
0.24±07 0.12±.1 0.14±0.05 0.09±7 0.21±0. 6 0.15±0.12 0.18±0.15 0.06±5 0.47±6 0.47±39 0.33±24 0.26±0.2
5.59±0.31 12.07±0.92 8.45±0 54 3.14±0 8 8.60±0.16 8.82±0 43 8.74±0.56 7.21±0.34 17.38±2 4.35±0 24 2.05±0 24 4.96±0.3
23.29 100.58 60.36 35.28 40.95 58.80 48.56 120.17 36.98 9.26 6.21 19.08
0.0002 0.0005 0.0003 0.0002 0 0.0001 0.0003 0.0001 0.0004 0.0002 0.0028 0.0003
0.49±0.1 0.81±0.4 0.27±0 0.11±0.03 1.19±0 4 0.82±09 4.32±0.32 0.26±0.01 6.53±0.21 4.34±0.4 0.61±0.22 3.13±0.28
2.01 6.85 1.94 1.27 5.29
0.075 0.17 0.17 0.44
5.750.0055
0.005






0.50±0.16 0.52±09 0.19±0.005 0.12±0.03 0.47±06 0.77±05 4.14±0 8 0.22±04 6.24±0.25 3.67±0 2 0.57±0.13 2.39±0.28
2.06 4.42 1.33 1.32 2.26 4.97 22.77 3.63 13.09 7.78 1.74 9.26
Pvalue 0.21 0.023 0.0034 0.46 0.02 0.001 0.0002 0.061 0.0002 0.0012 0.16 0.0049
AppendixChapter7Tabl20Prolif rativer sponsofsh pBMCdu i grimaryalinfecti nw h105 .gondiicysts
S-,6
Controls




DaysofinfectioncpmxlO3±sempmxlO1SIPvalue -2 -1 0 2 5 7 9 12 14 16 19 210.25±07 0.29±0.51 0.16+05 0.27±0.21 0.58±0.45 0.19±5 0.12±0.09 nd 0.33±0.25 0.31±0.23 0.30±0.23 0.30±0.238.82±0 64 18.09±0.5 10.16±0.27 9.60±0.54 11.07±0.5 7.67±0.2 11.34±0.45 nd 6.80±0.17 12.56±0.4 8.37±0.3 15.92±0.5
35.28 62.38 63.50 35.56 94.50 nd 20.61 40.52 27.90 53.07
0.0004 0 0 0.0002
19.090.0001 40.37 0.0001
nd
0 0 0.0001 0
12.5pg/ml
cpmxl03±semSIPvalu 0.83±0.26 1.19±0.44 0.54±0.17 0.71±0.2 1.20±0.9 2.79±0 35 7.10±0 8 nd 4.99±0.3 5.62±0 24 1.78±0.23 5.83±0.243.32 4.10 3.38 2.63 2.07 nd 15.12





cpmxlO3±semSIPvalue 0.86±0.23 1.82±0.73 0.27±04 0.64±0.11 1.14±0 3 2.24±0 62 6.93±0 26 nd 4.80±0.22 5.44±0 63 1.26±0 18 6.48±0 393.44 6.28 1.69 2.37 I.97 II.79 57.75 nd 14.55 17.55 4.20
0.039 0.063 0.034 0.025 0.012 0.023 0.0001 nd 0.0001 0.002 0.0062
21.600.0003
r x x




























































































































































0 2 5 7 9
12 14 16 19 21




4.42±0 27 8.58+1.1 13.78±0.65 9.45±1.31 8.60±0.35 13.16±0.48 8.67±1.3 10.54±8 10.85± 0.98±05 1.74±0.17 8.34±0 49
SI 21.35 153.69 96.69 203.18 32.85 93.78 2.29 753.18 46.53 19.31 5.09 4.42
Pvalue 0.0003 0.0021 0.0001 0.0028 0.0001 0.0001 0.018 0.005 0.0009 0.0002 0.002 0.0005
watersolublefractionfS48T.g ndiiantigen 12.5pg/ml
8.44±1 53 1.57±0.26 2.12±0.46 0.10±0. 5 0.95±22 5.20±0 03 10.90±4 0.07±4 18.81±2.52 0.03±7 1.62±0.54 18.30±2.2








4.73±0 97 0.83±0.32 3.38±0.36 0.07±2 0.56±0 4.57±0.22 9.91±0.9 0.35±0.14 20.99±1.42 0.03±1 2.13±0.66 17.94±2.22
22.84 14.84 23.73 1.48 2.14 32.58 2.61 24.81 90.04 0.62 6.24 9.51
Pvalue 0.0096 0.049 0.0015 0.19 0.01 0.0001 0.003 0.048 0.0003 0.9 0.037 0.0027









DaysofinfectioncpmxlO3±semcpmxl03±semSIPvalu -2 -1 0 2 5 7 9 12 14 16 19 211.63±0.17 0.44±08 2.03±0.6 0.08± .01 0.24±.009 0.23±0.03 1.13±0.2 0.05±.004 0.56±17 0.02±.0 08 1.24±0.23 0.29±086.01± .6 9.02±1 11.36±0.5 13.44±0.8 7.14±0.3 10.02±0.6 5.16±0.5 12.65± 11.98±0.56 2.63±0.11 2.82±0.09 11.14±
3.69 20.61 5.59 173.54 29.18 44.50 4.55 243.23 21.29 160.15 2.28 38.14
0.0032 0.0015 0.0003 0.0002 0.0001 0.0003 0.0005 0.0004 0.0001 0.0001 0.0002 0.0008
cpmxlO3±semSIPvalue 1.30±0.6 1.41±0.31 5.01±1 85 0.14±0.05 0.82±08 3.85±1.7 3.85±0.4 1.92±0.73 18.88±.02 0.05±.03 3.02± .5 10.58±60.80 3.21 2.47 1.81 3.35 17.11 3.40 36.82 33.55 3.36 2.44 36.23
0.68 0.026 0.1 0.15 0.0024 0.064 0.0033 0.042 0.0002 0.14 0.018 0.004
0.73±24 2.25±0.56 6.26±1 32 0.097±. 1 0.69±0.13 1.93±0.1 4.60±0 76 3.82±1.3 18.91±0.95 0.02±.00 3.17±0.3 9.64±0.9
0.45 5.15 3.08 1.26 2.82 8.58 4.06 73.47 33.61 0.99 2.56 33.01
0.98 0.024 0.025 0.088 0.021 0.0002 0.0098 0.03 0.0002 0.51 0.0048 0.0011
AppendixChapter7Tabl24Proliferativer sponsfca lBMCdu i gprimaryo linfecti nw h105 .gondiicysts
C44
Controls
watersolublefractionfS48T.g ndiiant g n
r x x <
-2 -1
0 2 5 7 9
12 14 16 19 21
Medium
DaysofinfectioncpmxlO'±sem 1.37+0 16
0.70±04 0.96±09 0.46±0.12 0.41±.025 0.35±07 1.81±0.37 0.41±04 3.92±3.18 2.28±0.46 0.32±06 0.65±0.12
Con-A5(ig/ml
4.07±0 39 5.31±0.59 7.85±0. 6.71±0.62 4.70±0 45 9.00± .57 5.92±0 45 7.71±0.5 7.83±0.68 15.34±0.56 1.81±0.21 12.88±0.64
2.98 7.58 8.16 14.58 2.00 6.73 5.71
0.003 0.0021 0.0004 0.001






5.06± . 1 5.03± .41 8.15±0. 8 2.03±0.5 3.71±0.32 14.40±0.38 16.02±0.68 14.96±.37 5.40±1 94 21.51±0.85 0.31±0.06 7.70±2 08
3.70 7.19 8.48 4.42 9.01 40.64 8.87 9.44 0.97 11.98
0.0045 0.0009 0.0006 0.026 0.001 0 0.0001
36.590.000 1.380 25 0.0001
0.55 0.021
6.25|i.g/ml
cpmxlO3±semSIPvalue 3.26±0. 7 3.87±0.38 7.71±0.9 1.43±0.34 3.86±0.23 11.74±0 4 13.94±0.5 15.13±.21 7.75±3.9 21.64±0.7 0.53±05 8.44±0 792.39 5.53 8.02 3.12 9.37 33.15 7.72 9.49 1.66













DaysofinfectioncpmxlO3±semxl 3 seSIPvaluecpmxlO3selcpmxlO3 mv lue -2 -1 0 2 5 7 9 12 14 16 19 210.11±0.04 0.04±2 1.48±1.12 0.08±2 0.18±0.01 0.13±0.03 0.18±0.011 0.09± .01 0.39±0. 0.38±0.04 0.08± .01 0.38±0.18.69±0 92 0.78±0.2 14.74±2 7.91±0.22 5.71±0.3 5.35±0.63 9.02±0 24 10.13±0.97 4.53±0.15 11,12±0.51 4.50±0.876.21 20.96 9.93 93.55 31.67 11.7 28.950.0013 0.013 0.0008 0 0.0002 40.560. 018 49.75 108.60. 009 0.0001 0.0001 59.050.0051 13.86±0.6636.280.0 016.95±1.8 0.04±2 8.03±1 36 1.73±0.51 1.42±0 18 2.63±0.11 8.63±0. 5 8.35±0.85 8.62±0. 6 13.49±0.4 0.89±0.2 18.33±.6260.89 1.14 5.42 20.47 7.88 22.29 35.10 11.74




5.52±1.8 0.04±.005 5.98±0.9 1.83±0.9 0.55±09 2.34±0.1 10.66±0.5 5.69±1.1 7.06±0 64 12.1±.7 1.27±0.5 14.75±2.1
48.40 1.10 4.03 21.64 3.07 17.75
0.027 0.25 0.0076 0.068 0.014 0.0001
58.830.0001 61.040.0069 18.250.0009 31.440.0033 16.680.046 38.630.0032











DaysofinfectioncpmxlO3±semcpmxlO3semSIPvaluecpmxlO3/'valuecpmxlO3semIvalu -2 -1 0 2 5 7 9 12 14 16 19 210.08±08 1.23±0.42 0.51±0.07 0.18±0.013 0.16±0.02 0.13±0.009 0.99±.2 0.28±03 0.17±.1 0.20±04 0.37±08 0.27±055.39±0. 566.70.0056 14.7±2.71.990.00 6 16.96±0.833 50.0 01 8.64±146.540.00 7 4.19±0.426.080.0 0 6.13±0.548.040.0 06 5.15±0.9230.0 67 7.97±1 5228.020.00 4 11.25±0.667 80.0 02 10.19±0.34 40. 07 3.26±08 79.0007 8.85±0.232.6300.44±0.1 4.56±0 48 3.18±0.7 1.16±0.2 0.28±05 0.56±0 6.70±0.9 2.44±0 25 8.74±1.35.500 019 3.72
0.003
6.300 033 6.270.0098 1.740 046 4.370.0024 6.800.0037 8.600.0064 52.240.0034
6.77±0.1422.60.0003 1.39±0.13 750.0 49 9.92±1.836.570.016
0.29±0.1 4.83±1.2 2.08±0 45 0.74±0.14 0.29±05 0.52±09 5.47±0.4 3.15±0.84 8.69±0.8 4.46±0.4 0.97±.2 2.44±0.6
3.63 3.94 4.13 3.96 I.81 4.11 5.56 II.06 51.96 14.95 2.60 9.00
0.068 0.028 0.02 0.016 0.043 0.0097 0.0006 0.021 0.0008 0.0009 0.025 0.022
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TOXOPLASMA GONDII INFECTION IN SHEEP AND
CATTLE
IRMA ESTEBAN-REDONDO* and ELISABETH A. 1NNES
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(Received for publication 16 July 1996)
Abstract—Toxoplasma gondii is a protozoan parasite that can infect all warm-blooded animals.
Sheep and cattle show different susceptibilities to T. gondii infection. Primary infection in pregnant
sheep can result in abortion or the birth of weak lambs but they are then protected against further
challenge by the development of an effective immunity. Cattle on the other hand can be readily
infected, but abortion or perinatal mortality have not been recorded. The evidence suggests that
cattle develop a more effective immune response to T. gondii infection than sheep. Potential
mechanisms to explain these differences are discussed in this paper. Published by Elsevier
Science Ltd
Key words: Toxoplasma gondii, sheep, cattle
Resume—Le Toxoplasma gondii est un protozoo parasite qui peut infecter tous les animaux de sang
chaude. Le mouton et les bovines sont differentment sousceptibles a l'infection pour T. gondii.
L'infection primaire chez le mouton pendant la periode de gestation peut provoquer l'abortement
ou la naissance du animaux faibles mais ils sont alors proteges contre une infection posterieur par
le developement d'une immunite effective. Bovines. par contre, peuvent etre vraiment infectes mais
ni l'abortement ni la mortalite perinatal ont ete decrites. L'evidence sugere que les bovines
developent une response immune plus effective contre le T. gondii que le mouton. Les posibles
mecanismes pour expliquer ces difference sont discutes dans ce article. Published by Elsevier
Science Ltd
Mots-clefs: Toxoplasma gondii, mouton, bovines
Toxoplasma gondii, a protozoan parasite, was described for the first time in 1908. While
the sexual life cycle of the parasite is confined to cats (the definitive host), the asexual cycle
can take place in all warm-blooded animals but causes disease only in certain species [1].
Cattle, like deer and horses, are susceptible to infection but resistant to disease induced
by T. gondii, whereas the parasite can cause a lethal infection in the developing fetus of
sheep. Toxoplasma also has been recognised as one of the most important opportunistic
pathogens in AIDS patients, in whom it can cause a severe, non-suppurative, necrotising
encephalitis.
Abortion and neonatal disease in sheep and humans result from primary infection
occurring during pregnancy [2], but immunity developed after such an episode will protect
the mother against subsequent challenge [3, 4]. Despite this immune response, the parasite
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The ingestion of meat containing viable T. gondii tissue cysts is an important source of
human infection [1], While the parasite has been isolated frequently from sheep meat, it
is not so readily isolated from cattle meat [5]. The reasons for this difference are unclear
and the objective of the work reported in this communication was to compare the course
of T. gondii infection in sheep and cattle.
Toxoplasma gondii: life cycle
Toxoplasma gondii is an obligate, intracellular, protozoan parasite, with a sexual life
cycle confined to the enteroepithelium of Felidae, resulting in the production of oocysts
(Fig. 1). The asexual cycle, with little host specificity, comprises two developmental stages,
rapidly dividing tachyzoites and slowly multiplying bradyzoites [1], Tachyzoites actively
penetrate host cells and are surrounded by a parasitophorous vacuole in which they
multiply by endodyogeny before breaking out to infect other cells. The process continues
until the host develops immunity to the parasite [6]. Normally, a persistent infection is
established, extracellular parasites are eliminated, intracellular multiplication slows down
and the parasite remains in the host as bradyzoites contained within tissue cysts. These
are most frequently detected in brain, heart and skeletal muscle. The host remains
persistently infected but immune to further challenge by the parasite [1].
The sexual cycle is initiated when a cat ingests Toxoplasma tissue cysts for the first time to
release bradyzoites in the small intestine. These penetrate the gut epithelial cells and undergo
merogony before gametogeny commences. The development and subsequent fusing of
microgametes with macrogametes results in the formation of oocysts, which are usually
excreted in the faeces between the fourth and tenth days. After sporulation outside the host,
oocysts become infectious and may remain so for many months in the environment [1],
Clinical toxoplasmosis
Sheep. Toxoplasmosis has been recognised as a major cause of abortion in sheep since
1951, when T. gondii-like structures were described in placentas and aborted fetuses in New
Zealand [7]. Abortions may occur in ewes of all ages when infection is acquired for the
first time during pregnancy. Subsequently, ewes remain infected for life but will not abort
from this cause again [4],
The modes of transmission of T. gondii to herbivores are either transplacental or by
ingestion of fodder or concentrate rations contaminated with oocysts. The oocysts, after
asexual cycle sexual cycle
all warm blooded animals
bradyzoites in tissue cysts ingestion intestinal infection
tachvzoites ingestion oocysts in faeces
v—
Fig. i. Life cycle of Toxoplasma gondii.
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excysting in the small intestine, release sporozoites, which reach the mesenteric lymph node
within 4 days of infection [8], Experiments suggest that the tachyzoites become widely
disseminated during the parasitaemia that occurs between the fifth and the twelfth days
of infection [9, 10]. This is followed by the onset of a protective immune response, although
the organism then persists as bradyzoites within tissue cysts in a variety of organs [11],
Infection is generally unapparent, although fever may be detected in the initial days.
However, if established for the first time during pregnancy, a progressive infection may
establish in the gravid uterus [11], In these circumstances, tachyzoites invade the caruncular
septa, the maternal tissue of the placentome, and then invade the placental villi and the
fetus [12], The ability of the fetal immune system to respond to T. gondii develops
progressively after 70 days of gestation, so that infection before this age results in rapid
fetal death with resorption, mummification, maceration or abortion of the fetus. Infection
later in pregnancy may be less damaging and result in stillborn or weak lambs, or even
clinically normal lambs that are infected and immune to natural challenge [12]. Stillborn
or weak lambs usually have brain damage such as focal leukomalacia and a characteristic
non-suppurative meningo-encephalitis [13]. Lambs that survive the first few days of life
generally grow normally to adulthood without neurological defect [11].
Cattle. In 1953, what was thought to be clinical toxoplasmosis in cattle was reported
for the first time in the United States. The clinical features and demonstration of T.
gondii-like structures were reported in four separate herds, in which some of the adult cattle
died but greater losses occurred in young animals. Parasites were demonstrated in tissue
sections from calves and cows. The surviving animals had a positive reaction to the
intradermal toxoplasmin test and respiratory and central nervous system symptoms were
described [14]. These findings have been challenged since further examinations of the
tissues failed to reveal T. gondii or related protozoan parasites [15]. Other studies of natural
and experimental toxoplasmosis in cattle carried out since 1953 have shown that
toxoplasmosis does not appear to cause abortion or neonatal mortality in cattle under
natural conditions [15, 17], However, in several cases the parasite has been isolated in mice
inoculated with pooled homogenates of tissues from cattle with suspected infection, and
from colostrum or unpasteurised milk, indicating that beef and milk cannot be ruled out
as potential reservoirs of infection in the epidemiology of the disease [15], Pregnant cattle
inoculated with T. gondii oocysts or tissue cysts developed transient fever and anorexia
and gave birth to healthy calves. In this case the parasite was not isolated from the tissues
of the newborn calves or placentas [16]. However, after experimental infection of four
calves with T. gondii tachyzoites, two had lesions in the central nervous system when
examined within ten days after infection and the parasite was isolated from several of their
tissues [17]. Other groups have studied toxoplasmosis in cattle by the administration of
tachyzoites, tissue cysts or oocysts of the parasite by several routes (orally, parenterally,
intra-amniotically or intra-ruminally). In general, animals developed a febrile response and
loss of appetite. Some had diarrhoea and respiratory distress, but recovered within 3 weeks.
In only four of eight calves orally inoculated with oocysts was T. gondii subsequently found
in the mesenteric lymph nodes 3 and 6 days later [15].
Humoral response
In sheep, the serological diagnosis of the infection is conventionally made by an
immunofluorescence antibody test (IFAT) and enzyme-linked immunosorbent assay
(ELISA). In this species, following both experimental and natural infection with T. gondii,
194 Irma Esteban-Redondo and Elisabeth A. Innes
specific antibody titres rise 2-3 weeks after infection and remain elevated for several
years [18]. IgM is more readily detected during the first month, with IgG becoming the
predominant immunoglobulin subclass during the second month of infection; reinfection
does not elicit an increase in antibody titre [4, 18]. Seroprevalence in sheep increases with
age, reflecting increased exposure to the parasite over time[l].
In cattle, serum antibodies to T. gondii have been found world-wide, although the actual
prevalence rates are difficult to ascertain [1], The Sabin-Feldman dye test (DT) is probably
not suitable for use in cattle as it may give a false-positive reaction owing to a naturally
occurring globulin, thought to be IgM. This globulin can be partially inactivated by
heating the sera to 6CFC for 60 min [19]. Furthermore, in experimentally infected cattle,
DT titres increase briefly during the first month after inoculation before returning to
baseline levels. By comparison, the modified agglutination test (MAT) titres for the same
samples increased dramatically during the first 4 weeks and persisted for several months.
In this context it may be relevant that live tachyzoites are used in the DT, whereas the
MAT relies on dead organisms [19].
In cattle there is also an age effect in antibody development, with calves producing higher
and longer lasting antibody titres than adult cattle, following experimental challenge with
the same dose of T. gondii [15, 19]. Under natural conditions it has been shown that sheep
grazing on a pasture alongside cattle developed significant antibody titres to T. gondii, as
measured by IFAT, while none of the calves became seropositive [20]. In addition, a study
of seroprevalence in cattle in Montana, U.S.A., showed that most naturally infected
animals had only low titres of antibody to T. gondii [1], Thus, sheep and cattle appear to
differ in their susceptibility and humoral responses to the parasite.
It is concluded that the differences in humoral responses to T. gondii between sheep and
cattle as measured by IFAT are real, as this test has been shown to be appropriate for
use in both species [21].
Cell-mediated immunity
As T. gondii is an intracellular parasite, cell-mediated immunity (CMI) would be
expected to play a major role in host defence. In sheep, the incomplete S48 strain of T.
gondii, which lacks the ability to produce tissue cysts (and therefore to establish persistent
infection), has been used in experimental infections [22], Following subcutaneous
inoculation of naive sheep with S48 tachyzoites, phenotypic analysis of lymphoblasts in
the efferent lymph showed that the cells responding to infection were mainly T-cells.
Initially those with a CD4 + phenotype were more numerous than CD8 + cells but
around the ninth or tenth day after infection the latter became predominant. The
disappearance of the parasite from the lymph also occurred at this time [23]. Interferon
gamma (IFN-y) was detected in cell-free lymph supernatant from the third to the tenth
day after primary infection but appeared in lymph as early as 24 h after secondary-
challenge [24]. Both CD4 + and CDS + T-cell subsets have the potential to produce
IFN-y after appropriate stimulation [25, 26], but the source of IFN-y in the sheep following
T. gondii infection is not yet known. These observations suggest that a T-cell response
combined with IFN-y production plays a major role in immunity to T. gondii infection
in sheep. These in vivo observations are further supported by in vitro studies, which have
shown that recombinant ovine IFN-y will inhibit the growth of T. gondii in ovine cells [27],
Studies of CMI in cattle in response to T. gondii infection have not been published,
however, in view of the perceived importance of CD4 + and CDS + cells and IFN-y in
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ovine immunity to the parasite, it would be of value to make comparative studies in cattle
and combine those results with investigations of the humoral responses in both species.
Tissue cyst development
Toxoplasma gondii tissue cysts have been isolated frequently from the tissues of naturally
and experimentally infected sheep [1], Viable parasites have been detected by inoculation
of mice or cats with soft tissues such as brain, skeletal muscle, small intestine, liver and
diaphragm. However, the brain is the most heavily infected tissue in aborted fetuses or
live lambs born to infected ewes and should be the organ of choice for isolating T. gondii
for diagnostic purposes [28].
The parasite has been isolated only rarely from naturally infected bovine tissues
although there have been occasional reports from Japan, Czechoslovakia, Italy and
Argentina of successful isolations [15]. The parasite has been recovered from the intestinal
wall of a naturally infected adult cow [5] and a recent report has stated that T. gondii can
remain viable in tissues of experimentally infected cattle for more than 3 years [29], The
most sensitive method of isolating T. gondii from infected cattle is by feeding cats with
tissues and subsequently demonstrating oocysts in the faeces of the latter. The tissues to
be examined in this way should include the heart, tongue, intestines, liver [29] and brain
(unpublished data).
In an attempt to study the distribution of T. gondii cysts in cattle tissues, Dubey dosed
calves orally with 100 000 oocysts of the GT-1 strain of T. gondii [30], Samples of small
intestine, mesenteric lymph nodes, lung and liver of infected calves were sampled after 3,
6, 8, 11 and 14 days and fed to mice to determine the prevalence of the parasite in the
tissues. It was found that T. gondii was present in the small intestine and mesenteric lymph
nodes on all the days tested. It was not detected in liver on day 8 and lung on days 8 and
11 but was recovered from both tissues at all the other times points tested. The number
of recovered live organisms diminished rapidly within the first week after inoculation and
the parasite was recovered more frequently from liver than from muscle, and not at all
from blood or retina.
CONCLUSION
Toxoplasma gondii infection affects all warm-blooded animals with a wide species
variation in the disease it causes. The outcome of a primary infection in pregnant sheep
may result in abortion or neonatal infection, while in cattle the parasite is eliminated
quickly from the tissues and clinical abortion has not been reported.
The factors that confer this natural resistance or susceptibility to toxoplasmosis are not
yet known. Comparative studies on T. gondii infection in sheep and cattle may offer a
valuable insight into the development of protective immunity to the parasite.
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